[
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT: tysabri- natalizumab. Comments on DMT: Avonex - Rebif - Gilenya. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 117.7 sec. SDMT done. SDMT numerator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.1 sec. 9-hole peg non-dominant:30.87 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 21, 2018. Vit D at visit: 61.47. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 02, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.25 sec. SDMT done. SDMT numerator: 71. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:15.74 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:80.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Bronchitis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Tendinitis. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 01, 2015. Comments on DMT: Endoxan. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 165 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 32. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:33 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2018. Vit D at visit: 65.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.8 sec. 9-hole peg non-dominant:15.7 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:spms. MRI of brain or spine done. Cervical spine MRI date: August 22, 2014. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2016. Comments on DMT: Rebif nutil May 2016, d\/C due to relapse. Vit D at visit: 68.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: June 20, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.47 sec. 9-hole peg non-dominant:18.97 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on August 01, 2015. Comments on DMT: Rebif. Vit D at visit: 14.1. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 24. SDMT denominator: 27. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.3 sec. 9-hole peg non-dominant:22.04 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. New DMT:Discontinue Aubagio. The patient is in NEDA. Will the patient be in NEDA or EDA after 36 months?",
        "output":"After 36 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.83. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. Vit D at visit: 32.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:24.21 sec. 9-hole peg non-dominant:20.47 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.488. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2021. Comments on DMT: None . The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on February 01, 2018. Comments on DMT: Aubagio, Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 03, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.55 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.22 sec. 9-hole peg non-dominant:35.73 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.682. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:rosacea . Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 01, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.5 sec. 9-hole peg non-dominant:16.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.69. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on June 01, 2016. Vit D at visit: 44.4. MRI of brain or spine done. No new lesions on Brain MRI. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:0.77. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:carotid stenosis. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2018. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 06, 2018. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 11.3 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.4 sec. 9-hole peg non-dominant:23.8 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Total relapses until visit: 2. There were new relapses since the previous visit. MRI of brain or spine done. Received Gadolinium for Brain MRI. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:22.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.11. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 24, 2022. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:21 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:ocrevus - ocrelizumab on December 01, 2019. Comments on DMT: Tecfidera, Gilenya. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.63 sec. 9-hole peg non-dominant:31.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.79. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: June 05, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 1. The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.91 sec. 9-hole peg non-dominant:25.33 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.78. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Vit D at visit: 29.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 01, 2022. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.5 sec. 9-hole peg non-dominant:22.16 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:ocrevus - ocrelizumab on December 01, 2019. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 33. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.9 sec. 9-hole peg non-dominant:25 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. More information on co-morbidity:herpes zoster ophthalmicus. Outcome:completely recovered from illness. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:endoxan- cyclophosphamide on May 02, 2014. Comments on DMT: avonex, rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 10.9 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. Total relapses until visit: 23. DMT taken. Current DMT:mabthera- rituximab on July 01, 2018. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 01, 2020. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 36 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.4 sec. 9-hole peg non-dominant:26.1 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:negative. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:tension headache. Outcome:completely recovered from illness. Name of co-morbidity:elevated LFTs. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 26, 2019. Tobacco smoker: non-smoker  Vit D at visit: 10.5. MRI of brain or spine done. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Name of co-morbidity:Anxiety. Visit diagnosis:spms. Total relapses until visit: 13. DMT taken. Current DMT:mabthera- rituximab on June 01, 2016. Comments on DMT: off since August 2020 . Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 11.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:19.2 sec. 9-hole peg non-dominant:19.3 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on May 11, 2016. Comments on DMT: Avonex, Betaferon. Tobacco smoker: non-smoker  Vit D at visit: 8.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 24, 2017. Cervical spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 5.01 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.47 sec. 9-hole peg non-dominant:24.16 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, bowel\/bladder dysfunction. IgG index in CSF:1.6. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. Comments on DMT: Rebif . MRI of brain or spine done. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 65 sec. SDMT done. SDMT numerator: 24. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:96.3 sec. 9-hole peg non-dominant:60.3 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Blood and lymphatic disorders. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2015. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 39.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: October 31, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.74 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.95 sec. 9-hole peg non-dominant:18.85 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: June 22, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:negative. Visit diagnosis:rrms. Vit D at visit: 18.5. The 25-foot walk done. 25-foot walk test time was 6.49 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:80.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Bronchitis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Tendinitis. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 26, 2015. Comments on DMT: endoxan. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 20.66 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.37 sec. 9-hole peg non-dominant:27.86 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on June 01, 2018. Vit D at visit: 28.4. The 25-foot walk done. 25-foot walk test time was 7.5 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27023 sec. 9-hole peg non-dominant:21.34 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on September 01, 2021. Comments on DMT: Avonex, Rebif, Gilenya, Siponimod. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Cervical spine MRI date: September 01, 2021. The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:32 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:5. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2014. Comments on DMT: rebif betaferon. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 59.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Cervical spine MRI date: February 17, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.5 sec. 9-hole peg non-dominant:20.16 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on March 01, 2019. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. Comments on DMT: AVONEX, REBIF, GILENYA. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 7. Vit D at visit: 50.8. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.8 sec. 9-hole peg non-dominant:18.7 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. Comments on DMT: ATAMS trial - Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 9. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 11.9 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:23 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 52 months?",
        "output":"After 52 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:completely recovered from illness. Name of co-morbidity:Left breast cancer s\/p mastectomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 12, 2016. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 4.32 sec. SDMT done. SDMT numerator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:20.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2016. Comments on DMT: Betaferon. MRI of brain or spine done. Cervical spine MRI date: February 16, 2019. The 25-foot walk done. 25-foot walk test time was 3.87 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.7 sec. 9-hole peg non-dominant:20.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.88. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on January 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.05 sec. 9-hole peg non-dominant:18.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 05, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.31 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.05 sec. 9-hole peg non-dominant:17.05 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2017. Comments on DMT: Rebif, Tecfidera. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. The 25-foot walk done. 25-foot walk test time was 3.79 sec. SDMT done. SDMT numerator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.7 sec. 9-hole peg non-dominant:18.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:gastric sleeve. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on February 08, 2019. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.5 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:1.29. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on December 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Has experienced progressive symptoms since onset. Name of co-morbidity:Spinal cord compression. Outcome:ongoing illness. Visit diagnosis:ppms. Total relapses until visit: 0. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.4 sec. 9-hole peg non-dominant:27 sec. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS . Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: Plegridy, Tecfidera. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.5 sec. 9-hole peg non-dominant:19 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:0.81. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on March 01, 2021. Tobacco smoker: ex-smoker  The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.75. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on January 17, 2019. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2013. Comments on DMT: Avonex March 2013 until Oct 2013. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: twice\/week. Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 4.31 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.59 sec. 9-hole peg non-dominant:21.41 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2013. Tobacco smoker: non-smoker  Vit D at visit: 56.0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.84 sec. 9-hole peg non-dominant:20.94 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 4. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 02, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. SDMT done. SDMT numerator: 56. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.8 sec. 9-hole peg non-dominant:17.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:2.43. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2011. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 cigarette daily. Coffee cups per week: 14. The 25-foot walk done. 25-foot walk test time was 7.13 sec. SDMT done. SDMT numerator: 16. SDMT denominator: 16. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.17 sec. 9-hole peg non-dominant:29.1 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 20 months?",
        "output":"After 20 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:ocrevus - ocrelizumab on December 01, 2019. Tobacco smoker: ex-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 17.9 sec. SDMT done. SDMT numerator: 28. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:50 sec. 9-hole peg non-dominant:28 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:74.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hashimoto thyroiditis. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:arthritis. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:decompression of spondylolisthesis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:right tronchanteric bursitis. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:total hip replacement. Outcome:completely recovered from illness. Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2007. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: No lesions. Cervical spine MRI date: February 03, 2010. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 94 months?",
        "output":"After 94 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:90.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Hysterectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:bilateral cataract surgery. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:PTCA stenting. Outcome:completely recovered from illness. Name of co-morbidity:Posterior capsular opasification of lens bilaterally. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:chronic nausea. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 16.34 sec. SDMT done. SDMT numerator: 25. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:36 sec. 9-hole peg non-dominant:29 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. IgG index in CSF:0.87. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.76. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2016. Tobacco smoker: current  Tobacco type: hubble bubble. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:19.27 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, bowel\/bladder dysfunction. IgG index in CSF:1.6. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. Comments on DMT: Rebif - Biotin. The 25-foot walk done. 25-foot walk test time was 60.09 sec. SDMT done. SDMT numerator: 31. 9-HPT done. 9-HPT ability: unable with both hands. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2016. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2016. MRI of brain or spine done. Cervical spine MRI date: April 10, 2017. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Renal disorders. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on October 15, 2021. Comments on DMT: Avonex, Gilenya, Tysabri. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on June 01, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 35. Alcohol drinsk per week: 1. Exercise hrs per week:3. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:17 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:gastric sleeve. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.3 sec. 9-hole peg non-dominant:22.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:avonex or cinnovex- im interferon on May 01, 2011. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 26, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.5 sec. 9-hole peg non-dominant:21.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 43 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:63 sec. 9-hole peg non-dominant:64 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:8. Visit diagnosis:spms. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on July 01, 2018. Comments on DMT: Betaferon. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 01, 2018. Cervical spine MRI: Not compared to previous spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 2. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 6.7 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.3 sec. 9-hole peg non-dominant:27.2 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.77. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on May 17, 2021. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2017. Tobacco smoker: non-smoker  Coffee cups per week: 7. Alcohol drinsk per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 09, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:19.9 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, optic neuritis, brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2017. Comments on DMT: rebif. Vit D at visit: 67.0. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15.3 sec. 9-hole peg non-dominant:16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.45. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Nasopharyngeal carcinoma. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on October 01, 2009. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 5. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: February 10, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.78 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.12 sec. 9-hole peg non-dominant:16.12 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on October 01, 2019. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:19.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.98. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Endometriosis. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on August 25, 2014. Comments on DMT: Betaferon. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 07, 2019. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.7 sec. 9-hole peg non-dominant:19.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Asthma. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on June 01, 2020. Comments on DMT: Rebif, Tysabri. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:17.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1.5ppd. Coffee cups per week: 35. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.8 sec. 9-hole peg non-dominant:19.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on July 05, 2022. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 2.6 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.53 sec. 9-hole peg non-dominant:19.7 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:disc disease. Outcome:ongoing illness. Visit diagnosis:ppms. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 7.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 21, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 8.1 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.4 sec. 9-hole peg non-dominant:22.7 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. Vit D at visit: 91.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 14, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.26 sec. SDMT done. SDMT numerator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:21.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:ris. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar, slurred speech. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.08. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 39 months?",
        "output":"After 39 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2017. Comments on DMT: rebif, gilenya. MRI of brain or spine done. No new lesions on Brain MRI. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on September 11, 2019. Comments on DMT: Avonex, Rebif, Gilenya. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 20.5 sec. SDMT done. SDMT numerator: 19. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32 sec. 9-hole peg non-dominant:56 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:negative. IgG index in second:0.46. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:anterior uveitis. Outcome:completely recovered from illness. Name of co-morbidity:iridocorneal adhesions. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Name of co-morbidity:Sciatica. Outcome:ongoing illness. Name of co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:prolactinemia 2ry to Tegretol. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Klebsiella pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:tysabri- natalizumab on September 22, 2015. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 58.8. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.54 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.67 sec. 9-hole peg non-dominant:21.09 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:5. Visit diagnosis:spms. DMT taken. Current DMT:imuran-azathioprine on February 01, 2016. Comments on DMT: Avonex - Rebif. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 16.5 sec. SDMT done. SDMT numerator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:20.4 sec. 9-hole peg non-dominant:22.7 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.804. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:low back pain. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on November 30, 2017. Comments on DMT: rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 03, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 33. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.31 sec. 9-hole peg non-dominant:21.15 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 18, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: May 09, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on September 01, 2017. Comments on DMT: rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 59.0. The 25-foot walk done. 25-foot walk test time was 3.46 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:19.44 sec. 9-hole peg non-dominant:2016 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Hidradenitis Suppurutiva. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. Comments on DMT: Cellcept - Avonex -  Tysabri, Cycophosphamide. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 31. SDMT denominator: 31. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:90 sec. EDSS:7.5- unable to take more than a few steps; restricted to wheelchair; may need some help in transferring and in wheeling self. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2018. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.7 sec. 9-hole peg non-dominant:17.94 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hepatic disorders. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. Vit D at visit: 42.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.53 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.62 sec. 9-hole peg non-dominant:20.71 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.89. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2019. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:18.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. Total relapses until visit: 1. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5.4 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:67 sec. 9-hole peg non-dominant:18.28 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on April 01, 2013. Comments on DMT: Avonex, Imuran. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:17.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 29 months?",
        "output":"After 29 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Surgeries. More information on co-morbidity:oophorectomy for ovrian teratoma. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2017. MRI of brain or spine done. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Visit diagnosis:ppms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on September 01, 2018. Comments on DMT: Rebif. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 38 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:42.72 sec. 9-hole peg non-dominant:23.22 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2014. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.71 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.25 sec. 9-hole peg non-dominant:27.51 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Remarks about CSF: but the results of the LP were not known. Name of co-morbidity:Epilepsy . Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2017. Comments on DMT: Tecfidera. Vit D at visit: 67.2. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27 sec. 9-hole peg non-dominant:25 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2016. Vit D at visit: 61.8. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Cervical spine MRI date: November 24, 2017. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 80. SDMT denominator: 81. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18.9 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2017. Comments on DMT: Cellcept. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:18 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:75.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:negative. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:ppms. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 45.47 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.4 sec. 9-hole peg non-dominant:32.2 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 26 months?",
        "output":"After 26 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:rrms. Comments on DMT: Avonex. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 14. SDMT denominator: 14. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:44 sec. 9-hole peg non-dominant:49 sec. EDSS:7.5- unable to take more than a few steps; restricted to wheelchair; may need some help in transferring and in wheeling self. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2004. The 25-foot walk done. 25-foot walk test time was 5.3 sec. SDMT done. SDMT numerator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.78 sec. 9-hole peg non-dominant:20.1 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT: cellcept or imuxigen- mycophenolate. Comments on DMT: Betaferon - Mabthera - Monthly steroids. The 25-foot walk done. 25-foot walk test time was 11.7 sec. SDMT done. SDMT numerator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.16 sec. 9-hole peg non-dominant:23.71 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 23, 2002. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 ppd. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on October 01, 2015. Comments on DMT: Cinnovex, Gilenya, Rebif, Tysabri. Vit D at visit: 18.0. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.9 sec. 9-hole peg non-dominant:28.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 71. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:18.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:demyelinating disease: rrms vs nmosd. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.87. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:recurrent myelitis. Total relapses until visit: 2. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.32 sec. 9-hole peg non-dominant:17 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.81. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Name of co-morbidity:Asthma. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on July 01, 2018. Comments on DMT: Aubagio. Tobacco smoker: non-smoker  Vit D at visit: 82.0. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.44 sec. 9-hole peg non-dominant:22.42 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:72.  Gender:male.  Diagnosis:mog. Has not converted to SPMS. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:mog. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on May 01, 2018. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.4 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2019. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 5.85 sec. SDMT done. SDMT numerator: 16. SDMT denominator: 16. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:33.53 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mavenclad- Cladribine. The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:GERD. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia minor. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2014. Comments on DMT: Avonex Sep 2009-July 2014. Tobacco smoker: non-smoker  Coffee cups per week: 21. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 25, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.28 sec. SDMT done. SDMT numerator: 87. SDMT denominator: 87. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:13.45 sec. 9-hole peg non-dominant:17.34 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:5. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:endoxan- cyclophosphamide on October 22, 2013. Comments on DMT: Betaferon, Avonex, Rebif. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 8.32 sec. SDMT done. SDMT numerator: 23. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.4 sec. 9-hole peg non-dominant:36 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on November 01, 2022. The 25-foot walk done. SDMT done. SDMT numerator: 43. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:22 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.682. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:rosacea . Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 11, 2019. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2008. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 56 months?",
        "output":"After 56 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on November 01, 2014. The 25-foot walk done. 25-foot walk test time was 15.2 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.864. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Essential tremor. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2015. Comments on DMT: Avonex. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.11 sec. 9-hole peg non-dominant:20.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 PPD. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 9. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.8 sec. 9-hole peg non-dominant:18.7 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2016. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Vit D at visit: 36.8. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.66 sec. 9-hole peg non-dominant:19.21 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on May 01, 2017. SDMT done. SDMT numerator: 41. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right. EDSS:7.5- unable to take more than a few steps; restricted to wheelchair; may need some help in transferring and in wheeling self. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:positive. IgG index in CSF:999. Name of co-morbidity:Anxiety. More information on co-morbidity:Panic attacks. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2022. Vit D at visit: 42.0. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 01, 2023. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.8. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2013. Comments on DMT: Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: September 19, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:24.7 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.77. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 10, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 2. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.81 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.95 sec. 9-hole peg non-dominant:15.53 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2012. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 69.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 09, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.27 sec. 9-hole peg non-dominant:21.6 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 21 months?",
        "output":"After 21 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:76.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Disk surgery. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Right ear congenital hearing loss. Outcome:ongoing illness. Name of co-morbidity:Tooth abscess + extraction. Outcome:completely recovered from illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total Left hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2009. Comments on DMT: atoricept trial. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on September 09, 2019. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.28 sec. 9-hole peg non-dominant:18.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.95. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on August 01, 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 19, 2012. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 5.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.9 sec. 9-hole peg non-dominant:25.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on July 01, 2017. Comments on DMT: betaferon, gilenya, tysabri. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 57.9. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: December 01, 2019. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2012. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.79 sec. 9-hole peg non-dominant:20.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Anterior Uveitis. Name of co-morbidity:Migraine. Name of co-morbidity:Depression. Visit diagnosis:rrms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on April 01, 2011. Comments on DMT: Rebid Avonex. Vit D at visit: 70.0. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2013. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 46.0. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.8 sec. 9-hole peg non-dominant:16.9 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:ocrevus - ocrelizumab on December 01, 2019. Comments on DMT: Tecfidera, Gilenya. Tobacco smoker: non-smoker  Exercise hrs per week:2. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.5 sec. 9-hole peg non-dominant:28.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on December 01, 2014. Comments on DMT: Rebif. MRI of brain or spine done. Cervical spine MRI date: July 29, 2016. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on September 01, 2017. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 38.5. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 32. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.8 sec. 9-hole peg non-dominant:16.96 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:80.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Bronchitis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Tendinitis. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 26, 2015. Comments on DMT: Endoxan (Cyclophosphamide). Tobacco smoker: non-smoker  Vit D at visit: 100.0. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 1.4 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30 sec. 9-hole peg non-dominant:28 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Visit diagnosis:rrms. Total relapses until visit: 8. Comments on DMT: Mabthera. MRI of brain or spine done. Cervical spine MRI date: July 24, 2020. Cervical spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 5.9 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:30 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, incidental mri findings. OCBs in CSF:negative. IgG index in CSF:999. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: Avonex 30 mcg IM once weekly (June 2007-June 2017, was never compliant). Tobacco smoker: non-smoker  Vit D at visit: 41.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: March 13, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 5.4 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.51 sec. 9-hole peg non-dominant:21.27 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in NEDA. Will the patient be in NEDA or EDA after 26 months?",
        "output":"After 26 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Psychiatric disorders. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 30, 2016. Comments on DMT: Tecfidera (Jan 2015-May 2015\/0 Avonex (July 2015-Aug 2016). The 25-foot walk done. 25-foot walk test time was 5.19 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Avonex or Cinnovex- IM Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: mabthera- rituximab. Comments on DMT: Rebif. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.39 sec. 9-hole peg non-dominant:43.53 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:positive. IgG index in CSF:0.69. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on May 28, 2019. Tobacco smoker: ex-smoker  Vit D at visit: 56.7. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.48 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.5 sec. 9-hole peg non-dominant:19.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2009. MRI of brain or spine done. Cervical spine MRI date: September 21, 2012. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Exercise hrs per week:14. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 26. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2014. Comments on DMT: Rebif - Avonex - Imuran. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 13, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 13.72 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.51 sec. 9-hole peg non-dominant:25.14 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:74.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Transurethra resenction of bladder tumor. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Right double J insertion and laser stone fragmentation. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Colonic polyps and diverticula. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on January 06, 2016. Comments on DMT: Avonex. Vit D at visit: 19.5. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2014. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1ppd. Coffee cups per week: 21. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 06, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 74. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.17 sec. 9-hole peg non-dominant:18.11 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.3. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2014. Tobacco smoker: non-smoker  Vit D at visit: 38.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 01, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.55 sec. 9-hole peg non-dominant:20.84 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.82. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:hearing problem. Name of co-morbidity:thrombocytopenia medication induced. Outcome:ongoing illness. Visit diagnosis:ppms. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 18, 2007. The patient is in EDA. Will the patient be in NEDA or EDA after 36 months?",
        "output":"After 36 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Has experienced progressive symptoms since onset. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2018. Vit D at visit: 31.3. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 01, 2018. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.42 sec. 9-hole peg non-dominant:16.74 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 41 months?",
        "output":"After 41 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2017. Tobacco smoker: non-smoker  EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:pregnancy plans. The patient is in NEDA. Will the patient be in NEDA or EDA after 30 months?",
        "output":"After 30 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:65.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: Avonex, Rituximab. Tobacco smoker: non-smoker  Exercise hrs per week:2. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 53 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:23.4 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Solumedrol- IV Methylprednisolone. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 25 months?",
        "output":"After 25 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.77. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on May 12, 2022. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Coffee cups per week: 56. Exercise hrs per week:6. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 23, 2022. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.9 sec. 9-hole peg non-dominant:20.2 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:4. OCBs in CSF:negative. IgG index in CSF:1.047. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on August 01, 2018. Comments on DMT: Avonex, Gilenya, Tysabri. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:15.46 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:67.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis, sarcoidosis. OCBs in CSF:negative. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 3. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on February 01, 2011. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 13, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.22. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 07, 2016. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. Total relapses until visit: 0. The 25-foot walk done. 25-foot walk test time was 4.31 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:39.2 sec. 9-hole peg non-dominant:19.3 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Biotin . The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on July 01, 2018. Tobacco smoker: ex-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Has experienced progressive symptoms since onset. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. The 25-foot walk done. 25-foot walk test time was 11.7 sec. SDMT done. SDMT numerator: 22. SDMT denominator: 22. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.74 sec. 9-hole peg non-dominant:45.53 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tysabri- Natalizumab. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, optic neuritis, brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on June 07, 2016. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:65 sec. 9-hole peg non-dominant:21 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 28 months?",
        "output":"After 28 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:4. OCBs in CSF:negative. IgG index in CSF:1.047. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on February 01, 2016. Comments on DMT: Avonex 2013 (5 months), Gilenya Dec 2013-Feb 2016. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 49.7. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 19, 2016. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.7 sec. 9-hole peg non-dominant:19.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT: tecfidera-dimethylfumarate. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: November 27, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.62 sec. 9-hole peg non-dominant:20.16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.607. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on April 01, 2022. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on August 01, 2016. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. Exercise hrs per week:2. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:36 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Stop DMT and watchfull waiting . The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2017. Tobacco smoker: ex-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 84. SDMT denominator: 84. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.4 sec. 9-hole peg non-dominant:13.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on December 28, 2015. Comments on DMT: betaferon. Tobacco smoker: ex-smoker  Vit D at visit: 59.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 09, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. Assistance required for 25-foot walk test: Unilateral assistance by a person. 25-foot walk test time was 8.57 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.97 sec. 9-hole peg non-dominant:29.28 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on November 30, 2012. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 60.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 71. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:21 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on June 01, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 1. Exercise hrs per week:5. Vit D at visit: 37.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: February 12, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 91. SDMT denominator: 91. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Sclemod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.82. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2015. Vit D at visit: 69.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:18.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:4. OCBs in CSF:negative. IgG index in CSF:1.047. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on February 01, 2016. Comments on DMT: Avonex. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: November 01, 2017. The 25-foot walk done. 25-foot walk test time was 3.65 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.47 sec. 9-hole peg non-dominant:17.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:66.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Familial tremor. Outcome:ongoing illness. Name of co-morbidity:OCD. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 03, 2017. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 210. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 13, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.42 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.56 sec. 9-hole peg non-dominant:24.22 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.034. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2020. Tobacco smoker: ex-smoker  9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.9 sec. 9-hole peg non-dominant:52 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.49. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:HEPATITIS C infection. Outcome:ongoing illness. Visit diagnosis:nmo. Total relapses until visit: 3. Comments on DMT: Immuran. Anti-MOG Abs seropositivity: Pending results. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Cervical spine MRI date: March 30, 2016. Received Gadolinium for Cervical spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:mavenclad- cladribine on August 01, 2010. Comments on DMT: None (Cladribine was part of a trial). MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. The patient is in EDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2017. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 12. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: June 19, 2019. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 1. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:5. OCBs in second CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2014. Comments on DMT: Avonex, betaferon. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.24 sec. 9-hole peg non-dominant:19.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT: cellcept or imuxigen- mycophenolate. Comments on DMT: Betaferon - Mabthera - Monthly steroids. MRI of brain or spine done. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 11.5 sec. SDMT done. SDMT numerator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.6 sec. 9-hole peg non-dominant:22.4 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:74.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on April 09, 2013. Comments on DMT: Avonex - Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 2ppd. Vit D at visit: 24.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 14.3 sec. SDMT done. SDMT numerator: 10. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.4 sec. 9-hole peg non-dominant:24.3 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:5. OCBs in CSF:positive. Visit diagnosis:spms. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 63 sec. SDMT done. SDMT numerator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.66 sec. 9-hole peg non-dominant:30.58 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 20 months?",
        "output":"After 20 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on May 01, 2013. Comments on DMT: Cellcept July 2012-Oct 2012. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 40.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 30, 2013. The 25-foot walk done. 25-foot walk test time was 5.4 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31 sec. 9-hole peg non-dominant:27 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 7. Alcohol drinsk per week: 2. Exercise hrs per week:6. Vit D at visit: 44.3. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27 sec. 9-hole peg non-dominant:30 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.96. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT: tecfidera-dimethylfumarate. Comments on DMT: aubagio. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 4.51 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:21.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.51. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2018. Tobacco smoker: non-smoker  Coffee cups per week: 21. Alcohol drinsk per week: 1. Exercise hrs per week:6. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.4 sec. 9-hole peg non-dominant:16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Visit diagnosis:rrms. Vit D at visit: 38.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 31, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.39 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.63 sec. 9-hole peg non-dominant:16.97 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2018. Tobacco smoker: non-smoker  Vit D at visit: 55.6. The 25-foot walk done. 25-foot walk test time was 3.43 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14 sec. 9-hole peg non-dominant:15.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 6.74 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.07 sec. 9-hole peg non-dominant:19.91 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. OCBs in CSF:negative. Name of co-morbidity:Anemia. More information on co-morbidity:Normocytic anemia- Thallasemia ?. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on February 03, 2020. Comments on DMT: Tecfidera. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: May 09, 2020. Thoracic spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 74. SDMT denominator: 74. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.65 sec. 9-hole peg non-dominant:15.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Bilateral deafness. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on April 26, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.17. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2014. Comments on DMT: Rebif. Tobacco smoker: current  The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:19 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 27, 2012. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2017. Vit D at visit: 102.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 2. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.7 sec. 9-hole peg non-dominant:28.2 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:76.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Disk surgery. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Right ear congenital hearing loss. Outcome:ongoing illness. Name of co-morbidity:Tooth abscess + extraction. Outcome:completely recovered from illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total Left hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 5. DMT taken. Current DMT: biotin on September 21, 2016. Comments on DMT: Mabthera , rebif and Atacicept. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 49.0. The 25-foot walk done. 25-foot walk test time was 21.12 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2017. Vit D at visit: 96.3. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: February 01, 2018. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.19 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.73 sec. 9-hole peg non-dominant:29.55 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Avonex, Mitoxantone, Rituximab. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:patient preference- convenience. New DMT:Imuran-Azathioprine. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.83. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2016. MRI of brain or spine done. Cervical spine MRI date: July 13, 2017. The 25-foot walk done. 25-foot walk test time was 3.6 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.9 sec. 9-hole peg non-dominant:24 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2010. Comments on DMT: None . MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT: mabthera- rituximab. Comments on DMT: Rebif. The 25-foot walk done. 25-foot walk test time was 6.4 sec. SDMT done. SDMT numerator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.2 sec. 9-hole peg non-dominant:42.6 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 15. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.9 sec. 9-hole peg non-dominant:27.7 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:cis. Total relapses until visit: 2. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 4.1 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Total relapses until visit: 4. Comments on DMT: Tysabri, Rebif. Tobacco smoker: ex-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 27, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 16 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation focal spasms. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on May 01, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2018. Tobacco smoker: non-smoker  Vit D at visit: 66.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Cervical spine MRI date: February 21, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Remarks about MRI: A new enhancing lesion in the left posterior temporal region. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 32. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.57 sec. 9-hole peg non-dominant:23.78 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:subclinical hypothyroidism . Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:chronic idiopathic urticaria . Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 26, 2020. Comments on DMT: current off tecfidera (since early July) bc cant obtain it. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: March 01, 2021. Received Gadolinium for Cervical spine MRI. Change in DMT or management done. Reason for DMT change:financial difficulties to get the DMT. New DMT:Gilenya- Fingolimod. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on September 01, 2014. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.29 sec. SDMT done. SDMT numerator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.37 sec. 9-hole peg non-dominant:26.48 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 1. Alcohol drinsk per week: 1. Exercise hrs per week:4. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:19.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.83. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Tobacco type: 1 PPD, 1 hubble bubble\/day. Alcohol drinsk per week: 1. Anti-MOG Abs seropositivity: Negative. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. 25-foot walk test time was 4.06 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.4 sec. 9-hole peg non-dominant:27.91 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2018. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: August 23, 2019. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:20 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar, cognitive dysfunction. Has experienced progressive symptoms since onset. Visit diagnosis:ppms. The 25-foot walk done. 25-foot walk test time was 26 sec. SDMT done. SDMT numerator: 13. SDMT denominator: 13. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Oral Candidiasis. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on May 29, 2017. Comments on DMT: Betaferon. Vit D at visit: 52.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: April 01, 2017. The 25-foot walk done. 25-foot walk test time was 4.15 sec. SDMT done. SDMT numerator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.52 sec. 9-hole peg non-dominant:17.91 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:5. OCBs in CSF:positive. Name of co-morbidity:Asthma. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on January 04, 2012. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 PPD. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.82 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.75 sec. 9-hole peg non-dominant:23.96 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.09. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on June 01, 2017. Vit D at visit: 56.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: July 01, 2020. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:15.81 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.93. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: ex-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 01, 2022. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.61 sec. 9-hole peg non-dominant:21 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on August 15, 2016. Comments on DMT: Tecfidera. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.9 sec. 9-hole peg non-dominant:22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:negative. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:ppms. Comments on DMT: Cyclophosphamide, cellcept, betaferon. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 27.0. The 25-foot walk done. 25-foot walk test time was 59 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.79 sec. 9-hole peg non-dominant:23.05 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.5. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Right breast nodule resection. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Lower back cyst resection. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Laser surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 03, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on October 01, 2019. Comments on DMT: Rebif, Tysabri. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.45 sec. 9-hole peg non-dominant:20.94 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.84. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.92. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on September 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 15, 2016. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 44 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:122 sec. 9-hole peg non-dominant:60 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:7. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2000. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 6.9 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.3 sec. 9-hole peg non-dominant:49.3 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis, cerebellar, bowel\/bladder dysfunction, incidental mri findings. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.5. IgG index category in CSF:Normal (< 0.77). Past medical history: MVA IN 2012. Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on April 01, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: October 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.2 sec. 9-hole peg non-dominant:36.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. There were new relapses since the previous visit. Vit D at visit: 30.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 15, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:21.65 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.805. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:cardiac valve disease. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on May 01, 2021. Comments on DMT: Avonex. Tobacco smoker: non-smoker  SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.4 sec. 9-hole peg non-dominant:20 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.66. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:endoxan- cyclophosphamide on April 01, 2014. Comments on DMT: Avonex - Gilenya. Vit D at visit: 46.7. The 25-foot walk done. 25-foot walk test time was 4.85 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 32. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:33.03 sec. 9-hole peg non-dominant:23.54 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2016. Comments on DMT: Rebif, Tecfidera. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:ocrevus - ocrelizumab on March 01, 2020. The 25-foot walk done. 25-foot walk test time was 8.5 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:60 sec. 9-hole peg non-dominant:38 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on September 18, 2017. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.96. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2020. Comments on DMT: Aubagio, Rebif. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2017. Vit D at visit: 47.2. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:20 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Has experienced progressive symptoms since onset. Name of co-morbidity:Spinal cord compression. Outcome:ongoing illness. Visit diagnosis:ppms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on June 01, 2022. Vit D at visit: 32.1. EDSS:7.5- unable to take more than a few steps; restricted to wheelchair; may need some help in transferring and in wheeling self. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. Several relapses until this visit. Comments on DMT: Rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 12, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Evidence of LETM. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Left. 9-hole peg non-dominant:29.53 sec. EDSS:7.5- unable to take more than a few steps; restricted to wheelchair; may need some help in transferring and in wheeling self. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:tysabri- natalizumab on September 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 12, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.61. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: June 03, 2011. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 25 months?",
        "output":"After 25 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Tension headache. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. Comments on DMT: Betaferon. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: September 01, 2019. Received Gadolinium for Cervical spine MRI. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.98 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:20 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Start DMT since off treatment . New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Vit D at visit: 54.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: September 17, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 3.42 sec. SDMT done. SDMT numerator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.4 sec. 9-hole peg non-dominant:16.85 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:schizoaffective. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on November 30, 2012. Comments on DMT: Rebif, Betaferon. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 28. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 16, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.43 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.34 sec. 9-hole peg non-dominant:29.21 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:2. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mavenclad- cladribine on September 01, 2019. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.28 sec. 9-hole peg non-dominant:20.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT: imuran-azathioprine. Tobacco smoker: non-smoker  MRI of brain or spine done. Cervical spine MRI date: September 27, 2022. Cervical spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 6 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30 sec. 9-hole peg non-dominant:27 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:sub-optimal tx. New DMT:Gilenya- Fingolimod. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:abortion. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on June 18, 2015. Comments on DMT: Rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 06, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 6.4 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: April 01, 2019. The 25-foot walk done. 25-foot walk test time was 7.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.76 sec. 9-hole peg non-dominant:41.5 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:papillary urothelial cancer . Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on January 01, 2019. Comments on DMT: avonex, rebif. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.4 sec. 9-hole peg non-dominant:25 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Anterior Uveitis. Name of co-morbidity:Migraine. Name of co-morbidity:Depression. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2009. Comments on DMT: Rebif . MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:spms. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35 sec. 9-hole peg non-dominant:25 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2018. Tobacco smoker: non-smoker  The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.67. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2022. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Coffee cups per week: 21. Vit D at visit: 19.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 25, 2023. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:19.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:rrms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on May 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 16, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.9 sec. 9-hole peg non-dominant:21 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on June 15, 2015. Comments on DMT: Cinnovex Rebif Mycophenolate. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 26, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:18.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on May 01, 2018. Comments on DMT: Betaferon. Vit D at visit: 37.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:stop DMT. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2012. Comments on DMT: Avonex Rebif. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 6.1 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.6 sec. 9-hole peg non-dominant:19.6 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:80.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Bronchitis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Tendinitis. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:endoxan- cyclophosphamide on June 10, 2013. Tobacco smoker: non-smoker  Vit D at visit: 28.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 27, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: July 01, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:20.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mavenclad- Cladribine. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:papillary urothelial cancer . Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on January 01, 2019. Vit D at visit: 64.0. The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 19. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.9 sec. 9-hole peg non-dominant:26 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: July 10, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.94 sec. 9-hole peg non-dominant:34.95 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. Comments on DMT: Endoxan (Cyclophosphamide); Imuran (Azathioprine); Mitoxantrone; Other; Rebif; Solumedrol. SDMT done. SDMT numerator: 18. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:69 sec. 9-hole peg non-dominant:26.3 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2016. Comments on DMT: Rebif (Jan 2015-Aug 2015) Tecfidera (Aug 2015-Aug 2016)  . Vit D at visit: 29.5. The 25-foot walk done. 25-foot walk test time was 3.53 sec. SDMT done. SDMT numerator: 87. SDMT denominator: 87. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.4 sec. 9-hole peg non-dominant:18.01 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 12. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2011. Comments on DMT: Betaferon - Rebif. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.55 sec. 9-hole peg non-dominant:26.06 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 25 months?",
        "output":"After 25 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.864. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Essential tremor. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2015. Vit D at visit: 97.4. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 18, 2016. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.72. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:ACL repair. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:L4-5 laminectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:corrective eye surgery. Outcome:completely recovered from illness. Visit diagnosis:ppms. The patient is in EDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on May 10, 2023. Tobacco smoker: non-smoker  Vit D at visit: 95.5. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: May 09, 2023. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.5 sec. 9-hole peg non-dominant:21 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Name of co-morbidity:Anxiety. Visit diagnosis:rrms. Total relapses until visit: 7. There were new relapses since the previous visit. Comments on DMT: Rebif, Imuran, Gilenya. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 4. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: December 06, 2013. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.71. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Comments on DMT: rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 33.5. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 04, 2019. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:20 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory, motor weakness, shoulder pain. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on August 01, 2017. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 35. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Cervical spine MRI date: October 10, 2018. Received Gadolinium for Cervical spine MRI. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.38 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:21.78 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.61. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2011. Tobacco smoker: non-smoker  Vit D at visit: 88.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 27, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.47 sec. 9-hole peg non-dominant:24.36 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hashimoto thyroiditis. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. There were new relapses since the previous visit. Tobacco smoker: non-smoker  MRI of brain or spine done. Cervical spine MRI date: September 15, 2021. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.2 sec. 9-hole peg non-dominant:19.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2017. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2012. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 10, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 9.77 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.07 sec. 9-hole peg non-dominant:21.49 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 31, 2017. Comments on DMT: Tecfidera. Vit D at visit: 47.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: November 07, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:81.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem. Name of co-morbidity:Trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Cellulitis. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:osteoporosis. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:relapsing-progressive ms. Total relapses until visit: 4. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2002. Comments on DMT: avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 25, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.76 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.36 sec. 9-hole peg non-dominant:22 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 PPD. Coffee cups per week: 49. Vit D at visit: 21.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 8. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 01, 2014. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:27 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation brainstem. Has experienced progressive symptoms since onset. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:OCD. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT: mabthera- rituximab. The 25-foot walk done. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:abortion. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2014. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Exercise hrs per week:3. Vit D at visit: 20.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: June 19, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.29 sec. 9-hole peg non-dominant:23.42 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on September 05, 2016. Comments on DMT: Rebif, Tecfidera. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: February 20, 2020. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 80. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.4 sec. 9-hole peg non-dominant:15.1 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 09, 2017. Vit D at visit: 53.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 25, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 88. SDMT denominator: 88. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:17.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on May 08, 2017. Comments on DMT: Betaferon . MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2011. MRI of brain or spine done. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2018. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:20 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1.5ppd. Coffee cups per week: 35. Vit D at visit: 29.2. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.8 sec. 9-hole peg non-dominant:17.64 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 51 months?",
        "output":"After 51 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2019. Comments on DMT: Avonex; Rebif; Tecfidera. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 50.0. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:20.2 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2016. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 01, 2021. Tobacco smoker: non-smoker  EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:logistic issues to obtain the DMT. New DMT:Mavenclad- Cladribine. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:2. Visit diagnosis:spms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Coffee cups per week: 49. The 25-foot walk done. 25-foot walk test time was 26 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.4 sec. 9-hole peg non-dominant:46.6 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on October 01, 2017. Comments on DMT: Betaferon; Tecfidera. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.5 sec. 9-hole peg non-dominant:25.5 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:5. OCBs in CSF:positive. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on September 01, 2017. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 66.4 sec. SDMT done. SDMT numerator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.8 sec. 9-hole peg non-dominant:30.57 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.06. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Sciatica. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on June 01, 2020. Vit D at visit: 28.0. The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:24.7 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:10. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on October 01, 2017. Comments on DMT: Avonex, Betaferon, Cyclophosphamide, Gilenya, Imuran, Rebif. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 18.4 sec. SDMT done. SDMT numerator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.73 sec. 9-hole peg non-dominant:18.35 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:1.47. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on May 01, 2014. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: June 15, 2019. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:OCD. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2019. Tobacco smoker: non-smoker  Vit D at visit: 14.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: June 01, 2019. Received Gadolinium for Cervical spine MRI. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.38 sec. 9-hole peg non-dominant:21.83 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2020. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 1. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.29 sec. 9-hole peg non-dominant:20.19 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.06. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Sciatica. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2015. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 4.05 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 50. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:16.24 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on April 01, 2023. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: August 01, 2023. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 2.4 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.5 sec. 9-hole peg non-dominant:22.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2019. Comments on DMT: Rebif. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:23 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 27. DMT taken. Current DMT:mabthera- rituximab on August 01, 2015. The 25-foot walk done. 25-foot walk test time was 7.4 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.64 sec. 9-hole peg non-dominant:16.7 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:25.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Seizures\/convulsions. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:ris. Total relapses until visit: 0. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 1 daily. Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:19.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:1.47. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:gilenya- fingolimod on May 01, 2014. Comments on DMT: rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 7. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: June 01, 2019. SDMT done. SDMT numerator: 62. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:20.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 23 months?",
        "output":"After 23 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:75.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH s\/p TURP. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Constipation. Outcome:ongoing illness. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on May 01, 2017. Comments on DMT: Avonex; Betaseron; Rebif. Tobacco smoker: non-smoker  Vit D at visit: 88.6. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 42. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.7 sec. 9-hole peg non-dominant:70.74 sec. EDSS:7.5- unable to take more than a few steps; restricted to wheelchair; may need some help in transferring and in wheeling self. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:aubagio- teriflunomide on September 01, 2018. The 25-foot walk done. 25-foot walk test time was 5.81 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.01 sec. 9-hole peg non-dominant:20.59 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:neurosarcoidosis, initially thought rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.79. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.79. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:previously thought ms, but after v2 diagnosed with neurosarcoidosis. Comments on DMT: Avonex - Gilenya. Vit D at visit: 27.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 7.03 sec. SDMT done. SDMT numerator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.22 sec. 9-hole peg non-dominant:39.95 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2015. Vit D at visit: 101.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.7 sec. 9-hole peg non-dominant:26.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: off Gilenya as she is trying to get pregnant . Vit D at visit: 34.0. The 25-foot walk done. 25-foot walk test time was 4.05 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.88 sec. 9-hole peg non-dominant:15.79 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. OCBs in CSF:positive. IgG index in CSF:1.01. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2020. Tobacco smoker: non-smoker  Exercise hrs per week:5. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.78 sec. 9-hole peg non-dominant:15.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Comments on DMT: Rebif Feb 2013 until May 2013. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:21.2 sec. 9-hole peg non-dominant:21.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.83. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on February 18, 2019. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2013. Comments on DMT: Avonex March 2013 until Oct 2013. The 25-foot walk done. 25-foot walk test time was 3.68 sec. SDMT done. SDMT numerator: 74. SDMT denominator: 74. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.59 sec. 9-hole peg non-dominant:20.28 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on August 01, 2020. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:22 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 01, 2013. Vit D at visit: 43.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 30, 2014. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.75 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.11 sec. 9-hole peg non-dominant:17.39 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:VZV Trigeminal neuritis. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 14, 2015. Tobacco smoker: non-smoker  Coffee cups per week: 21. Vit D at visit: 22.0. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Cervical spine MRI date: December 16, 2015. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 3. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 2.5 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.39 sec. 9-hole peg non-dominant:26.3 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: May 04, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.12. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on November 01, 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 28, 2021. The 25-foot walk done. 25-foot walk test time was 9 sec. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2014. Comments on DMT: Cinnovex. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 6.18 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 34. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.56 sec. 9-hole peg non-dominant:34.71 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.72. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2022. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.92. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:nmo. Total relapses until visit: 3. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Cervical spine MRI date: August 13, 2014. Received Gadolinium for Cervical spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 28.1 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:33.5 sec. 9-hole peg non-dominant:18.4 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2017. Comments on DMT: Tecfidera. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 28, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29 sec. 9-hole peg non-dominant:28.1 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.04. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Rosacea. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:avonex or cinnovex- im interferon on May 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.84 sec. 9-hole peg non-dominant:19.74 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2016. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.19 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.4 sec. 9-hole peg non-dominant:20.2 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Bipolar disorder. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2014. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. Name of co-morbidity:Absence Seizures. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.96 sec. 9-hole peg non-dominant:16.53 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT: tysabri- natalizumab. Vit D at visit: 56.4. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: April 12, 2018. The 25-foot walk done. 25-foot walk test time was 5.84 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:45.99 sec. 9-hole peg non-dominant:28.65 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:7. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 7. There were new relapses since the previous visit. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2014. Tobacco smoker: non-smoker  Coffee cups per week: 21. Vit D at visit: 46.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 21, 2017. The 25-foot walk done. 25-foot walk test time was 7.4 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.58 sec. 9-hole peg non-dominant:40.65 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 4. There were new relapses since the previous visit. Comments on DMT: Avonex - Gilenya. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 42. Vit D at visit: 95.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 8. Total T1 Gad-enhancing lesions in Brain: 4. Cervical spine MRI date: July 25, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 8.8 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:23.4 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. OCBs in CSF:positive. IgG index in CSF:1.15. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 29, 2019. Tobacco smoker: ex-smoker  Exercise hrs per week:5. Vit D at visit: 45.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: July 01, 2019. Received Gadolinium for Cervical spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. The 25-foot walk done. 25-foot walk test time was 3.86 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.33 sec. 9-hole peg non-dominant:28.71 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 39 months?",
        "output":"After 39 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 13.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 16, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.32 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.6 sec. 9-hole peg non-dominant:15.5 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.4. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 47.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 18, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.12 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.79 sec. 9-hole peg non-dominant:19.64 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:patient preference- convenience. New DMT:Gilenya- Fingolimod. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:86.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation myelitis. Number of attacks until the first visit:3. Name of co-morbidity:Diffuse cystic mastopathy s\/p subtotal mastectomy. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonitis. Outcome:completely recovered from illness. Name of co-morbidity:Sepsis. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:hemorrhage. Outcome:death due to illness. Visit diagnosis:spms. Total relapses until visit: 3. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:cis. Total relapses until visit: 1. There were new relapses since the previous visit. Tobacco smoker: non-smoker  Vit D at visit: 39.3. MRI of brain or spine done. Cervical spine MRI date: March 15, 2016. Cervical spine MRI: Not compared to previous spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 5.18 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.74 sec. 9-hole peg non-dominant:21.96 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Blood and lymphatic disorders. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2016. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 14. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: February 13, 2018. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:18.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2011. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Tobacco type: 1.5 PPD + Hubble Bubble 1\/week. Coffee cups per week: 7. Alcohol drinsk per week: 4. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.28 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.38 sec. 9-hole peg non-dominant:18.85 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:24 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on August 01, 2016. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.39 sec. 9-hole peg non-dominant:28.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:3. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on July 24, 2019. Comments on DMT: tecfidera. Tobacco smoker: non-smoker  Vit D at visit: 61.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:22.92 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.29. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:vitiligo. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 13, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:1.42. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Right breast cancer. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:right shoulder tendinitis. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on December 07, 2017. Comments on DMT: avonex. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 28. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: April 05, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:25.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:1. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2015. Comments on DMT: Avonex, aubagio. Tobacco smoker: non-smoker  Vit D at visit: 59.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.48 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.24 sec. 9-hole peg non-dominant:21.95 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. Vit D at visit: 29.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on November 30, 2012. Vit D at visit: 69.9. The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 78. SDMT denominator: 78. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:21.86 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness.  Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Vit D at visit: 48.8. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 29, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The patient is in EDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Name of co-morbidity:Anxiety. Visit diagnosis:rrms. Total relapses until visit: 11. DMT taken. Current DMT:mabthera- rituximab on June 01, 2016. Comments on DMT: Gilenya, Imuran (Azathioprine), Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 49. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15.75 sec. 9-hole peg non-dominant:18.7 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2020. Comments on DMT: Tysabri. The 25-foot walk done. 25-foot walk test time was 3.6 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.75 sec. 9-hole peg non-dominant:19.1 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.88. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2014. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: October 16, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.7 sec. 9-hole peg non-dominant:22.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.78. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 2. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on November 01, 2020. Vit D at visit: 38.4. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Cervical spine MRI date: September 01, 2022. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.4 sec. 9-hole peg non-dominant:16.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. Comments on DMT: Betaferon. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 13.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: January 23, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.66 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:16.89 sec. 9-hole peg non-dominant:23.22 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses AND new EDSS findings. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2021. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 6.5 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.9 sec. 9-hole peg non-dominant:23 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.22. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2014. Comments on DMT: Rebif . The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:37 sec. 9-hole peg non-dominant:22 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on August 15, 2016. Vit D at visit: 42.8. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.24 sec. 9-hole peg non-dominant:21.32 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2001. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on September 01, 2019. Comments on DMT: betaferon, tecfidera, gilenya. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: December 20, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.7 sec. 9-hole peg non-dominant:20 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:75.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation gtc seizures. Has experienced progressive symptoms since onset. Name of co-morbidity:Surgeries. More information on co-morbidity:cholecystectomy. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:scoliosis. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:DM2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:seizures. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:tronchanteric bursitis. Outcome:completely recovered from illness. Visit diagnosis:ppms. DMT taken. Current DMT: methotrexate on December 01, 2014. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. Vit D at visit: 43.6. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 04, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 10.3 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.8 sec. 9-hole peg non-dominant:26.9 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:papillary urothelial cancer . Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on January 01, 2019. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on June 01, 2017. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.68 sec. SDMT done. SDMT numerator: 23. SDMT denominator: 23. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.1 sec. 9-hole peg non-dominant:23.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2016. Tobacco smoker: non-smoker  Vit D at visit: 123.0. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14 sec. 9-hole peg non-dominant:14.62 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hepatic disorders. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 90.7. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.46 sec. 9-hole peg non-dominant:22.24 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2014. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 ppd. Coffee cups per week: 7. Alcohol drinsk per week: 4. Vit D at visit: 20.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:21.9 sec. 9-hole peg non-dominant:22.01 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:rrms. Vit D at visit: 21.2. MRI of brain or spine done. Cervical spine MRI date: October 31, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.54 sec. 9-hole peg non-dominant:18.92 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2013. Comments on DMT: Avonex, Betaferon. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:18.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:endoxan- cyclophosphamide on October 01, 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 18, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.61. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on December 01, 2016. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 21.5. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 74. SDMT denominator: 74. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:16.57 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2013. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.2 sec. 9-hole peg non-dominant:31.45 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 20 months?",
        "output":"After 20 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on September 01, 2019. Tobacco smoker: non-smoker  Coffee cups per week: 2. Alcohol drinsk per week: 1. Exercise hrs per week:2. The 25-foot walk done. 25-foot walk test time was 19 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:37.3 sec. 9-hole peg non-dominant:53 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: Avonex - Rebif - Gilenya. The 25-foot walk done. 25-foot walk test time was 21.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.22 sec. 9-hole peg non-dominant:34.8 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness, brainstem. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:breast cancer. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 99. DMT taken. Current DMT:mabthera- rituximab on September 01, 2020. Comments on DMT: Betaferon 2008-2016 (discontinued due to patient preference) Avonex 2016-June 2020 (discontinued due to progression)  . MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: February 25, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 16 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26 sec. 9-hole peg non-dominant:24 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Hidradenitis Suppurutiva. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2014. Comments on DMT:  - Avonex -  Tysabri, . The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 28.99 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right.  9-hole peg dominant:43.28 sec. 9-hole peg non-dominant:75.17 sec. EDSS:8- essentially restricted to bed or chair or perambulated in wheelchair but out of bed most of day; retains many self-care functions; generally has effective use of arms. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:negative. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:tension headache. Outcome:completely recovered from illness. Name of co-morbidity:elevated LFTs. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 27, 2019. Tobacco smoker: non-smoker  Vit D at visit: 75.33. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: June 01, 2020. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.61. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on February 26, 2015. Comments on DMT: Avonex(2011-2013) Gilenya (2013-2015). Vit D at visit: 66.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 8.79 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.53 sec. 9-hole peg non-dominant:50.27 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2020. Comments on DMT: Rebif Plegridy. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: October 13, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.67 sec. 9-hole peg non-dominant:16.43 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.94. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on December 11, 2013. Vit D at visit: 53.1. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. SDMT done. SDMT numerator: 59. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.7 sec. 9-hole peg non-dominant:19.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on November 01, 2016. Comments on DMT: Avonex, Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 30.8. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: July 16, 2019. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:18.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on May 01, 2016. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 5.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:22.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 26 months?",
        "output":"After 26 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Has experienced progressive symptoms since onset. Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:s\/p thyroidectomy. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:disc repair. Outcome:completely recovered from illness. Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on May 25, 2017. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 05, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 16.5 sec. SDMT done. SDMT numerator: 24. SDMT denominator: 26. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.7 sec. 9-hole peg non-dominant:34.8 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:1.46. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Mild mental retardation. Outcome:ongoing illness. Name of co-morbidity:Chronic Hepatitis B. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on September 01, 2020. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 6.9 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.56 sec. 9-hole peg non-dominant:24 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 8. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on May 01, 2016. Comments on DMT: Avonex, Betaferon. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.15 sec. 9-hole peg non-dominant:26.4 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on May 31, 2016. Comments on DMT: Avonex, Gilenya, Tecfidera. Tobacco smoker: non-smoker  Vit D at visit: 69.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. 25-foot walk test time was 4.08 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.8 sec. 9-hole peg non-dominant:32.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. Visit diagnosis:ppms. Total relapses until visit: 0. Comments on DMT: Interferon - Imuran - Mitoxantrone. Vit D at visit: 39.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. 25-foot walk test time was 29.4 sec. SDMT done. SDMT numerator: 22. SDMT denominator: 22. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:99 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.16. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2019. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 01, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 2. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.24 sec. 9-hole peg non-dominant:18.21 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on March 01, 2020. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 6.3 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:20 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:7. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on October 01, 2019. Comments on DMT: Avonex, Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 14. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.4 sec. 9-hole peg non-dominant:23.6 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 25 months?",
        "output":"After 25 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:86.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation myelitis. Number of attacks until the first visit:3. Name of co-morbidity:Diffuse cystic mastopathy s\/p subtotal mastectomy. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonitis. Outcome:completely recovered from illness. Name of co-morbidity:Sepsis. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:hemorrhage. Outcome:death due to illness. Visit diagnosis:spms. Total relapses until visit: 3. Comments on DMT: Mitoxantrone  - Avonex - Mabthera  - Betaferon . Tobacco smoker: non-smoker  Vit D at visit: 63.72. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 16. SDMT denominator: 16. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:40.69 sec. 9-hole peg non-dominant:98.83 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2018. Comments on DMT: rebif. Tobacco smoker: non-smoker  Vit D at visit: 42.2. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:18.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. Total relapses until visit: 2. Comments on DMT: Cyclophosphamide - Syncathen. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 11. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:98.92 sec. EDSS:8- essentially restricted to bed or chair or perambulated in wheelchair but out of bed most of day; retains many self-care functions; generally has effective use of arms. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 11, 2021. Comments on DMT: Rebif from October 2020 to July 2021 Plegridy since July 2021- August 2021. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: October 01, 2022. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:17.44 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:patient preference- convenience. New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2011. Comments on DMT: Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 25, 2014. Comments on DMT: Avonex, Rebif. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 90. SDMT denominator: 90. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.7 sec. 9-hole peg non-dominant:22.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:8. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:endoxan- cyclophosphamide on June 01, 2013. Comments on DMT: Imuran - Rebif. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:17.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. OCBs in CSF:positive. IgG index in CSF:0.93. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on December 01, 2021. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:18.52 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on December 01, 2014. Comments on DMT: Betaferon. Vit D at visit: 43.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 27, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 6.65 sec. SDMT done. SDMT numerator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.9 sec. 9-hole peg non-dominant:20.8 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on July 01, 2016. Comments on DMT: Rebif. Vit D at visit: 41.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 12, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.82 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cognitive dysfunction. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:susac. DMT taken. Current DMT:mabthera- rituximab on September 01, 2023. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.9 sec. 9-hole peg non-dominant:27.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.9. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2013. Comments on DMT: Avonex. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.75 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.05 sec. 9-hole peg non-dominant:22.9 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:77.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH . Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Disk disease. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Tinea versicolor. Outcome:completely recovered from illness. Visit diagnosis:spms vs rpms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2000. Comments on DMT: Betaferon, Imuran. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 14, 2012. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 120 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.37 sec. 9-hole peg non-dominant:24.05 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 39 months?",
        "output":"After 39 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 15, 2014. Comments on DMT: avonex, betaferon. Tobacco smoker: non-smoker  MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:23.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:7. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on April 01, 2017. Comments on DMT: Rebif, Tysabri. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.3 sec. 9-hole peg non-dominant:43.4 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.04. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:1.04. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on November 01, 2016. Comments on DMT: Rebif - Avonex. Vit D at visit: 47.84. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 7.26 sec. SDMT done. SDMT numerator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.59 sec. 9-hole peg non-dominant:31.77 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:asthma. Outcome:completely recovered from illness. Name of co-morbidity:Keratoconus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2014. Tobacco smoker: non-smoker  Vit D at visit: 41.5. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Cervical spine MRI date: December 14, 2016. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Name of co-morbidity:EPILEPSY. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2009. The 25-foot walk done. SDMT done. SDMT numerator: 32. SDMT denominator: 35. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:26.21 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:5. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2013. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:21 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:logistic issues to obtain the DMT. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2013. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: July 01, 2018. The 25-foot walk done. 25-foot walk test time was 5.77 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.45 sec. 9-hole peg non-dominant:29.8 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.804. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:low back pain. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 5. The 25-foot walk done. 25-foot walk test time was 4.21 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.59 sec. 9-hole peg non-dominant:23.09 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: Rebif - Avonex. The 25-foot walk done. 25-foot walk test time was 6.12 sec. SDMT done. SDMT numerator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.71 sec. 9-hole peg non-dominant:26.16 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:2.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 7. DMT taken. Current DMT:tysabri- natalizumab on April 01, 2015. Comments on DMT: Rebif. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.86 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31.07 sec. 9-hole peg non-dominant:34.12 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:3. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2014. Comments on DMT: Avonex, Rebif. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.33 sec. SDMT done. SDMT numerator: 82. SDMT denominator: 82. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.36 sec. 9-hole peg non-dominant:14.59 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:10. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:spms. Comments on DMT: Betaseron (Mar 1999-Aug 1999), Avonex Sep 1999-Feb 2003, Rebif Feb 2003-Nov 2011, Imuran Sep 2004-Sep 2008, Gilenya Nov 2011-Feb 2013, Endoxan Apr 2013-Aug 2014. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: occaisionally. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 22.33 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.8 sec. 9-hole peg non-dominant:20.4 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 99. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.13 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:25 sec. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 80. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:16.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.67. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2021. Tobacco smoker: ex-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 01, 2021. Received Gadolinium for Cervical spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:21 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:3.41. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2016. Vit D at visit: 31.6. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.9 sec. 9-hole peg non-dominant:18.9 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar, incidental mri findings. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on January 18, 2016. Comments on DMT: gilenya. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 45.5. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: January 29, 2018. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.1 sec. 9-hole peg non-dominant:32.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2005. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.34 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2018. Tobacco smoker: non-smoker  Alcohol drinsk per week: 2. Exercise hrs per week:6. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.79 sec. 9-hole peg non-dominant:17.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on September 01, 2017. Comments on DMT: 2024-11-19 00:00:00. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 14.85 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34 sec. 9-hole peg non-dominant:35 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.84. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.92. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on September 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: March 21, 2018. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 30.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:67.6 sec. 9-hole peg non-dominant:87.5 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.56. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:thyroid nodule. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. Vit D at visit: 78.1. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:18.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:73.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: Avonex - Rebif - Tysabri - Monthly IV steroids. Vit D at visit: 120.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 6. 9-HPT done. 9-HPT ability: unable with both hands. EDSS:9- helpless bed patient; can communicate and eat. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.17. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:19 sec. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, incidental mri findings. OCBs in CSF:negative. IgG index in CSF:999. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on June 01, 2007. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.22. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2016. Vit D at visit: 63.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 19, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.89 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.26 sec. 9-hole peg non-dominant:20.55 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Initial presentation incidental mri findings. OCBs in CSF:positive. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:ris. Total relapses until visit: 0. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: December 01, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.18 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.13 sec. 9-hole peg non-dominant:18.12 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2014. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 PPD. Vit D at visit: 70.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:16.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 8. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on May 01, 2014. Comments on DMT: Betaferon - Imuran - Mabthera - Endoxan. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 28.34 sec. SDMT done. SDMT numerator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.38 sec. 9-hole peg non-dominant:27.76 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2013. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 52.1. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.7 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2014. Comments on DMT: Betaferon (Oct 2007-Jan 2012); Gilenya (Mar 2012-Nov 2013). Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 2.9 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.4 sec. 9-hole peg non-dominant:21.9 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on September 01, 2019. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 27 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31 sec. 9-hole peg non-dominant:60 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:3. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2010. Comments on DMT: Avonex 09\/2009-01\/2010. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. Vit D at visit: 15.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.33 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:17.7 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:DMT Aubagio. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.79. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on July 24, 2015. Vit D at visit: 28.4. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.28 sec. 9-hole peg non-dominant:21.65 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. Comments on DMT: no. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: March 17, 2017. Whole spinal cord lesion load on MRI: No lesions. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. Name of co-morbidity:Absence Seizures. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2018. Comments on DMT: Avonex. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: October 22, 2018. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.9 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.12. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2010. Tobacco smoker: non-smoker  Vit D at visit: 42.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: February 26, 2015. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.54 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.95 sec. 9-hole peg non-dominant:20.22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on December 18, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 12, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Thoracic spine: 2. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:idiopathic optic neuritis. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.46. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:idiopathic optic neuritis. Total relapses until visit: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.7 sec. 9-hole peg non-dominant:27 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on October 01, 2017. MRI of brain or spine done. Cervical spine MRI date: December 15, 2018. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 16.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25 sec. 9-hole peg non-dominant:37.1 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:80.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Bronchitis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Tendinitis. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 01, 2015. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 23. SDMT denominator: 23. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27 sec. 9-hole peg non-dominant:40 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.44. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on March 01, 2017. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:67.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis, sarcoidosis. OCBs in CSF:negative. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 3. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:nmo. DMT taken. Current DMT: cellcept and monthly ivig on May 01, 2011. Comments on DMT: Mabthera and monthly IVMP. The patient is in EDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.804. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:low back pain. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.7 sec. 9-hole peg non-dominant:21.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2019. Comments on DMT: Rebif. Anti-MOG Abs seropositivity: Negative. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. Tobacco smoker: ex-smoker  Coffee cups per week: 1. Exercise hrs per week:5. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: No lesions. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:spms. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 9.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:10. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:epilepsy. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on December 21, 2011. Comments on DMT: Avonex 2008-2011. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: once weekly. The 25-foot walk done. 25-foot walk test time was 4.41 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.16 sec. 9-hole peg non-dominant:24.84 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2021. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.16 sec. 9-hole peg non-dominant:24.9 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:1. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on December 01, 2013. Tobacco smoker: non-smoker  Vit D at visit: 58.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.9 sec. 9-hole peg non-dominant:20.3 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 12. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2011. Comments on DMT: Betaferon, Rebif. Vit D at visit: 49.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.4 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:22 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2013. Comments on DMT: Betaferon, Gilenya. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:17.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:negative. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: August 04, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 29 months?",
        "output":"After 29 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation bowel\/bladder dysfunction. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on May 01, 2023. The 25-foot walk done. 25-foot walk test time was 8.3 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.2 sec. 9-hole peg non-dominant:18.83 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.91. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Vit D at visit: 15.5. The 25-foot walk done. 25-foot walk test time was 3.49 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.66 sec. 9-hole peg non-dominant:20.17 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.07. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on September 27, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.25. Visit diagnosis:ppms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on December 01, 2019. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 7.35 sec. SDMT done. SDMT numerator: 33. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.5 sec. 9-hole peg non-dominant:24.6 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:trigeminal neuralgia s\/p balloon decompression. Outcome:ongoing illness. Name of co-morbidity:multinodular goiter. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on September 01, 2019. Comments on DMT: Avonex discontinued due to intolerance. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 7.3 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.5 sec. 9-hole peg non-dominant:25.6 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:76.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Disk surgery. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Right ear congenital hearing loss. Outcome:ongoing illness. Name of co-morbidity:Tooth abscess + extraction. Outcome:completely recovered from illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total Left hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on April 05, 2012. Comments on DMT: rebif, atoricept trial. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 21. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 16.1 sec. SDMT done. SDMT numerator: 25. SDMT denominator: 27. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.5 sec. 9-hole peg non-dominant:31.81 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.71. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.45 sec. 9-hole peg non-dominant:20 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.98. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Endometriosis. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2013. Comments on DMT: Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: August 15, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 20, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.4 sec. 9-hole peg non-dominant:15.9 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on June 01, 2016. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 8.75 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.97 sec. 9-hole peg non-dominant:23.48 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on October 11, 2011. Comments on DMT: Avonex Sep 2010-Mar 2011, Betaferon May 2011-Sep 2011. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.72 sec. 9-hole peg non-dominant:21.08 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:negative. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:endoxan- cyclophosphamide on August 01, 2014. Comments on DMT: Betaferon - Cellcelpt. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 37.1 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on September 01, 2022. Vit D at visit: 46.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: March 01, 2023. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.78 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:22 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:solumedrol- iv methylprednisolone on January 01, 2014. Comments on DMT: Avonex (failed treatment), Mitoxantone, Rituximab. Tobacco smoker: non-smoker  Vit D at visit: 24.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 4. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.79 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.18 sec. 9-hole peg non-dominant:23.99 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. Comments on DMT: Avonex. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 5.31 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.53 sec. 9-hole peg non-dominant:22.62 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:asthma. Outcome:completely recovered from illness. Name of co-morbidity:Keratoconus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2014. Tobacco smoker: non-smoker  Vit D at visit: 44.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 87. SDMT denominator: 88. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.26 sec. 9-hole peg non-dominant:17.81 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation brainstem. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Alzheimer's. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Pityriasis versicolor. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:delayed gastric emptying. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2006. Comments on DMT: imuran. Tobacco smoker: non-smoker  Coffee cups per week: 14. The 25-foot walk done. 25-foot walk test time was 13.8 sec. SDMT done. SDMT numerator: 13. SDMT denominator: 13. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.8 sec. 9-hole peg non-dominant:40 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:patient preference- convenience. New DMT:Plegridy (peginterferon beta 1-a). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Comments on DMT: Betaferon. Vit D at visit: 7.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 02, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.81 sec. 9-hole peg non-dominant:24.26 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on April 01, 2019. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.22 sec. 9-hole peg non-dominant:19.45 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.17. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2014. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 01, 2023. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.6 sec. 9-hole peg non-dominant:19.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: January 14, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 3.86 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.75 sec. 9-hole peg non-dominant:21.52 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:0.96. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:bipolar depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on April 01, 2019. Comments on DMT: Aubagio, Rebif. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2007. Comments on DMT: Avonex(2006-2007). MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 5.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.12. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2015. Comments on DMT: rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.5ppd. Vit D at visit: 40.8. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:18.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:77.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH . Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Disk disease. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Tinea versicolor. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2012. Comments on DMT: Rebif - Betaseron - Imuran - Po Prednisone. Tobacco smoker: non-smoker  Coffee cups per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 06, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 69.16 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.66 sec. 9-hole peg non-dominant:28.34 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:3.41. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on December 01, 2017. Comments on DMT: Rebif. Vit D at visit: 25.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 13, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.02 sec. 9-hole peg non-dominant:18.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on September 01, 2018. Vit D at visit: 46.9. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 76. SDMT denominator: 76. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.71 sec. 9-hole peg non-dominant:19 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. Visit diagnosis:spms. DMT taken. Current DMT: mabthera- rituximab. Comments on DMT: Avonex - Rebif - Tysabri. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Cervical spine MRI date: November 01, 2017. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:76.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Disk surgery. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Right ear congenital hearing loss. Outcome:ongoing illness. Name of co-morbidity:Tooth abscess + extraction. Outcome:completely recovered from illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total Left hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rpms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on April 05, 2012. Comments on DMT: rebif, atoricept trial. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 40. The 25-foot walk done. 25-foot walk test time was 20.11 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 32. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right.  9-hole peg dominant:23.74 sec. 9-hole peg non-dominant:29.38 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mavenclad- cladribine on December 01, 2019. Comments on DMT: Rebif, Tecfidera, Gilenya. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: February 01, 2022. The 25-foot walk done. 25-foot walk test time was 2.8 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14 sec. 9-hole peg non-dominant:15.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:1.89. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Comments on DMT: None . Vit D at visit: 23.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. The patient is in EDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2011. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.9 sec. 9-hole peg non-dominant:26.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:aubagio- teriflunomide on October 01, 2017. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: January 01, 2019. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.5 sec. 9-hole peg non-dominant:25.5 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:6. OCBs in CSF:negative. IgG index in CSF:0.45. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on June 30, 2022. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 2. Alcohol drinsk per week: 1. The patient is in NEDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.91. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 4. Cervical spine MRI date: April 17, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Vit D at visit: 54.2. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 24, 2019. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.6 sec. 9-hole peg non-dominant:16.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Vit D at visit: 102.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 17, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 6 sec. SDMT done. SDMT numerator: 64. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.21 sec. 9-hole peg non-dominant:21.57 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 25, 2012. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.25 PPD. Coffee cups per week: 21. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 11, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 77. SDMT denominator: 77. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:21.9 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. Name of co-morbidity:glaucoma. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Peptic ulcer disease. Outcome:completely recovered from illness. Visit diagnosis:ppms. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 40.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 01, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 8. SDMT denominator: 10. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:102 sec. 9-hole peg non-dominant:69 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:62.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Name of co-morbidity:asthma. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2014. Tobacco smoker: non-smoker  Vit D at visit: 66.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 13, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.45 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 64. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.57 sec. 9-hole peg non-dominant:27.91 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:7. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on April 01, 2017. Comments on DMT: Rebif Oct 2000-July 2014, Tysabri Aug 2014-Feb 2017. Tobacco smoker: non-smoker  Coffee cups per week: 21. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 11, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 8.16 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.58 sec. 9-hole peg non-dominant:43.87 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.98. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. Tobacco smoker: non-smoker  Alcohol drinsk per week: 2. SDMT done. SDMT numerator: 81. SDMT denominator: 81. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.51 sec. 9-hole peg non-dominant:17.09 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Breastfeeding . New DMT:Solumedrol- IV Methylprednisolone. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:3.61. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:avonex or cinnovex- im interferon on October 01, 2018. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 36.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 01, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 2. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:5. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:endoxan- cyclophosphamide on October 22, 2013. Comments on DMT: Betaferon, Avonex, Rebif. The 25-foot walk done. 25-foot walk test time was 6.57 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.62. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 15, 2016. Tobacco smoker: non-smoker  Coffee cups per week: 21. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 80. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:19 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female. . Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on November 01, 2021. Tobacco smoker: non-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 1. Exercise hrs per week:2. The 25-foot walk done. 25-foot walk test time was 46.8 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.4 sec. 9-hole peg non-dominant:26 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.3. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2014. Tobacco smoker: non-smoker  Coffee cups per week: 21. Vit D at visit: 43.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: December 28, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.93 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.32 sec. 9-hole peg non-dominant:20.89 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: November 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 1. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 10. DMT taken. Current DMT:mabthera- rituximab on May 01, 2016. Comments on DMT: avonex, betaferon. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: March 16, 2020. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:completely recovered from illness. Name of co-morbidity:Left breast cancer s\/p mastectomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 01, 2016. Vit D at visit: 41.7. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: March 29, 2018. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.3 sec. 9-hole peg non-dominant:19.9 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:74.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hashimoto thyroiditis. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:arthritis. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:decompression of spondylolisthesis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:right tronchanteric bursitis. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:total hip replacement. Outcome:completely recovered from illness. Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2014. Comments on DMT: rebif. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 7 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.8 sec. 9-hole peg non-dominant:23.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on June 01, 2019. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: December 02, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.06 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:19.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, bowel\/bladder dysfunction. IgG index in CSF:1.6. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. The 25-foot walk done. 25-foot walk test time was 40.83 sec. SDMT done. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:nmosd. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on April 01, 2018. Comments on DMT: rebif. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:18.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.84. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:urticaria. Outcome:ongoing illness. Visit diagnosis:cis. MRI of brain or spine done. Cervical spine MRI date: March 01, 2021. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:7. OCBs in CSF:positive. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2000. Tobacco smoker: non-smoker  Coffee cups per week: 28. The 25-foot walk done. 25-foot walk test time was 7.8 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.2 sec. 9-hole peg non-dominant:42.1 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation brainstem. OCBs in CSF:positive. IgG index in CSF:1.49. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: avonex. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 6.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: March 11, 2020. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 4. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.7 sec. 9-hole peg non-dominant:18.3 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Hyperthyroidism. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on January 01, 2015. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Vit D at visit: 27.2. MRI of brain or spine done. Cervical spine MRI date: June 01, 2019. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 16.9 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 42 months?",
        "output":"After 42 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. Name of co-morbidity:glaucoma. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Peptic ulcer disease. Outcome:completely recovered from illness. Visit diagnosis:ppms. Vit D at visit: 24.0. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 6. SDMT denominator: 8. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:69 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.92. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:nmo. Total relapses until visit: 3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 13, 2014. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:endoxan- cyclophosphamide on October 01, 2012. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 12.7 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:1. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on June 01, 2022. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 14. Exercise hrs per week:1. The 25-foot walk done. Assistance required for 25-foot walk test: AFO. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:19.73 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.25. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT: ataricept trial on July 01, 2019. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. The patient is in EDA. Will the patient be in NEDA or EDA after 52 months?",
        "output":"After 52 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.06. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2018. Comments on DMT: rebif. Tobacco smoker: non-smoker  Vit D at visit: 80.0. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:18.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:74.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hashimoto thyroiditis. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:arthritis. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:decompression of spondylolisthesis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:right tronchanteric bursitis. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:total hip replacement. Outcome:completely recovered from illness. Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2014. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Vit D at visit: 21.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 06, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 6.5 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.85 sec. 9-hole peg non-dominant:25.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2014. Vit D at visit: 35.6. MRI of brain or spine done. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 01, 2018. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:knee surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendenctomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.5ppd. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: December 30, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Evidence of LETM. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 6.6 sec. SDMT done. SDMT numerator: 22. SDMT denominator: 26. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:20.7 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2010. Comments on DMT: None . MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 4. The patient is in NEDA. Will the patient be in NEDA or EDA after 38 months?",
        "output":"After 38 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 3.86 sec. SDMT done. SDMT numerator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:21.93 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. OCBs in CSF:negative. Name of co-morbidity:Anemia. More information on co-morbidity:Normocytic anemia- Thallasemia ?. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2020. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 03, 2022. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:12.5 sec. 9-hole peg non-dominant:13.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:2. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:tysabri- natalizumab on April 01, 2016. Comments on DMT: Tecfidera, Tysabri. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.5 PPD. Coffee cups per week: 70. The 25-foot walk done. 25-foot walk test time was 4.96 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.9 sec. 9-hole peg non-dominant:35.19 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 57 months?",
        "output":"After 57 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Bell's Palsy. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on November 01, 2017. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 90 sec. SDMT done. SDMT numerator: 5. SDMT denominator: 6. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:50 sec. 9-hole peg non-dominant:61 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.94. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on June 06, 2022. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 1. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:23.3 sec. 9-hole peg non-dominant:21 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on October 11, 2011. Comments on DMT: Avonex Sep 2010-Mar 2011, Betaferon May 2011-Sep 2011. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: occasionally. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 28, 2017. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.9 sec. 9-hole peg non-dominant:20.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.45. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Nasopharyngeal carcinoma. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on October 01, 2009. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 14, 2012. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The patient is in NEDA. Will the patient be in NEDA or EDA after 35 months?",
        "output":"After 35 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:10. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:endoxan- cyclophosphamide on April 01, 2013. MRI of brain or spine done. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:avonex or cinnovex- im interferon on February 01, 2014. Tobacco smoker: non-smoker  Coffee cups per week: 7. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 3.76 sec. SDMT done. SDMT numerator: 74. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.69 sec. 9-hole peg non-dominant:19.52 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2010. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:20.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.58. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on May 01, 2018. Comments on DMT: Rebif. Vit D at visit: 52.8. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.8 sec. 9-hole peg non-dominant:19 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar, cognitive dysfunction. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on November 01, 2022. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 15, 2022. Cervical spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. SDMT done. SDMT numerator: 22. SDMT denominator: 26. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.5 sec. 9-hole peg non-dominant:24.3 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). IgG index in second:0.99. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Vit D at visit: 17.2. MRI of brain or spine done. Cervical spine MRI date: February 01, 2016. Cervical spine MRI: Not compared to previous spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 3.72 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.5 sec. 9-hole peg non-dominant:18.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on January 01, 2017. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: HB Weekly. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4.01 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.22 sec. 9-hole peg non-dominant:24.63 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:cis. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:19.87 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on June 01, 2013. Comments on DMT: Avonex - Cyclophosphamide. The 25-foot walk done. 25-foot walk test time was 6.75 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.07 sec. 9-hole peg non-dominant:47.36 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.3. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. There were new relapses since the previous visit. DMT taken. Current DMT:tysabri- natalizumab on June 01, 2016. Vit D at visit: 42.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 03, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.87 sec. 9-hole peg non-dominant:20.32 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. Comments on DMT: Tysabri, Rebif. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation incidental mri findings. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: No lesions. Cervical spine MRI date: December 30, 2019. The 25-foot walk done. 25-foot walk test time was 3.38 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.8 sec. 9-hole peg non-dominant:19.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:1.04. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 20, 2012. Tobacco smoker: current  Tobacco type: marijuana. Alcohol drinsk per week: 1. Vit D at visit: 35.6. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:21.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:1.04. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on October 01, 2013. Comments on DMT: Avonex 2012-2013. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 45.4. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 76. SDMT denominator: 77. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:22.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.75. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on December 09, 2013. Comments on DMT: rebif, avonex, imran. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.7 sec. 9-hole peg non-dominant:16.22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Alcohol abuse disorder. Name of co-morbidity:Migraine. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.1 sec. 9-hole peg non-dominant:22.7 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on July 01, 2014. Comments on DMT: Avonex. SDMT done. SDMT numerator: 14. SDMT denominator: 14. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:44 sec. 9-hole peg non-dominant:43 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 35 months?",
        "output":"After 35 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.88. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. Tobacco smoker: non-smoker  Coffee cups per week: 7. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.55 sec. 9-hole peg non-dominant:18.39 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2016. Vit D at visit: 54.29. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.6 sec. 9-hole peg non-dominant:18.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Uveitis. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Behcet Disease. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2018. The 25-foot walk done. 25-foot walk test time was 6.12 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.84 sec. 9-hole peg non-dominant:23.39 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Visit diagnosis:rrms. Total relapses until visit: 2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 01, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:20.3 sec. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:6. Visit diagnosis:rrms. Total relapses until visit: 9. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on March 11, 2019. Comments on DMT: avonex, betaferon, rebif, gilenya. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: September 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.85 sec. 9-hole peg non-dominant:28 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 8.45 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.05 sec. 9-hole peg non-dominant:22.85 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Renal disorders. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on October 01, 2021. The 25-foot walk done. 25-foot walk test time was 6.2 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:21.5 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:negative. IgG index in CSF:0.72. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:suclinical hypothyrodism. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:ocrevus - ocrelizumab on August 20, 2018. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on October 10, 2019. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 21, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.14 sec. SDMT done. SDMT numerator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.04 sec. 9-hole peg non-dominant:25.07 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Initial presentation incidental mri findings. Number of attacks until the first visit:0. OCBs in CSF:positive. IgG index in CSF:0.64. Visit diagnosis:ris. Total relapses until visit: 0. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: IQOS. Coffee cups per week: 8. Alcohol drinsk per week: 3. Exercise hrs per week:3. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). SDMT done. SDMT numerator: 73. SDMT denominator: 74. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.9 sec. 9-hole peg non-dominant:18.4 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:74.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Transurethra resenction of bladder tumor. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Right double J insertion and laser stone fragmentation. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Colonic polyps and diverticula. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on October 01, 2014. Vit D at visit: 53.7. The 25-foot walk done. 25-foot walk test time was 3.92 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.3 sec. 9-hole peg non-dominant:27.1 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation focal spasms. Visit diagnosis:rrms. DMT taken. Current DMT: gilenya- fingolimod. Vit D at visit: 41.4. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Mitoxantrone, rebif. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2020. Tobacco smoker: non-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: December 01, 2022. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:15.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2017. Tobacco smoker: ex-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 01, 2021. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.4 sec. 9-hole peg non-dominant:25.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 4. The 25-foot walk done. 25-foot walk test time was 3.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.23 sec. 9-hole peg non-dominant:13.23 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Surgeries. More information on co-morbidity:oophorectomy for ovrian teratoma. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on July 02, 2018. Comments on DMT: Rebif. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.89 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.84 sec. 9-hole peg non-dominant:26.42 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Anterior Uveitis. Name of co-morbidity:Migraine. Name of co-morbidity:Depression. Visit diagnosis:rrms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on March 01, 2011. Comments on DMT: Rebif, Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 12, 2012. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 9. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in second CSF:negative. IgG index in second:0.59. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2015. The 25-foot walk done. 25-foot walk test time was 3.35 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.48 sec. 9-hole peg non-dominant:21.03 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. Total relapses until visit: 1. DMT taken. Current DMT: avonex or cinnovex- im interferon. Comments on DMT: None . MRI of brain or spine done. Cervical spine MRI date: March 13, 2013. Cervical spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:22.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2014. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1ppd. Coffee cups per week: 14. Alcohol drinsk per week: 1. Vit D at visit: 55.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.58 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.87 sec. 9-hole peg non-dominant:19.53 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:knee trauma. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: Cinnovex until 2014. Tobacco smoker: non-smoker  Vit D at visit: 4.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: November 27, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 5. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 32. SDMT denominator: 32. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.5 sec. 9-hole peg non-dominant:38.9 sec. EDSS:7.5- unable to take more than a few steps; restricted to wheelchair; may need some help in transferring and in wheeling self. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Solumedrol- IV Methylprednisolone. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2003. Vit D at visit: 92.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.48 sec. SDMT done. SDMT numerator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.59 sec. 9-hole peg non-dominant:16.72 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:lemtrada- alemtuzumab on January 01, 2017. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:20.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:20.  Gender:female.  Diagnosis:mog disease. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:congenital aortic stenosis and regurge. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2021. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.2 sec. 9-hole peg non-dominant:19.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.47. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on November 07, 2014. Comments on DMT: Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 05, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.75 sec. 9-hole peg non-dominant:22.69 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:76.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Disk surgery. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Right ear congenital hearing loss. Outcome:ongoing illness. Name of co-morbidity:Tooth abscess + extraction. Outcome:completely recovered from illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total Left hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on April 05, 2012. Comments on DMT: rebif, atoricept. The 25-foot walk done. 25-foot walk test time was 23.31 sec. SDMT done. SDMT numerator: 24. SDMT denominator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31.32 sec. 9-hole peg non-dominant:34.45 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.83. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2020. Tobacco smoker: non-smoker  Exercise hrs per week:2. Vit D at visit: 55.6. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.3 sec. 9-hole peg non-dominant:15.7 sec. Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.12. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Exercise hrs per week:3. Vit D at visit: 45.8. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 06, 2019. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.5 sec. 9-hole peg non-dominant:23 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Visit diagnosis:ppms. Total relapses until visit: 0. The 25-foot walk done. 25-foot walk test time was 9.4 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.9 sec. 9-hole peg non-dominant:80 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2021. Comments on DMT: Avonex. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.6 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.8 sec. 9-hole peg non-dominant:21.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:5. Visit diagnosis:spms. Total relapses until visit: 5. DMT taken. Current DMT:endoxan- cyclophosphamide on July 01, 2012. Comments on DMT: avonex, Rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 12.2 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:19.92 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:negative. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 30, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.7 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:copaxone- glatiramer acetate on May 01, 2019. MRI of brain or spine done. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: April 04, 2019. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.89 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.5 sec. 9-hole peg non-dominant:21.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 55 months?",
        "output":"After 55 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:spms. DMT taken. Current DMT:endoxan- cyclophosphamide on September 10, 2012. Comments on DMT: Betaferon, Avonex, Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 26, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.75. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:hashimoto thyroiditis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2014. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:17 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:0.88. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2012. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.82 sec. SDMT done. SDMT numerator: 71. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.38 sec. 9-hole peg non-dominant:16.16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 36 months?",
        "output":"After 36 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2014. Comments on DMT: Betaferon (Sep 2012-Mar 2013), Rebif (Mar 2013-Jan 2014). Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.5 ppd. The 25-foot walk done. 25-foot walk test time was 4.48 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.5 sec. 9-hole peg non-dominant:24.07 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 23, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 33. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:46.7 sec. 9-hole peg non-dominant:41.3 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:53.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on May 28, 2018. Comments on DMT: Avonex. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT: mabthera- rituximab. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 43. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 10, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 20.5 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.3 sec. 9-hole peg non-dominant:26.8 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.11. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. Comments on DMT: Rebif. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.5 sec. 9-hole peg non-dominant:15 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Rash. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.6 sec. 9-hole peg non-dominant:22.8 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:19.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.89. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Coffee cups per week: 1. Alcohol drinsk per week: 1. Exercise hrs per week:6. Vit D at visit: 42.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 01, 2023. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. Remarks about MRI: lesions involving hippocampi. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:16.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 5. There were new relapses since the previous visit. DMT taken. Current DMT:lemtrada- alemtuzumab on April 01, 2016. Comments on DMT: betaferon. Tobacco smoker: ex-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 11, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 5.77 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:41.5 sec. 9-hole peg non-dominant:23.64 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2021. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Cervical spine MRI date: February 10, 2022. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.25. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: Avonex (2000-June 2005, July 2007-Apr 2008), Atacicept (July 2008-Sep 2009), Rebif (2000, Apr 2008-July 2008, Dec 2009-Mar 2013). Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: daily. Coffee cups per week: 21. The 25-foot walk done. 25-foot walk test time was 5.1 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.4 sec. 9-hole peg non-dominant:19.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.42. Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT: gilenya- fingolimod. Comments on DMT: Avonex. The 25-foot walk done. 25-foot walk test time was 2.98 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.05 sec. 9-hole peg non-dominant:18.38 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2016. Comments on DMT: Avonex (Mar 2013-Jan 2016). MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 10, 2021. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.87 sec. 9-hole peg non-dominant:16.35 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2019. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: December 05, 2020. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:spms. Comments on DMT: Avonex, Rebif, Gilenya. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 21 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:43 sec. 9-hole peg non-dominant:31.4 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Anti phospholipid syndrome. Outcome:ongoing illness. Name of co-morbidity:Familial Mediteranean Fever. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: non-smoker  Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on July 01, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 25 sec. SDMT done. SDMT numerator: 19. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:46 sec. 9-hole peg non-dominant:35 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2011. Comments on DMT: Avonex Sep 2010-Mar 2011, Betaferon May 2011-Sep 2011. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: hubble bubble occasionally. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 02, 2015. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.36 sec. 9-hole peg non-dominant:21.64 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.16. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:RL fracture s\/p surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. There were new relapses since the previous visit. Comments on DMT: Tecfidera. The 25-foot walk done. 25-foot walk test time was 4.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 39 months?",
        "output":"After 39 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:3.79. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on February 01, 2021. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2022. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: No lesions. Cervical spine MRI date: June 22, 2023. The 25-foot walk done. 25-foot walk test time was 10.7 sec. SDMT done. SDMT numerator: 21. SDMT denominator: 22. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31 sec. 9-hole peg non-dominant:29 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 01, 2016. Comments on DMT: Avonex. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 08, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.69 sec. 9-hole peg non-dominant:19 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:75.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH s\/p TURP. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Constipation. Outcome:ongoing illness. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on May 12, 2017. Comments on DMT: Rebif - Avonex- Betaseron. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 42. SDMT denominator: 43. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:45.22 sec. EDSS:8- essentially restricted to bed or chair or perambulated in wheelchair but out of bed most of day; retains many self-care functions; generally has effective use of arms. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Visit diagnosis:cis. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 14, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 40. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.93 sec. 9-hole peg non-dominant:20.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 26, 2014. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.7 sec. 9-hole peg non-dominant:25.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:tysabri- natalizumab on April 01, 2017. Comments on DMT: avonex, cladribine. Vit D at visit: 67.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 21, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 6.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.3 sec. 9-hole peg non-dominant:46.8 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.8. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2008. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. The patient is in EDA. Will the patient be in NEDA or EDA after 54 months?",
        "output":"After 54 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on April 07, 2016. MRI of brain or spine done. Cervical spine MRI date: November 15, 2017. The 25-foot walk done. 25-foot walk test time was 5.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.7 sec. 9-hole peg non-dominant:31.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on June 23, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 17, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:19.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:62.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.5. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:progressive myelopathy. Several relapses until this visit. SDMT done. SDMT numerator: 15. SDMT denominator: 17. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:58.78 sec. 9-hole peg non-dominant:53.1 sec. EDSS:7.5- unable to take more than a few steps; restricted to wheelchair; may need some help in transferring and in wheeling self. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2011. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.26 sec. 9-hole peg non-dominant:16.54 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on September 01, 2017. The 25-foot walk done. 25-foot walk test time was 13.9 sec. SDMT done. SDMT numerator: 28. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.9 sec. 9-hole peg non-dominant:29 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:5. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 10. There were new relapses since the previous visit. DMT taken. Current DMT:mavenclad- cladribine on February 01, 2020. Comments on DMT: Avonex, betaferon, gilenya, tysabri, tecfidera. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.18 sec. 9-hole peg non-dominant:15.67 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Anterior Uveitis. Name of co-morbidity:Migraine. Name of co-morbidity:Depression. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2002. Comments on DMT: None . MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:1. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on December 01, 2013. Comments on DMT: Betaferon - Avonex. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: March 17, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.44 sec. 9-hole peg non-dominant:22.01 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 5. Comments on DMT: Rebif  (May 2016 until June 2017)- Gilenya  (June 2017 - October 2017) Tecfidera (December 202. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:18 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.06. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Sciatica. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2015. Vit D at visit: 43.5. The 25-foot walk done. 25-foot walk test time was 4.86 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.56 sec. 9-hole peg non-dominant:24.16 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on August 01, 2015. Comments on DMT: rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 25. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.5 sec. 9-hole peg non-dominant:23.3 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2010. Comments on DMT: Copaxone - Betaferon - Mitoxantrone. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 11.4 sec. SDMT done. SDMT numerator: 18. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:50.7 sec. 9-hole peg non-dominant:51.3 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 44 months?",
        "output":"After 44 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Visit diagnosis:rrms. Several relapses until this visit. The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 25. SDMT denominator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.3 sec. 9-hole peg non-dominant:29.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on May 01, 2013. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: April 24, 2018. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:VZV Trigeminal neuritis. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:mavenclad- cladribine on July 01, 2020. Comments on DMT: Tecfidera, Rebif. Tobacco smoker: non-smoker  Vit D at visit: 55.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: May 30, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:24.56 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 20 months?",
        "output":"After 20 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem. Number of attacks until the first visit:4. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on April 01, 2016. Comments on DMT: Avonex - Betaferon - Recigen - Mitoxantrone. Vit D at visit: 105.4. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: May 03, 2017. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:5. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on December 01, 2012. Comments on DMT: Avonex Sep 2010-Sep 2011, Betaferon Oct 2011-Feb 2012, Gilenya Mar 2010-Oct 2012. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.2 sec. 9-hole peg non-dominant:18.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.61. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on December 01, 2016. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 18, 2023. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:16.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.92. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Allergies. More information on co-morbidity:penicillin. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:lumpectomy. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:fibroid resection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 5.9 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.1 sec. 9-hole peg non-dominant:34.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:22.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. OCBs in CSF:positive. IgG index in CSF:0.82. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Comments on DMT: aubagio. Vit D at visit: 18.92. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.9 sec. 9-hole peg non-dominant:19.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 26 months?",
        "output":"After 26 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation incidental mri findings. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Vit D at visit: 19.1. MRI of brain or spine done. Cervical spine MRI date: August 02, 2018. The 25-foot walk done. 25-foot walk test time was 3.93 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:21.59 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. Visit diagnosis:spms. Total relapses until visit: 3. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 47 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31 sec. 9-hole peg non-dominant:79 sec. EDSS:8- essentially restricted to bed or chair or perambulated in wheelchair but out of bed most of day; retains many self-care functions; generally has effective use of arms. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 5. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: May 26, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.29 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.9 sec. 9-hole peg non-dominant:23.7 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:1.29. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 0. Comments on DMT: Rebif . MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 21, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. More information on co-morbidity:herpes zoster ophthalmicus. Outcome:completely recovered from illness. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: avonex, rebif, cyclophosphamide . Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 56 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:38 sec. 9-hole peg non-dominant:46 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation focal spasms. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.88. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on August 18, 2017. Comments on DMT: Rebif (2016-2017). MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:18 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2011. Comments on DMT: Cladribine trial. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 39 months?",
        "output":"After 39 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Anterior Uveitis. Name of co-morbidity:Migraine. Name of co-morbidity:Depression. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on April 01, 2011. Comments on DMT: Rebif Avonex. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 21. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:17 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. Comments on DMT: Avonex, Aubagio. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 20, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.9 sec. 9-hole peg non-dominant:22.42 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:Continue DMT Aubagio (stopped recently for no reason). New DMT:Aubagio- Teriflunomide. The patient is in EDA due to relapses AND new EDSS findings. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on March 01, 2009. Comments on DMT: Rebif. Vit D at visit: 24.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2020. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: March 01, 2021. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 86. SDMT denominator: 88. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.66 sec. 9-hole peg non-dominant:18.72 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.804. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:low back pain. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2017. Comments on DMT: rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 3.92 sec. SDMT done. SDMT numerator: 23. SDMT denominator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.29 sec. 9-hole peg non-dominant:19.41 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2014. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Vit D at visit: 70.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: August 12, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.8 sec. 9-hole peg non-dominant:21.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2016. Comments on DMT: Betaferon, Rebif. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.7 sec. 9-hole peg non-dominant:21.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2013. Tobacco smoker: non-smoker  Vit D at visit: 60.0. The 25-foot walk done. 25-foot walk test time was 2.9 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.6 sec. 9-hole peg non-dominant:19.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. IgG index in CSF:0.87. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.76. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:18.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:2.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on September 15, 2022. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:20 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:74.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Transurethra resenction of bladder tumor. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Right double J insertion and laser stone fragmentation. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Colonic polyps and diverticula. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on January 06, 2016. Comments on DMT: avonex. Tobacco smoker: ex-smoker  Vit D at visit: 49.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.6 sec. 9-hole peg non-dominant:22 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 23 months?",
        "output":"After 23 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:86.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation myelitis. Number of attacks until the first visit:3. Name of co-morbidity:Diffuse cystic mastopathy s\/p subtotal mastectomy. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonitis. Outcome:completely recovered from illness. Name of co-morbidity:Sepsis. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:hemorrhage. Outcome:death due to illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2010. Comments on DMT: Mitoxantrone  - Avonex - Mabthera  -. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:20.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. Visit diagnosis:rrms. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:19.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:7. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 6. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2000. Tobacco smoker: non-smoker  Coffee cups per week: 28. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 6.9 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29 sec. 9-hole peg non-dominant:51 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 11, 2021. Tobacco smoker: ex-smoker  Vit D at visit: 33.9. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.26 sec. 9-hole peg non-dominant:20.5 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:logistic issues to obtain the DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation brainstem. Has experienced progressive symptoms since onset. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:OCD. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on March 01, 2019. Comments on DMT: Rebif\u00c2\u00a0(2019). Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. Assistance required for 25-foot walk test: Unilateral assistance by a person. 25-foot walk test time was 14.5 sec. SDMT done. SDMT numerator: 7. SDMT denominator: 7. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:47 sec. 9-hole peg non-dominant:80 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Brain Tumor. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on July 01, 2015. Tobacco smoker: non-smoker  Vit D at visit: 63.6. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:14.33 sec. 9-hole peg non-dominant:16 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on May 11, 2016. Comments on DMT: Avonex, Betaferon. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.38 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.13 sec. 9-hole peg non-dominant:28.83 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.58. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT: solumedrol- iv methylprednisolone. Comments on DMT: REbif, Tecfidera, off due to pregnancy, solumedrol while breastfeeding . Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 89. SDMT denominator: 89. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on September 01, 2021. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:16.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2014. Comments on DMT: 2002-2005: Avonex; 2005 - dec 2013: Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 21.2 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 27. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:38.9 sec. 9-hole peg non-dominant:46.5 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2018. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. Cervical spine MRI date: October 22, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. The 25-foot walk done. 25-foot walk test time was 4.47 sec. SDMT done. SDMT numerator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.99 sec. 9-hole peg non-dominant:21.04 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Hyperlipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2016. Vit D at visit: 68.5. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.88 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.2 sec. 9-hole peg non-dominant:23.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:5. Visit diagnosis:spms. Total relapses until visit: 5. The 25-foot walk done. 25-foot walk test time was 9.27 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:19.92 sec. 9-hole peg non-dominant:19.29 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.92. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Allergies. More information on co-morbidity:penicillin. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:lumpectomy. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:fibroid resection. Outcome:completely recovered from illness. Visit diagnosis:ppms. Total relapses until visit: 0. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 26, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 5.32 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. Dominant hand:Right.  9-hole peg dominant:23.2 sec. 9-hole peg non-dominant:27.3 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2016. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:20.3 sec. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.61. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on December 01, 2016. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 35. Alcohol drinsk per week: 1. Exercise hrs per week:3. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 12, 2023. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.4 sec. 9-hole peg non-dominant:16.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on May 11, 2016. Comments on DMT: Avonex, Betaferon. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5.98 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.48 sec. 9-hole peg non-dominant:27 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS . Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on November 02, 2022. Tobacco smoker: non-smoker  Exercise hrs per week:5. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on May 01, 2022. Vit D at visit: 37.1. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.6 sec. 9-hole peg non-dominant:23.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 10. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 88. SDMT denominator: 88. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15.9 sec. 9-hole peg non-dominant:17.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Visit diagnosis:rrms. DMT taken. Current DMT:copaxone- glatiramer acetate on June 01, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 14, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.1 sec. 9-hole peg non-dominant:21.8 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:80.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Bronchitis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Tendinitis. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 26, 2015. Comments on DMT: endoxan. Tobacco smoker: non-smoker  Vit D at visit: 69.0. The 25-foot walk done. Assistance required for 25-foot walk test: Rollator. 25-foot walk test time was 82 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.37 sec. 9-hole peg non-dominant:27.86 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on November 01, 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 03, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.2 sec. 9-hole peg non-dominant:16.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on March 05, 2014. Comments on DMT: Betaferon. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:5. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2013. Comments on DMT: rebif, betaferon. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 24. The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.8 sec. 9-hole peg non-dominant:19.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:76.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Disk surgery. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Right ear congenital hearing loss. Outcome:ongoing illness. Name of co-morbidity:Tooth abscess + extraction. Outcome:completely recovered from illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total Left hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on April 05, 2012. Comments on DMT: rebif, atoricept trial. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 28.1 sec. SDMT done. SDMT numerator: 22. SDMT denominator: 22. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.79 sec. 9-hole peg non-dominant:28.4 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Biotin. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on June 01, 2021. The 25-foot walk done. 25-foot walk test time was 17 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30 sec. 9-hole peg non-dominant:21 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:86.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation myelitis. Number of attacks until the first visit:3. Name of co-morbidity:Diffuse cystic mastopathy s\/p subtotal mastectomy. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonitis. Outcome:completely recovered from illness. Name of co-morbidity:Sepsis. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:hemorrhage. Outcome:death due to illness. Visit diagnosis:spms. Total relapses until visit: 3. Comments on DMT: Mitoxantrone  - Avonex - Mabthera  - Betaferon . Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 7. SDMT denominator: 9. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:48.2 sec. 9-hole peg non-dominant:89.59 sec. EDSS:8- essentially restricted to bed or chair or perambulated in wheelchair but out of bed most of day; retains many self-care functions; generally has effective use of arms. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:ocrevus - ocrelizumab on September 01, 2020. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.91 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.04 sec. 9-hole peg non-dominant:25.08 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:logistic issues to obtain the DMT. New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. OCBs in CSF:negative. Name of co-morbidity:Anemia. More information on co-morbidity:Normocytic anemia- Thallasemia ?. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2020. Tobacco smoker: ex-smoker  Coffee cups per week: 14. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 93. SDMT denominator: 93. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.5 sec. 9-hole peg non-dominant:14.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:1.04. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on October 01, 2013. Comments on DMT: Avonex 2012-2013. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 41.23. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 78. SDMT denominator: 79. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:20.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.9. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2016. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.62 sec. 9-hole peg non-dominant:18.51 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:2.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.5 sec. 9-hole peg non-dominant:33 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.91. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2021. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 01, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 34. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:23 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT: aubagio- teriflunomide. Comments on DMT: betaferon. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on June 01, 2013. Comments on DMT: Betaferon. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.67 sec. 9-hole peg non-dominant:24.05 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:pregnancy plans. New DMT:Solumedrol- IV Methylprednisolone. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:nmo. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on July 01, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.9 sec. 9-hole peg non-dominant:21.01 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:67.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis, sarcoidosis. OCBs in CSF:negative. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 3. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:nmo. Several relapses until this visit. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on May 01, 2011. Comments on DMT: Mabthera and monthly IVMP. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2018. Comments on DMT: Rebif. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: April 23, 2019. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:21 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 01, 2011. Comments on DMT: Betaferon - Mabthera - Monthly steroids. The 25-foot walk done. 25-foot walk test time was 12.2 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 23 months?",
        "output":"After 23 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:7. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on October 10, 2019. Comments on DMT: Rebif. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 26. SDMT denominator: 26. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.3 sec. 9-hole peg non-dominant:21 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2011. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.94 sec. 9-hole peg non-dominant:16.84 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.82. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:hearing problem. Name of co-morbidity:thrombocytopenia medication induced. Outcome:ongoing illness. Visit diagnosis:ppms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 02, 2006. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Both enhancing and non-enhancing lesions. Total T1 Gad-enhancing lesions in Cervical spine: 1. The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:2.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on April 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 01, 2022. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:90.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Hysterectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:bilateral cataract surgery. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:PTCA stenting. Outcome:completely recovered from illness. Name of co-morbidity:Posterior capsular opasification of lens bilaterally. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:chronic nausea. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. Tobacco smoker: non-smoker  Exercise hrs per week:2. Vit D at visit: 24.5. The 25-foot walk done. 25-foot walk test time was 23.54 sec. SDMT done. SDMT numerator: 16. SDMT denominator: 18. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.88 sec. 9-hole peg non-dominant:31.66 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: Betaferon, Rebif. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:30 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tysabri- Natalizumab. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:lemtrada- alemtuzumab on March 23, 2016. Comments on DMT: Betaferon. Tobacco smoker: ex-smoker  Coffee cups per week: 4. Alcohol drinsk per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 13, 2018. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:19.7 sec. 9-hole peg non-dominant:20.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Rheumatoid arhritis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on January 01, 2019. Comments on DMT: gilenya, tysabri, cyclophosphamide. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 35.4. The 25-foot walk done. 25-foot walk test time was 6.2 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.75 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on October 08, 2019. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:75.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:5. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2001. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 9.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:45.9 sec. 9-hole peg non-dominant:31.3 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:5. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on April 29, 2015. Comments on DMT: avonex. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.9 sec. 9-hole peg non-dominant:23.3 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on March 01, 2014. MRI of brain or spine done. Cervical spine MRI date: February 07, 2019. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.75. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2013. Comments on DMT: Rebif - Avonex - Azathioprine. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 01, 2018. Received Gadolinium for Cervical spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. The 25-foot walk done. 25-foot walk test time was 5.17 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:67.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.95. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2014. Comments on DMT: Rebif - Avonex. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 2ppd. Coffee cups per week: 21. Alcohol drinsk per week: 2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.49 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.11 sec. 9-hole peg non-dominant:23.45 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Vitamin B 12 deficiency. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on February 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 10.15 sec. SDMT done. SDMT numerator: 18. SDMT denominator: 18. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.9 sec. 9-hole peg non-dominant:31.68 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:2. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mavenclad- cladribine on September 01, 2019. The 25-foot walk done. 25-foot walk test time was 3.26 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.12 sec. 9-hole peg non-dominant:20.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 20 months?",
        "output":"After 20 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Comments on DMT: rebif. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 83. SDMT denominator: 83. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:16.4 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:2. OCBs in second CSF:positive. OCBs in third CSF:positive. IgG index in third CSF:0.52. IgG index category in third CSF:Normal (< 0.77). Name of co-morbidity:schizoaffective. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: gilenya- fingolimod. Comments on DMT: Betaferon. The 25-foot walk done. 25-foot walk test time was 4.78 sec. SDMT done. SDMT numerator: 27. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.5 sec. 9-hole peg non-dominant:31.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2018. Comments on DMT: rebif. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.4 sec. 9-hole peg non-dominant:15.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:10. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2011. Comments on DMT: Betaseron - Avonex - Rebif - Imuran. MRI of brain or spine done. Cervical spine MRI date: January 28, 2013. The patient is in EDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2013. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 6 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.5 sec. 9-hole peg non-dominant:33.9 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: tysabri- natalizumab. Comments on DMT: Rebif - Avonex. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.1 sec. 9-hole peg non-dominant:17.3 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. More information on co-morbidity:herpes zoster ophthalmicus. Outcome:completely recovered from illness. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: Avonex, Endoxan (Cyclophosphamide), Rebif. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 37 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:36.1 sec. 9-hole peg non-dominant:31.1 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:6. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2012. Comments on DMT: avonex, betaferon, rebif. The 25-foot walk done. 25-foot walk test time was 3.48 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.33 sec. 9-hole peg non-dominant:25.94 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:tysabri- natalizumab on December 10, 2014. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.17 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.64. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 21, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:T2 N0 M0, ER\/PR positive and HER-2 negative breast cancer. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 4. Comments on DMT: Gilenya, Aubagio, Tecfidera, Mabthera. Tobacco smoker: ex-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 55 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.44 sec. 9-hole peg non-dominant:22.5 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:5. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:gilenya- fingolimod on April 29, 2015. Comments on DMT: avonex. Vit D at visit: 61.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.1 sec. 9-hole peg non-dominant:23.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:negative. IgG index in second:0.46. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:anterior uveitis. Outcome:completely recovered from illness. Name of co-morbidity:iridocorneal adhesions. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Name of co-morbidity:Sciatica. Outcome:ongoing illness. Name of co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:prolactinemia 2ry to Tegretol. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Klebsiella pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on October 01, 2017. Comments on DMT: Tysabri (2015-June 2017). Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 21. Alcohol drinsk per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 28, 2021. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.4 sec. 9-hole peg non-dominant:18.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: Tecfidera. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Cervical spine MRI date: September 28, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left. 9-hole peg non-dominant:36.9 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Name of co-morbidity:Anxiety. Visit diagnosis:rrms. Total relapses until visit: 11. DMT taken. Current DMT:mabthera- rituximab on June 01, 2016. Comments on DMT: Rebif - Imuran - Gilenya. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.39 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:17.78 sec. 9-hole peg non-dominant:20.27 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. Name of co-morbidity:Absence Seizures. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:avonex or cinnovex- im interferon on October 10, 2014. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:5. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on September 15, 2014. Comments on DMT: Betaferon (June 2006-August 2012). Vit D at visit: 70.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 24, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 2. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.61 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.19 sec. 9-hole peg non-dominant:24.57 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2014. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 6.6 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.4 sec. 9-hole peg non-dominant:23.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female. . Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.84. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on April 01, 2017. Comments on DMT: rebif, avonex. Tobacco smoker: current  Tobacco type: water-pipe. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: January 11, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.9 sec. 9-hole peg non-dominant:32.1 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:2. Visit diagnosis:rrms. Comments on DMT: Avonex - Rebif. The patient is in NEDA. Will the patient be in NEDA or EDA after 27 months?",
        "output":"After 27 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.61. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:spms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on September 01, 2017. Comments on DMT: Rebif, Avonex. The 25-foot walk done. 25-foot walk test time was 7.2 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.5 sec. 9-hole peg non-dominant:23 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 3. Tobacco smoker: non-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: April 01, 2022. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on September 01, 2021. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:16 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:1.47. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 08, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.7 sec. 9-hole peg non-dominant:20.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 20 months?",
        "output":"After 20 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, bowel\/bladder dysfunction. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 55.68. The 25-foot walk done. 25-foot walk test time was 4 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.48. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on December 28, 2017. Tobacco smoker: non-smoker  Vit D at visit: 37.4. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:18.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on November 01, 2021. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 24. SDMT denominator: 26. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.5 sec. 9-hole peg non-dominant:24.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:hydronephrosis . Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:sinusitis . Name of co-morbidity:Surgeries. More information on co-morbidity:c section, sinus surgery, external fixation of ankle fracture. Outcome:completely recovered from illness. Visit diagnosis:cis. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.16 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.65 sec. 9-hole peg non-dominant:17.89 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation brainstem. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Alzheimer's. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Pityriasis versicolor. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:delayed gastric emptying. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 21, 2007. Comments on DMT:  + Imuran. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Name of co-morbidity:Hpodgkin's Lymphoma. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2022. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: October 19, 2022. Whole spinal cord lesion load on MRI: No lesions. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, incidental mri findings. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.91. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2020. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: February 23, 2023. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.35 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:67.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. DMT taken. Current DMT: imuran-azathioprine. Comments on DMT: Rebif - Betaferon - Imuran. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 28, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 95 sec. SDMT done. SDMT numerator: 12. SDMT denominator: 14. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:128 sec. 9-hole peg non-dominant:138 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:5. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on September 15, 2014. Comments on DMT: Betaferon June 2006 to August 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: October 19, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.55 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.47 sec. 9-hole peg non-dominant:22.46 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Rheumatoid arhritis. Outcome:ongoing illness. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on December 28, 2013. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 10 Pack years. Coffee cups per week: 7. Vit D at visit: 41.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 25, 2013. The 25-foot walk done. 25-foot walk test time was 9.5 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:22.4 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation expressive aphasia. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2020. Tobacco smoker: ex-smoker  Vit D at visit: 92.0. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:21 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:cis. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 12, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:16.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT: gilenya- fingolimod. Vit D at visit: 88.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.3 sec. 9-hole peg non-dominant:29.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 18, 2013. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 PPD. Coffee cups per week: 21. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.6 sec. 9-hole peg non-dominant:19.9 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.44. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 22, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 1. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.8 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.1 sec. 9-hole peg non-dominant:16.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:56.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 2 PPD. Coffee cups per week: 14. Alcohol drinsk per week: 1. Vit D at visit: 27.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: August 20, 2013. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.9 sec. 9-hole peg non-dominant:19.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Avonex or Cinnovex- IM Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness, brainstem. Number of attacks until the first visit:6. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on May 01, 2018. Comments on DMT: avonex, recigen. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 17.6 sec. SDMT done. SDMT numerator: 18. SDMT denominator: 22. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:22.8 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mavenclad- cladribine on December 01, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: June 01, 2020. Received Gadolinium for Cervical spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:15.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.98. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2019. Comments on DMT: REbif. Vit D at visit: 48.9. The 25-foot walk done. 25-foot walk test time was 3.87 sec. SDMT done. SDMT numerator: 80. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:16.88 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:5. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:spms. Comments on DMT: Betaferon, Avonex, Rebif, cyclophosphamide . MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 12.4 sec. SDMT done. SDMT numerator: 15. SDMT denominator: 15. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.4 sec. 9-hole peg non-dominant:42.1 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:ocrevus - ocrelizumab on June 01, 2018. Tobacco smoker: ex-smoker  Coffee cups per week: 21. Alcohol drinsk per week: 1. Exercise hrs per week:4. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis, brainstem. Number of attacks until the first visit:1. IgG index in CSF:3.2. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2014. Comments on DMT: Cladribine trial. Tobacco smoker: non-smoker  Vit D at visit: 20.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.68 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.97 sec. 9-hole peg non-dominant:18.74 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on February 01, 2015. Tobacco smoker: ex-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 2. Vit D at visit: 95.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 29, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 71. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.46 sec. 9-hole peg non-dominant:18.76 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2015. Comments on DMT: Betaferon- Tysabri. Tobacco smoker: non-smoker  Vit D at visit: 29.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 03, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 1. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 6.3 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.33 sec. 9-hole peg non-dominant:26.56 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis, cerebellar. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Vit D at visit: 3.2. MRI of brain or spine done. Cervical spine MRI date: June 16, 2014. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 6.2 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.3 sec. 9-hole peg non-dominant:22.1 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Visit diagnosis:ris. Total relapses until visit: 0. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.48 sec. 9-hole peg non-dominant:17.38 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. Comments on DMT: Avonex, Gilenya, Rebif. The 25-foot walk done. 25-foot walk test time was 4.92 sec. SDMT done. SDMT numerator: 34. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.85 sec. 9-hole peg non-dominant:28.8 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:knee surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendenctomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 49.8. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.18 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hepatic disorders. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on May 01, 2023. Comments on DMT: Cladribine in 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 21. Alcohol drinsk per week: 3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: August 01, 2023. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:17.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:80.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Bronchitis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Tendinitis. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 2. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. 25-foot walk test time was 12.6 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.5 sec. 9-hole peg non-dominant:30 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2011. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 21. Alcohol drinsk per week: 1. Exercise hrs per week:7. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.65 sec. 9-hole peg non-dominant:17.27 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 08, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. Dominant hand:Right.  9-hole peg dominant:21.3 sec. 9-hole peg non-dominant:22.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Visit diagnosis:rrms. Total relapses until visit: 8. DMT taken. Current DMT:mabthera- rituximab on April 01, 2019. Vit D at visit: 29.8. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:19.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 11. DMT taken. Current DMT:mabthera- rituximab on May 01, 2016. Coffee cups per week: 7. Exercise hrs per week:3. The 25-foot walk done. 25-foot walk test time was 6.69 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26 sec. 9-hole peg non-dominant:27 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female. . Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.84. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on March 26, 2019. Comments on DMT: Rebif, Avonex, Tysabri. Tobacco smoker: current  Tobacco type: water-pipe. Alcohol drinsk per week: 1. Exercise hrs per week:3. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 27. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.7 sec. 9-hole peg non-dominant:33.5 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 07, 2015. Vit D at visit: 71.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 11, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:18.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:ACID REFLUX . Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 3. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. Comments on DMT: Betaferon - Rebif. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on May 01, 2011. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 25, 2011. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 8.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:17.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.19. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: July 17, 2023. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.88 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:22.65 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:ocrevus - ocrelizumab on June 01, 2018. Comments on DMT: Mycophenolate Mofetil, Betaferon, Cyclophosphamide, Rituximab. The 25-foot walk done. 25-foot walk test time was 7.2 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31.8 sec. 9-hole peg non-dominant:21.8 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:prolactinoma. Outcome:ongoing illness. Name of co-morbidity:degenrative disk disease. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:chronic constipation. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2020. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: May 20, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:15.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on May 01, 2013. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 PPD. Coffee cups per week: 14. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 74. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.17 sec. 9-hole peg non-dominant:18.11 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2016. Comments on DMT: Avonex. Vit D at visit: 56.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 04, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 77. SDMT denominator: 77. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:18.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 10, 2003. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.19 sec. 9-hole peg non-dominant:19.07 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2017. Vit D at visit: 78.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: February 01, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 4. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. Comments on DMT: rebif, gilenya, ATAMS trial . MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 18 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.4 sec. 9-hole peg non-dominant:23.3 sec. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:74.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on April 01, 2013. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 2PPD. Coffee cups per week: 14. Vit D at visit: 36.5. MRI of brain or spine done. Cervical spine MRI date: November 16, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 12.8 sec. SDMT done. SDMT numerator: 9. SDMT denominator: 16. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.3 sec. 9-hole peg non-dominant:25.5 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.67. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. MRI of brain or spine done. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: January 05, 2016. Cervical spine MRI: Not compared to previous spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 4.06 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.57 sec. 9-hole peg non-dominant:18.17 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Avonex or Cinnovex- IM Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2019. Comments on DMT: Rebif Avonex Gilenya. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 44.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: October 04, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.96 sec. 9-hole peg non-dominant:18.12 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on December 28, 2015. Comments on DMT: betaferon. Tobacco smoker: ex-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 12.8 sec. SDMT done. SDMT numerator: 23. SDMT denominator: 23. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.6 sec. 9-hole peg non-dominant:27.4 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on May 01, 2022. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 01, 2022. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.44 sec. 9-hole peg non-dominant:20 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. Vit D at visit: 25.4. MRI of brain or spine done. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.72 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.3 sec. 9-hole peg non-dominant:22.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:ocrevus - ocrelizumab on March 01, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:19.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.8. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2016. Comments on DMT: Betaferon. Vit D at visit: 28.8. The 25-foot walk done. 25-foot walk test time was 5.1 sec. SDMT done. SDMT numerator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.9 sec. 9-hole peg non-dominant:21.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation brainstem. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Alzheimer's. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Pityriasis versicolor. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:delayed gastric emptying. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 21, 2007. Comments on DMT:  + imuran. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 14.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 20.8 sec. SDMT done. SDMT numerator: 17. SDMT denominator: 17. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:36.9 sec. 9-hole peg non-dominant:48.3 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 01, 2018. Comments on DMT: Betaferon. Tobacco smoker: ex-smoker  Vit D at visit: 46.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 18, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.52 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.47 sec. 9-hole peg non-dominant:22.87 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2018. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: November 12, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.16 sec. SDMT done. SDMT numerator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.28 sec. 9-hole peg non-dominant:18 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem. Number of attacks until the first visit:4. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on April 01, 2016. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Cervical spine MRI date: September 22, 2016. The 25-foot walk done. Assistance required for 25-foot walk test: Unilateral assistance by a person. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.5 sec. 9-hole peg non-dominant:29.4 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:22.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.61. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 0. DMT taken. Current DMT:tecfidera-dimethylfumarate on September 01, 2022. Tobacco smoker: non-smoker  Exercise hrs per week:6. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Cervical spine MRI date: May 24, 2023. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.21 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.8 sec. 9-hole peg non-dominant:21 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.25. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 12. DMT taken. Current DMT:tysabri- natalizumab on May 01, 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: hubble bubble. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:62.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Name of co-morbidity:asthma. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on August 29, 2019. Comments on DMT: Rebif Gilenya. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 01, 2020. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.92 sec. 9-hole peg non-dominant:29 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2016. Vit D at visit: 65.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26 sec. 9-hole peg non-dominant:41 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.47. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. Comments on DMT: Betaferon - Gilenya. Vit D at visit: 32.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: August 01, 2016. The 25-foot walk done. 25-foot walk test time was 4.73 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.2 sec. 9-hole peg non-dominant:25 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2009. Comments on DMT: Avonex. MRI of brain or spine done. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:22.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on September 01, 2020. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:22.35 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Vit D at visit: 18.4. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.57 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on October 01, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.77 sec. 9-hole peg non-dominant:15.92 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:73.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. Visit diagnosis:nmo. Comments on DMT: Rebif - Imuran - 5 sessions of plasma exchange in Oct 2014. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.4 sec. 9-hole peg non-dominant:33.3 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on April 17, 2017. Comments on DMT: 2012-Imuran \/ 2012-2015 Betaferon\/ 2015 Rebif\/ 2015-Mar2017 Betaferon. MRI of brain or spine done. Cervical spine MRI date: October 24, 2017. The 25-foot walk done. 25-foot walk test time was 15.3 sec. SDMT done. SDMT numerator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:27.3 sec. 9-hole peg non-dominant:69.2 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:positive. IgG index in CSF:1.42. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on August 25, 2023. Tobacco smoker: ex-smoker  Vit D at visit: 29.8. The 25-foot walk done. SDMT done. SDMT numerator: 80. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.8 sec. 9-hole peg non-dominant:17 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:3. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on July 24, 2019. Comments on DMT: tecfidera. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.18 sec. 9-hole peg non-dominant:18.97 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on July 01, 2016. Vit D at visit: 73.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. Assistance required for 25-foot walk test: Unilateral assistance by a person. 25-foot walk test time was 16.9 sec. SDMT done. SDMT numerator: 23. SDMT denominator: 23. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.6 sec. 9-hole peg non-dominant:23.6 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Cellcept or Imuxigen- Mycophenolate. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on October 01, 2018. Comments on DMT: Tysabri. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 6.8 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:70 sec. 9-hole peg non-dominant:25.94 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:80.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Bronchitis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Tendinitis. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 26, 2015. Comments on DMT: endoxan. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 53.04 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.05 sec. 9-hole peg non-dominant:26.97 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on May 12, 2022. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 56. Alcohol drinsk per week: 1. Exercise hrs per week:12. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 105. SDMT denominator: 105. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.9 sec. 9-hole peg non-dominant:15.57 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. Tobacco smoker: non-smoker  Exercise hrs per week:2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 16, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.89 sec. 9-hole peg non-dominant:36.23 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.62. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2013. MRI of brain or spine done. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:80.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Bronchitis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Tendinitis. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 26, 2015. Comments on DMT: endoxan. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 70.0. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2016. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.03 sec. SDMT done. SDMT numerator: 74. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.13 sec. 9-hole peg non-dominant:18.33 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:completely recovered from illness. Visit diagnosis:cis. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.58. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2017. Vit D at visit: 39.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 01, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). Remarks about MRI: Resolution of edema and decrease in size in C2 lesion. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:19.4 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2015. Comments on DMT: Avonex, gilenya. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 6. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 11, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.46. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:surgically-induced. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Rosacea . Outcome:ongoing illness. Name of co-morbidity:Hyperprolactinemia . Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2017. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.7 sec. 9-hole peg non-dominant:18.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.91. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on September 16, 2021. Comments on DMT: Rebif, Gilenya. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 85. SDMT denominator: 85. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:17.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Asthma. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on May 18, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 01, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:21.5 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:0.77. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:carotid stenosis. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2018. Comments on DMT: rebif. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 11.8 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.62 sec. 9-hole peg non-dominant:21.34 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:25.  Gender:female.  Diagnosis:mogad. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:negative. IgG index in CSF:0.15. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:mogad. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on November 01, 2022. MRI of brain or spine done. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: August 01, 2023. The 25-foot walk done. 25-foot walk test time was 3.75 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.15 sec. 9-hole peg non-dominant:20 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:logistic issues to obtain the DMT. New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 02, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.31 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.05 sec. 9-hole peg non-dominant:17.05 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 7. DMT taken. Current DMT:mabthera- rituximab on June 01, 2017. Comments on DMT: Betaferon, Gilenya, Tysabri. Vit D at visit: 68.8. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.36 sec. 9-hole peg non-dominant:18.62 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. 25-foot walk test time was 3.19 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.71 sec. 9-hole peg non-dominant:18.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.17. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 08, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on February 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 12, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 57.15 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.5 sec. 9-hole peg non-dominant:21.9 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2014. Comments on DMT: Imuran (started on 8\/8\/2014). MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.3 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.4 sec. 9-hole peg non-dominant:24.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:abortion. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on June 18, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 16, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 6 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.15 sec. 9-hole peg non-dominant:30.25 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Blood and lymphatic disorders. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2016. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 28, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:18.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:71.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Number of attacks until the first visit:2. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: Betaferon, Cellcept, Methotrexate. 9-HPT done. 9-HPT ability: unable with both hands. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in NEDA. Will the patient be in NEDA or EDA after 31 months?",
        "output":"After 31 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:78.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis, brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:right hip fracture. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on July 01, 2011. Comments on DMT: Avonex - Rebif - Mitoxantrone. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1ppd. Vit D at visit: 77.0. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.9 sec. 9-hole peg non-dominant:24.2 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. Vit D at visit: 17.3. MRI of brain or spine done. Cervical spine MRI date: April 19, 2013. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.9 sec. 9-hole peg non-dominant:21.4 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:67.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:2.33. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Retinal disorders. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2007. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.11 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:21.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:positive. IgG index in CSF:1.42. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 30, 2021. Tobacco smoker: current  Tobacco type: water-pipe. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:ocrevus - ocrelizumab on November 18, 2019. Comments on DMT: Avonex, Tysabri. The 25-foot walk done. 25-foot walk test time was 6.8 sec. SDMT done. SDMT numerator: 15. SDMT denominator: 15. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:38 sec. 9-hole peg non-dominant:40 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 26. DMT taken. Current DMT:mabthera- rituximab on August 01, 2015. MRI of brain or spine done. Cervical spine MRI date: April 13, 2017. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2014. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:12 sec. 9-hole peg non-dominant:15 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness.  Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on November 02, 2015. Comments on DMT: rebif. Tobacco smoker: ex-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 15, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27 sec. 9-hole peg non-dominant:21.1 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2015. Vit D at visit: 79.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on August 25, 2016. MRI of brain or spine done. Cervical spine MRI date: January 28, 2017. The 25-foot walk done. 25-foot walk test time was 5.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.2 sec. 9-hole peg non-dominant:21.7 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:6. Visit diagnosis:rrms. Total relapses until visit: 9. DMT taken. Current DMT:mabthera- rituximab on March 01, 2019. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:24 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Bell's Palsy. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on November 01, 2017. Comments on DMT: Betaferon, Cyclophosphamide. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 94 sec. SDMT done. SDMT numerator: 6. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:67 sec. 9-hole peg non-dominant:65.6 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:seizures . Name of co-morbidity:learning disability . Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2019. Tobacco smoker: ex-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 01, 2021. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.7 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 11, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:21.79 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on December 01, 2018. Comments on DMT: Rebif Aubagio Gilenya. Vit D at visit: 27.2. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: November 17, 2020. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:20 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2020. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 01, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 7 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:30.2 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 31 months?",
        "output":"After 31 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 12, 2019. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.1 sec. 9-hole peg non-dominant:20.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Initial presentation incidental mri findings. OCBs in CSF:positive. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:ris. Total relapses until visit: 0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.61 sec. 9-hole peg non-dominant:16.61 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:negative. IgG index in second:0.46. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:anterior uveitis. Outcome:completely recovered from illness. Name of co-morbidity:iridocorneal adhesions. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Name of co-morbidity:Sciatica. Outcome:ongoing illness. Name of co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:prolactinemia 2ry to Tegretol. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Klebsiella pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. Tobacco smoker: ex-smoker  Vit D at visit: 19.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: August 12, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.94 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.82 sec. 9-hole peg non-dominant:22.12 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.75. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 9. DMT taken. Current DMT:mabthera- rituximab on January 01, 2019. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 5.5 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 27, 2017. Tobacco smoker: non-smoker  Coffee cups per week: 21. MRI of brain or spine done. Cervical spine MRI date: March 21, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.79 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.05 sec. 9-hole peg non-dominant:24.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:25.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Seizures\/convulsions. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:ris. Total relapses until visit: 0. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:6. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:BELL'S PALSY. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2012. Comments on DMT: Betaferon 2001-2003, Avonex 2003-2009, Rebif Apr 2010-2012, Cladribine Jan 2006-2009. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 64.3. The 25-foot walk done. 25-foot walk test time was 7.4 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 34. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.97 sec. 9-hole peg non-dominant:23.68 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:1.29. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on December 01, 2017. Comments on DMT: mabthera, rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 47.8. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: February 24, 2020. Received Gadolinium for Thoracic (dorsal) spine MRI. The 25-foot walk done. Assistance required for 25-foot walk test: AFO. 25-foot walk test time was 9 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.9 sec. 9-hole peg non-dominant:22.6 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on July 01, 2018. The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 17. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.53 sec. 9-hole peg non-dominant:24.66 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:80.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Bronchitis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Tendinitis. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:endoxan- cyclophosphamide on June 10, 2013. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 28, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 8 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.8 sec. 9-hole peg non-dominant:33.2 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:0.88. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2012. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.56 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 74. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15.75 sec. 9-hole peg non-dominant:15.92 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.83. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2020. Vit D at visit: 92.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 20, 2020. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. More information on co-morbidity:FMF. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on October 01, 2018. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.3 sec. 9-hole peg non-dominant:19.36 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. MRI of brain or spine done. Cervical spine MRI date: April 26, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Ocrevus - Ocrelizumab. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on May 01, 2017. Comments on DMT: Gilenya February 2014 to March 2017 Rebif March 2013 to January 2014 Betaferon September 2012 to March 2013  . MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: August 17, 2019. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2016. MRI of brain or spine done. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.629. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:24.4 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:25.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2012. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Depression. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2016. Comments on DMT: avonex. Tobacco smoker: non-smoker  MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Cervical spine MRI date: May 01, 2016. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:20.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:prolactinoma. Outcome:ongoing illness. Name of co-morbidity:degenrative disk disease. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:chronic constipation. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2020. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 01, 2021. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:15.5 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2017. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 40.91. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Cervical spine MRI date: June 06, 2021. Received Gadolinium for Cervical spine MRI. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.6 sec. 9-hole peg non-dominant:19 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:avonex or cinnovex- im interferon on May 15, 2014. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 09, 2014. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.1 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:21 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2016. Vit D at visit: 37.2. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:cis. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 5 cigarett. Coffee cups per week: 14. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Avonex or Cinnovex- IM Interferon. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2011. Vit D at visit: 34.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.3 sec. 9-hole peg non-dominant:17.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:asthma. Outcome:completely recovered from illness. Name of co-morbidity:Keratoconus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2014. Vit D at visit: 37.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 19, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.82 sec. SDMT done. SDMT numerator: 85. SDMT denominator: 86. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.81 sec. 9-hole peg non-dominant:17.31 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.87. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:coronary Heart disease. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on May 30, 2019. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.3 sec. 9-hole peg non-dominant:17 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Betaferon. The 25-foot walk done. 25-foot walk test time was 7 sec. SDMT done. SDMT numerator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.3 sec. 9-hole peg non-dominant:28.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Hidradenitis Suppurutiva. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. Comments on DMT: Cellcept - Avonex -  Tysabri, Cycophosphamide. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 28. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:55.26 sec. 9-hole peg non-dominant:104.72 sec. EDSS:7.5- unable to take more than a few steps; restricted to wheelchair; may need some help in transferring and in wheeling self. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.04. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:1.04. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Comments on DMT: Rebif - Avonex. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.6 sec. 9-hole peg non-dominant:27.3 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 34 months?",
        "output":"After 34 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:negative. OCBs in second CSF:positive. IgG index in second:0.71. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on May 01, 2017. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:36.3 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on March 01, 2019. Comments on DMT: Avonex. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 76 sec. SDMT done. SDMT numerator: 22. SDMT denominator: 27. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Visit diagnosis:cis. Total relapses until visit: 1. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: April 20, 2020. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.38 sec. 9-hole peg non-dominant:21.57 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 36 months?",
        "output":"After 36 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.22. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2012. Comments on DMT: Rebif sept 12 - oct 14. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 1 HB\/d. Coffee cups per week: 21. Vit D at visit: 54.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 29, 2014. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.4 sec. 9-hole peg non-dominant:22.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Alcohol abuse disorder. Name of co-morbidity:Migraine. Visit diagnosis:rrms. Total relapses until visit: 1. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:23 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar, cognitive dysfunction. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on February 01, 2018. Comments on DMT: Avonex. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: No lesions. Cervical spine MRI date: February 28, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.72 sec. 9-hole peg non-dominant:20.15 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2018. Vit D at visit: 57.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 01, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. Dominant hand:Right.  9-hole peg dominant:16.1 sec. 9-hole peg non-dominant:16.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on October 01, 2012. The 25-foot walk done. 25-foot walk test time was 3.85 sec. SDMT done. SDMT numerator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:20.63 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:7. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2015. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 28. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.34 sec. 9-hole peg non-dominant:21.26 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:change in diagnosis. New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on November 01, 2012. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 1 hubble bubble per week. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 12, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.51 sec. 9-hole peg non-dominant:17.92 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Obstructive Sleep Apnea. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:avonex or cinnovex- im interferon on December 01, 2015. MRI of brain or spine done. Cervical spine MRI date: October 18, 2016. The 25-foot walk done. 25-foot walk test time was 5.3 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:19.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:23.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on September 01, 2016. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.98 sec. 9-hole peg non-dominant:26.69 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on September 01, 2017. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.2 sec. 9-hole peg non-dominant:20.26 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female. . Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.84. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on March 01, 2019. Comments on DMT: Rebif, Avonex, Tysabri. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 24. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.33 sec. 9-hole peg non-dominant:31.67 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 01, 2023. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:19 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on November 01, 2015. Comments on DMT: Dec 2013-Feb 2014 Gilenya, Jan 2015-Nov 2015 Avonex. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. Vit D at visit: 54.2. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.4 sec. 9-hole peg non-dominant:32.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on November 07, 2018. Comments on DMT: Tysabri. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 01, 2019. The 25-foot walk done. 25-foot walk test time was 5.89 sec. SDMT done. SDMT numerator: 33. SDMT denominator: 34. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:57 sec. 9-hole peg non-dominant:26.49 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:3.04. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:vascular malformation in right forearm. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2013. Tobacco smoker: non-smoker  Coffee cups per week: 14. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Rheumatoid arhritis. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: tysabri- natalizumab. MRI of brain or spine done. No new lesions on Brain MRI. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:75.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation gtc seizures. Has experienced progressive symptoms since onset. Name of co-morbidity:Surgeries. More information on co-morbidity:cholecystectomy. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:scoliosis. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:DM2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:seizures. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:tronchanteric bursitis. Outcome:completely recovered from illness. Visit diagnosis:ppms. Tobacco smoker: non-smoker  Vit D at visit: 49.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Methotrexate. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:CESARIAN SECTION. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on January 01, 2018. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 80. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:20.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2018. Vit D at visit: 31.2. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.83 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:17.43 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:spms. Total relapses until visit: 8. DMT taken. Current DMT:mabthera- rituximab on August 01, 2017. Comments on DMT: Avonex, Rebif, Gilenya, Tecfidera. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 1999. Vit D at visit: 56.9. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.7 sec. 9-hole peg non-dominant:25.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on December 01, 2018. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Vit D at visit: 44.7. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.3 sec. 9-hole peg non-dominant:17.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:0.81. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:nmo. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on March 31, 2021. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: No lesions. Cervical spine MRI date: June 01, 2021. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 999. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 21 months?",
        "output":"After 21 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:67.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:nmo. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on August 27, 2015. Comments on DMT: Immuran. The 25-foot walk done. 25-foot walk test time was 5.98 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.19 sec. 9-hole peg non-dominant:21.3 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Bell's Palsy. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. MRI of brain or spine done. The 25-foot walk done. Assistance required for 25-foot walk test: Unilateral assistance by a person. 25-foot walk test time was 55 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation brainstem. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Alzheimer's. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Pityriasis versicolor. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:delayed gastric emptying. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2006. Comments on DMT: imuran. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis, cerebellar, bowel\/bladder dysfunction, incidental mri findings. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.5. IgG index category in CSF:Normal (< 0.77). Past medical history: MVA IN 2012. Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on April 01, 2019. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.28. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Asthma. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Reflex trial, Rebif, aubagio. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: non-smoker  Coffee cups per week: 21. Vit D at visit: 17.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: July 15, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.85 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:37.38 sec. 9-hole peg non-dominant:21.33 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Visit diagnosis:ris. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 10, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:17.6 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:negative. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:negative. IgG index in second:0.55. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:ris. Total relapses until visit: 0. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 1 daily. MRI of brain or spine done. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.89 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.4 sec. 9-hole peg non-dominant:19.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Avonex or Cinnovex- IM Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 43 months?",
        "output":"After 43 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:10. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:endoxan- cyclophosphamide on April 01, 2013. Comments on DMT: Betaseron - Avonex - Rebif - Imuran. The 25-foot walk done. 25-foot walk test time was 11.3 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.12. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2010. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.9 sec. 9-hole peg non-dominant:21.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 8. DMT taken. Current DMT:mabthera- rituximab on June 01, 2009. Comments on DMT: Avonex. Vit D at visit: 46.2. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.9 sec. 9-hole peg non-dominant:18.06 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2011. Tobacco smoker: non-smoker  Vit D at visit: 40.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:19.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.69. Visit diagnosis:cis. Total relapses until visit: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 28, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.01 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.46 sec. 9-hole peg non-dominant:16.74 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness.  Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: Gilenya, Rebif. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. Vit D at visit: 33.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: No lesions. Cervical spine MRI date: September 13, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.7 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.5 sec. 9-hole peg non-dominant:24 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2011. Vit D at visit: 13.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 08, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.4 sec. SDMT done. SDMT numerator: 28. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29 sec. 9-hole peg non-dominant:31.72 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Avonex - Betaferon. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.71 sec. SDMT done. SDMT numerator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.25 sec. 9-hole peg non-dominant:27.51 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 1999. Vit D at visit: 58.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 5.42 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.61 sec. 9-hole peg non-dominant:20.45 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:67.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:2.33. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Retinal disorders. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2007. Tobacco smoker: non-smoker  Vit D at visit: 34.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:25.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 15, 2014. Comments on DMT: Avonex. MRI of brain or spine done. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2016. MRI of brain or spine done. Cervical spine MRI date: May 03, 2018. The 25-foot walk done. 25-foot walk test time was 3.8 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.9 sec. 9-hole peg non-dominant:19.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:25.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Seizures\/convulsions. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:avonex or cinnovex- im interferon on July 01, 2018. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.6 sec. 9-hole peg non-dominant:22.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2012. Tobacco smoker: non-smoker  Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 22, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:ocrevus - ocrelizumab on January 01, 2021. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.61 sec. 9-hole peg non-dominant:24.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on January 01, 2018. Comments on DMT: Avonex; Copaxone. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 08, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 6.6 sec. SDMT done. SDMT numerator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:18.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2013. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 17, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 81. SDMT denominator: 81. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:17.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:GERD. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia minor. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 01, 2009. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 88. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:21 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.84. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.92. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on September 01, 2015. Comments on DMT: Rebif - Betaferon. Vit D at visit: 40.2. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 33.83 sec. SDMT done. SDMT numerator: 19. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on November 30, 2012. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 1999. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The patient is in NEDA. Will the patient be in NEDA or EDA after 64 months?",
        "output":"After 64 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis, cerebellar, bowel\/bladder dysfunction, incidental mri findings. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.5. IgG index category in CSF:Normal (< 0.77). Past medical history: MVA IN 2012. Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 11.1. MRI of brain or spine done. Cervical spine MRI date: February 14, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). Remarks about MRI: Abnormal signal and atrophy of the corpus callosum and multiple foci of high FLAIR signal in the infra and supratentorial regions, right optic nerve and the upper cervical cord. The 25-foot walk done. 25-foot walk test time was 5.3 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.81 sec. 9-hole peg non-dominant:38.87 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Solumedrol- IV Methylprednisolone. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on April 01, 2014. Comments on DMT: Betaferon, Imuran (Azathioprine). Tobacco smoker: non-smoker  Vit D at visit: 42.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: October 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.7 sec. 9-hole peg non-dominant:28.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 05, 2017. Comments on DMT: rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 5. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.2 sec. 9-hole peg non-dominant:16.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:17.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. OCBs in CSF:positive. IgG index in CSF:0.93. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on December 01, 2021. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: February 01, 2023. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:17.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.51. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: None . Tobacco smoker: non-smoker  Coffee cups per week: 2. Vit D at visit: 18.96. MRI of brain or spine done. Cervical spine MRI date: May 07, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:16.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. More information on co-morbidity:FMF. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on October 01, 2018. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: February 01, 2020. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:19.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. More information on co-morbidity:herpes zoster ophthalmicus. Outcome:completely recovered from illness. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:endoxan- cyclophosphamide on May 02, 2014. Comments on DMT: avonex, rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 12.55 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.488. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 8. DMT taken. Current DMT:mabthera- rituximab on October 01, 2022. Comments on DMT: Avonex (2008 - 2011), Gilenya (2011 - 2022). Tobacco smoker: non-smoker  Coffee cups per week: 14. The 25-foot walk done. 25-foot walk test time was 4.19 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.2 sec. 9-hole peg non-dominant:24 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.864. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Essential tremor. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2013. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.2 sec. 9-hole peg non-dominant:20.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:financial difficulties to get the DMT. New DMT:Gilenya- Fingolimod. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: Rebif (withheld now due to pregnancy). Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.53 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:20.  Gender:female.  Diagnosis:mog disease. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:congenital aortic stenosis and regurge. Outcome:ongoing illness. Visit diagnosis:mog. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on December 04, 2019. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:tysabri- natalizumab on April 24, 2017. Comments on DMT: Avonex Cladribine Tecfidera. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 6.6 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:40 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. Vit D at visit: 20.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: October 31, 2017. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.72 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:22.6 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 01, 2016. Comments on DMT: avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 16, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.6 sec. 9-hole peg non-dominant:19.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Bipolar disorder. Total relapses until visit: 2. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.81 sec. 9-hole peg non-dominant:19.31 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.96. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on September 01, 2021. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 7. Exercise hrs per week:4. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 01, 2022. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 84. SDMT denominator: 84. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.5 sec. 9-hole peg non-dominant:20.85 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 1998. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 68 months?",
        "output":"After 68 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on November 30, 2012. Tobacco smoker: non-smoker  Vit D at visit: 65.3. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.9 sec. 9-hole peg non-dominant:22.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT: gilenya- fingolimod. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.53 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.34 sec. 9-hole peg non-dominant:28.17 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2013. Tobacco smoker: non-smoker  Vit D at visit: 36.9. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:19.35 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Comments on DMT: Plegridy (September 2019 - Jan 2022, d\/c due to unavailability). MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.64. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 11, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.37 sec. 9-hole peg non-dominant:21.46 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. Vit D at visit: 23.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 10. Total T1 Gad-enhancing lesions in Brain: 1. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. IgG index in CSF:0.87. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.76. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.5 sec. 9-hole peg non-dominant:20.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2015. Comments on DMT: REBIF. Vit D at visit: 110.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.4 sec. 9-hole peg non-dominant:18.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2017. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.6 sec. 9-hole peg non-dominant:17.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:75.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation gtc seizures. Has experienced progressive symptoms since onset. Name of co-morbidity:Surgeries. More information on co-morbidity:cholecystectomy. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:scoliosis. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:DM2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:seizures. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:tronchanteric bursitis. Outcome:completely recovered from illness. Visit diagnosis:ppms. DMT taken. Current DMT: methotrexate on December 01, 2014. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 5.87 sec. SDMT done. SDMT numerator: 33. SDMT denominator: 34. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.5 sec. 9-hole peg non-dominant:30.66 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Bell's Palsy. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 9. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 105 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:60 sec. 9-hole peg non-dominant:62 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Coffee cups per week: 4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 20, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. OCBs in CSF:positive. IgG index in CSF:0.87. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:aubagio- teriflunomide on September 01, 2019. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 3.25 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.62 sec. 9-hole peg non-dominant:24.06 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2016. Comments on DMT: avonex. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 04, 2019. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.69. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on June 01, 2016. Comments on DMT: rebif. Vit D at visit: 52.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 10, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.5 sec. 9-hole peg non-dominant:27.2 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:aubagio- teriflunomide on August 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: July 01, 2018. Received Gadolinium for Cervical spine MRI. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 7 sec. SDMT done. SDMT numerator: 26. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:37 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). Change in DMT or management done. Reason for DMT change:change in diagnosis. New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Alcohol abuse disorder. Name of co-morbidity:Migraine. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mavenclad- cladribine on May 01, 2021. Comments on DMT: Tecfidera. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.5 sec. 9-hole peg non-dominant:22 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.07. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on September 27, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 7.2 sec. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:44.6 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2011. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 74. SDMT denominator: 74. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.1 sec. 9-hole peg non-dominant:17.9 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Comments on DMT: None . MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 4. Cervical spine MRI date: November 09, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.2 sec. 9-hole peg non-dominant:21.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.96. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:19.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Uveitis. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Behcet Disease. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2018. MRI of brain or spine done. Cervical spine MRI date: December 01, 2021. The 25-foot walk done. 25-foot walk test time was 7.3 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:23 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.11. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14 sec. 9-hole peg non-dominant:16.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:6. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Comments on DMT: Betaferon - Avonex - Copaxone - Mitoxantrone - Gilenya - Tysabri - Tecfidera. Vit D at visit: 42.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 07, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 9.4 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.12 sec. 9-hole peg non-dominant:43.89 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Solumedrol- IV Methylprednisolone. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.47. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on November 01, 2018. The 25-foot walk done. 25-foot walk test time was 5.4 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.1 sec. 9-hole peg non-dominant:20.92 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:16.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. Visit diagnosis:ppms. Total relapses until visit: 0. DMT taken. Current DMT:mabthera- rituximab on November 29, 2016. Comments on DMT: Interferon - Imuran - Mitoxantrone. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 8. SDMT denominator: 8. 9-HPT done. 9-HPT ability: unable with both hands. Dominant hand:Right. EDSS:8.5- essentially restricted to bed much of the day; has some effective use of arm(s); retains some self-care functions. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. More information on co-morbidity:herpes zoster ophthalmicus. Outcome:completely recovered from illness. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: cyclophosphamide, rebif, avonex. Tobacco smoker: non-smoker  Coffee cups per week: 14. The 25-foot walk done. 25-foot walk test time was 40.67 sec. SDMT done. SDMT numerator: 28. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:39.25 sec. 9-hole peg non-dominant:30.95 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 10.3 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.2 sec. 9-hole peg non-dominant:25 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, brainstem. Number of attacks until the first visit:1. Name of co-morbidity:asthma. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:avonex or cinnovex- im interferon on March 01, 2014. Tobacco smoker: non-smoker  Vit D at visit: 60.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 71. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:17.39 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on November 30, 2012. Tobacco smoker: non-smoker  EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.77 sec. 9-hole peg non-dominant:18.74 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis, cerebellar, bowel\/bladder dysfunction, incidental mri findings. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.5. IgG index category in CSF:Normal (< 0.77). Past medical history: MVA IN 2012. Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on April 01, 2019. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 5.7 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31 sec. 9-hole peg non-dominant:52 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, bowel\/bladder dysfunction. IgG index in CSF:1.6. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:endoxan- cyclophosphamide on November 01, 2014. Comments on DMT: Rebif. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 38.3 sec. SDMT done. SDMT numerator: 27. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:60 sec. 9-hole peg non-dominant:110 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:ACID REFLUX . Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 3. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. The 25-foot walk done. 25-foot walk test time was 4.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.64 sec. 9-hole peg non-dominant:17.75 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:spms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2006. Comments on DMT: Betaferon, Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 04, 2012. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 15, 2014. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 02, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 5.78 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 34. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24 sec. 9-hole peg non-dominant:25 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.88. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: None . MRI of brain or spine done. Cervical spine MRI date: November 06, 2013. Cervical spine MRI: Not compared to previous spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 4.6 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.7 sec. 9-hole peg non-dominant:21.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:1.42. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Right breast cancer. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:right shoulder tendinitis. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:avonex or cinnovex- im interferon on May 01, 2017. Comments on DMT: Avonex 2005-2011. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 28. Vit D at visit: 19.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: November 16, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.2 sec. 9-hole peg non-dominant:25.8 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:gilenya- fingolimod on December 09, 2013. Comments on DMT: avonex, rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.5 sec. 9-hole peg non-dominant:30.5 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:patient preference- convenience. New DMT:Mayzent- Siponimod. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Rash. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 5. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: June 01, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.25 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.7 sec. 9-hole peg non-dominant:22.25 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2012. Comments on DMT: Betaferon. Tobacco smoker: non-smoker  Vit D at visit: 9.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: February 08, 2014. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 2. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 7 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 32. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.3 sec. 9-hole peg non-dominant:28.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:spms. Total relapses until visit: 2. Comments on DMT: Rebif (2000-2011) - Gilenya (March 2012 - May 2013) - Cyclophosphamide (September 2013 - May 2014). The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 24.2 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.77 sec. 9-hole peg non-dominant:21.14 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 30 months?",
        "output":"After 30 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:negative. IgG index in second:0.46. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:anterior uveitis. Outcome:completely recovered from illness. Name of co-morbidity:iridocorneal adhesions. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Name of co-morbidity:Sciatica. Outcome:ongoing illness. Name of co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:prolactinemia 2ry to Tegretol. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Klebsiella pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:vestibular migraine. Total relapses until visit: 3. There were new relapses since the previous visit. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The patient is in EDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness.  Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:ocrevus - ocrelizumab on January 22, 2020. Comments on DMT: gilenya, rebif. Tobacco smoker: ex-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 17, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. Assistance required for 25-foot walk test: AFO. 25-foot walk test time was 5.1 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34.5 sec. 9-hole peg non-dominant:20 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:7. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 7. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2014. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 7.78 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.46 sec. 9-hole peg non-dominant:44.59 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2020. Comments on DMT: Tecfidera. Tobacco smoker: current  Tobacco type: water-pipe. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 02, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 100. SDMT denominator: 101. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15.3 sec. 9-hole peg non-dominant:14.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. Name of co-morbidity:Absence Seizures. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:avonex or cinnovex- im interferon on October 10, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.09 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.85 sec. 9-hole peg non-dominant:21.17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.72. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Raynaud's Phenomenon. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on August 01, 2016. Vit D at visit: 93.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: March 14, 2019. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:20.31 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. OCBs in CSF:positive. IgG index in CSF:1.13. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 5. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: August 18, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.6 sec. 9-hole peg non-dominant:16.6 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on October 01, 2018. Comments on DMT: Rebif. The 25-foot walk done. 25-foot walk test time was 5.3 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:22 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:schizoaffective. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on November 30, 2012. Comments on DMT: Rebif, Betaferon. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 28. Alcohol drinsk per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 13, 2017. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.01 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.66 sec. 9-hole peg non-dominant:28.63 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: AFO. 25-foot walk test time was 5.18 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:23.6 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 30 months?",
        "output":"After 30 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on June 01, 2010. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. Vit D at visit: 47.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 25, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.6 sec. 9-hole peg non-dominant:21.54 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on June 01, 2017. Comments on DMT: Betaferon, Gilenya, Tysabri. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.8 sec. 9-hole peg non-dominant:18.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.83. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 01, 2020. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 2. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. Comments on DMT: Rebif - Mitoxantrone - Imuran - Endoxan - Mesenchymal stem cell injection. The 25-foot walk done. 25-foot walk test time was 24.4 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:88.3 sec. 9-hole peg non-dominant:25.3 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:endoxan- cyclophosphamide on September 03, 2013. Comments on DMT: rebif, gilneya . MRI of brain or spine done. Cervical spine MRI date: May 02, 2014. The patient is in EDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2020. The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 21. SDMT denominator: 23. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:27 sec. 9-hole peg non-dominant:26.9 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.38. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: August 02, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:72.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Tobacco smoker: non-smoker  Coffee cups per week: 14. The 25-foot walk done. 25-foot walk test time was 4.52 sec. SDMT done. SDMT numerator: 28. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.6 sec. 9-hole peg non-dominant:27.22 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. Remarks about CSF: CSF studies done outside AUBMC in 2016 for diagnosis. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on March 08, 2019. Comments on DMT: Rebif - Tysabri. Tobacco smoker: ex-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 56.63 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:41.7 sec. 9-hole peg non-dominant:64.8 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar, incidental mri findings. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on January 01, 2016. Comments on DMT: gilenya and rebif. Tobacco smoker: non-smoker  Vit D at visit: 48.9. The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.9 sec. 9-hole peg non-dominant:27.53 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on December 28, 2015. Comments on DMT: betaferon. Tobacco smoker: ex-smoker  Vit D at visit: 48.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 14.92 sec. SDMT done. SDMT numerator: 19. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.85 sec. 9-hole peg non-dominant:27.32 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, brainstem. Number of attacks until the first visit:1. Name of co-morbidity:asthma. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2015. Tobacco smoker: non-smoker  Exercise hrs per week:7. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:16.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2013. Comments on DMT: Betaferon . Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.5 PPD. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.6 sec. 9-hole peg non-dominant:21.8 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Gilenya- Fingolimod. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Tysabri; Avonex; Rebif. MRI of brain or spine done. Cervical spine MRI date: June 11, 2019. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.8 sec. 9-hole peg non-dominant:17.25 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. OCBs in CSF:positive. IgG index in CSF:1.13. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 6. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2019. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:17.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.22. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2014. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 62.0. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 26, 2020. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.14 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.7 sec. 9-hole peg non-dominant:22.8 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: recigen on September 01, 2015. Vit D at visit: 45.46. The 25-foot walk done. 25-foot walk test time was 4.75 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.77 sec. 9-hole peg non-dominant:30.22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. IgG index in CSF:1.33. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on June 13, 2017. Comments on DMT: Rebif. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. Exercise hrs per week:5. Vit D at visit: 46.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: March 08, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.01 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.8 sec. 9-hole peg non-dominant:19.35 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:6. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on June 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation seizure. Name of co-morbidity:Scleroderma. Outcome:ongoing illness. Visit diagnosis:spms. There were new relapses since the previous visit. Vit D at visit: 37.2. The 25-foot walk done. 25-foot walk test time was 35 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:36 sec. 9-hole peg non-dominant:49 sec. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation seizure. Name of co-morbidity:Scleroderma. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: Rebif . Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 31 sec. SDMT done. SDMT numerator: 18. SDMT denominator: 18. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:40.5 sec. 9-hole peg non-dominant:65 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Ocrevus - Ocrelizumab. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on February 10, 2023. Tobacco smoker: non-smoker  Vit D at visit: 59.0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.38 sec. 9-hole peg non-dominant:20.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. 25-foot walk test time was 5.78 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.04 sec. 9-hole peg non-dominant:17.96 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2016. Comments on DMT: Rebif. Vit D at visit: 52.1. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: December 19, 2017. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.5 sec. 9-hole peg non-dominant:20.9 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:6. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:solumedrol- iv methylprednisolone on May 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: June 11, 2015. The 25-foot walk done. 25-foot walk test time was 7.1 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Oral Candidiasis. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2006. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 20 months?",
        "output":"After 20 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:10. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:spms. There were new relapses since the previous visit. DMT taken. Comments on DMT: Betaseron (Mar 1999-Aug 1999), Avonex Sep 1999-Feb 2003, Rebif Feb 2003-Nov 2011, Imuran Sep 2004-Sep 2008, Gilenya Nov 2011-Feb 2013, Endoxan Apr 2013-Aug 2014. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: occaisionally. Coffee cups per week: 14. The 25-foot walk done. 25-foot walk test time was 22.5 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.5 sec. 9-hole peg non-dominant:23.6 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses AND new EDSS findings. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:74.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on April 09, 2013. Comments on DMT: Avonex; Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1ppd. Coffee cups per week: 14. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 16.75 sec. SDMT done. SDMT numerator: 8. SDMT denominator: 8. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24 sec. 9-hole peg non-dominant:22.7 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on March 01, 2013. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 2 HB\/Wk. Coffee cups per week: 7. Vit D at visit: 41.5. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.19 sec. 9-hole peg non-dominant:23.19 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.79. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on July 24, 2015. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.2 sec. 9-hole peg non-dominant:21.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:81.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem. Name of co-morbidity:Trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Cellulitis. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:osteoporosis. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:relpasing-progressive ms. Total relapses until visit: 7. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2002. Comments on DMT: avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 114 months?",
        "output":"After 114 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.62. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 15, 2016. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 06, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on March 01, 2019. Comments on DMT: avonex. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 54 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.84 sec. 9-hole peg non-dominant:26.28 sec. Change in DMT or management done. Reason for DMT change:stopped. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.64. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on January 01, 2015. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 3.65 sec. SDMT done. SDMT numerator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.82 sec. 9-hole peg non-dominant:30.21 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on October 22, 2018. Comments on DMT: rebif, tecfidera. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 24, 2019. Thoracic spine MRI: T2 lesion, unknown enhancement (MRI without gad). Number of new T2 lesions in  Thoracic spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 2.6 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.7 sec. 9-hole peg non-dominant:14.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on October 01, 2012. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: February 16, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:19.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2011. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: HB Weekly. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:26 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 27 months?",
        "output":"After 27 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 8. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on May 01, 2014. Vit D at visit: 21.2. The 25-foot walk done. 25-foot walk test time was 38.4 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 34. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34.79 sec. 9-hole peg non-dominant:23.92 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Visit diagnosis:rrms. DMT taken. Current DMT:copaxone- glatiramer acetate on June 01, 2013. Comments on DMT: Avonex. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 6.2 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.36 sec. 9-hole peg non-dominant:20.8 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 7. Alcohol drinsk per week: 1. Exercise hrs per week:4. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:17.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, bowel\/bladder dysfunction. IgG index in CSF:1.6. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. DMT taken. Current DMT: endoxan- cyclophosphamide. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 38.3 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:60 sec. 9-hole peg non-dominant:110 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:stop treatment. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.3. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on August 01, 2018. Comments on DMT: aubagio, rebif, gilenya, tysabri. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 78. SDMT denominator: 78. 9-HPT done.  9-hole peg dominant:14.3 sec. 9-hole peg non-dominant:18.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 2HB \/ Week. Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: November 30, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 1. The 25-foot walk done. 25-foot walk test time was 4.62 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.19 sec. 9-hole peg non-dominant:27.57 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Avonex or Cinnovex- IM Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2013. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: July 01, 2021. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14 sec. 9-hole peg non-dominant:20 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:77.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH . Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Disk disease. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Tinea versicolor. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 4. Comments on DMT: Avonex, rebif, betaferon, imuran. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 76 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.54 sec. 9-hole peg non-dominant:26.61 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. Comments on DMT: avonex. MRI of brain or spine done. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: January 22, 2018. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25 sec. 9-hole peg non-dominant:26.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Bell's Palsy. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 7. SDMT denominator: 8. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:72 sec. 9-hole peg non-dominant:71 sec. EDSS:7.5- unable to take more than a few steps; restricted to wheelchair; may need some help in transferring and in wheeling self. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Solumedrol- IV Methylprednisolone. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Remarks about CSF: but the results of the LP were not known. Name of co-morbidity:Epilepsy . Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2017. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:37 sec. 9-hole peg non-dominant:25.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:gilenya- fingolimod on December 09, 2013. Comments on DMT: avonex, rebif. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 62.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:19.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:10. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:epilepsy. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on December 21, 2011. Comments on DMT: Avonex 2008-2011. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.55 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.66 sec. 9-hole peg non-dominant:25.69 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.72. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Raynaud's Phenomenon. Visit diagnosis:rrms. Vit D at visit: 23.5. MRI of brain or spine done. Cervical spine MRI date: July 29, 2016. Cervical spine MRI: Not compared to previous spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.17 sec. 9-hole peg non-dominant:18 sec. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.62. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on July 07, 2019. Comments on DMT: cellcept, betaferon. Tobacco smoker: non-smoker  Vit D at visit: 65.1. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 25, 2020. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 11.9 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.5 sec. 9-hole peg non-dominant:19.8 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. Comments on DMT: Betaferon -Gilenya -Tecfidera - Rebif. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.8 sec. 9-hole peg non-dominant:22 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, lightheadedness. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:avonex or cinnovex- im interferon on October 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 15.64. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.31 sec. 9-hole peg non-dominant:19.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:0.81. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on March 01, 2021. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: No lesions. Cervical spine MRI date: May 29, 2023. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.2 sec. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:36 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 2. Vit D at visit: 8.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.56 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.3 sec. 9-hole peg non-dominant:21.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:1.89. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2016. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:26.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 4.33 sec. SDMT done. SDMT numerator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:20.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Name of co-morbidity:asthma. Outcome:ongoing illness. Visit diagnosis:rrms. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.8 sec. 9-hole peg non-dominant:28 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on December 01, 2018. Comments on DMT: Rebif, Aubagio, Gilenya. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: June 11, 2021. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:17.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on November 01, 2015. Comments on DMT: rebif, REFLEX trial, betafer. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: lighlt. Vit D at visit: 96.8. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.51 sec. 9-hole peg non-dominant:24.81 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on September 01, 2017. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.47. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 01, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:22 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2017. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:18.1 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.04. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:1.04. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Comments on DMT: Rebif - Avonex. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 6. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.31 sec. 9-hole peg non-dominant:38.3 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:disc disease. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on May 18, 2018. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 9.2 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.16. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on August 19, 2019. Comments on DMT: avonex, rebif, aubagio. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 13, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.38 sec. 9-hole peg non-dominant:17.66 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2011. The 25-foot walk done. 25-foot walk test time was 2.9 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.32 sec. 9-hole peg non-dominant:17.5 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:patient preference- convenience. New DMT:Plegridy (peginterferon beta 1-a). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Bell's Palsy. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:endoxan- cyclophosphamide on March 01, 2014. Comments on DMT: Betaferon. The 25-foot walk done. 25-foot walk test time was 81 sec. SDMT done. SDMT numerator: 8. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:54 sec. 9-hole peg non-dominant:48 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. IgG index in CSF:0.82. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 23, 2014. Comments on DMT: Avonex . Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. Exercise hrs per week:7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.31 sec. SDMT done. SDMT numerator: 110. SDMT denominator: 110. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.79 sec. 9-hole peg non-dominant:16.95 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.36. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on October 05, 2020. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 25, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.25 sec. 9-hole peg non-dominant:16.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2012. Comments on DMT: Betaferon. Tobacco smoker: non-smoker  MRI of brain or spine done. Cervical spine MRI date: November 08, 2013. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:21 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.07. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on March 01, 2021. Tobacco smoker: non-smoker  The patient is in NEDA. Will the patient be in NEDA or EDA after 26 months?",
        "output":"After 26 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on July 01, 2014. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.57 sec. 9-hole peg non-dominant:24.82 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:knee surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendenctomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 16, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1ppd. The 25-foot walk done. 25-foot walk test time was 5.51 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory, motor weakness, shoulder pain. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on August 01, 2017. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.81. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Name of co-morbidity:Asthma. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on July 04, 2018. Comments on DMT: Aubagio. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: May 14, 2018. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2014. Vit D at visit: 62.0. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:22.8 sec. 9-hole peg non-dominant:24 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness, brainstem. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:breast cancer. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 99. Comments on DMT: Betaferon 2008-2016 (discontinued due to patient preference) Avonex 2016-June 2020 (discontinued due to progression)  . Vit D at visit: 11.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: July 21, 2020. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 3. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 3. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 17 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.8 sec. 9-hole peg non-dominant:25.48 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2008. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.5 sec. 9-hole peg non-dominant:23.1 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 27. DMT taken. Current DMT:mabthera- rituximab on August 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 21, 2019. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.11 sec. 9-hole peg non-dominant:19.74 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:6. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Comments on DMT: Betaferon - Avonex - Copaxone - Mitoxantrone - Gilenya - Tysabri - Tecfidera. Vit D at visit: 103.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 12, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 8.1 sec. SDMT done. SDMT numerator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.31 sec. 9-hole peg non-dominant:42.38 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on September 01, 2017. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:1.58. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 7. DMT taken. Current DMT:mabthera- rituximab on September 23, 2019. Tobacco smoker: ex-smoker  Vit D at visit: 92.25. The 25-foot walk done. 25-foot walk test time was 21.6 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:33.8 sec. 9-hole peg non-dominant:37.5 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 29 months?",
        "output":"After 29 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2018. Comments on DMT: Rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:21.55 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:71.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on December 01, 2002. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. Assistance required for 25-foot walk test: Unilateral assistance by a person. 25-foot walk test time was 12.9 sec. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:70.2 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 36 months?",
        "output":"After 36 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Surgeries. More information on co-morbidity:hemorrhoidectomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 31, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.2 sec. 9-hole peg non-dominant:18.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on October 01, 2012. MRI of brain or spine done. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on March 29, 2018. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 80. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.68 sec. 9-hole peg non-dominant:16.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Anti phospholipid syndrome. Outcome:ongoing illness. Name of co-morbidity:Familial Mediteranean Fever. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2013. Tobacco smoker: non-smoker  Vit D at visit: 58.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 99. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.5 sec. 9-hole peg non-dominant:23.4 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:1.47. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:gilenya- fingolimod on May 01, 2014. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:18 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2006. Comments on DMT: imuran. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 45 months?",
        "output":"After 45 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Name of co-morbidity:Anxiety. Visit diagnosis:rrms. Total relapses until visit: 11. DMT taken. Current DMT:mabthera- rituximab on June 01, 2016. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:17.3 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Obstructive Sleep Apnea. Outcome:ongoing illness. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 04, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.37 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.95 sec. 9-hole peg non-dominant:16.54 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Avonex or Cinnovex- IM Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: non-smoker  Anti-MOG Abs seropositivity: Negative. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 999. Cervical spine MRI date: May 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 999. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14 sec. 9-hole peg non-dominant:18 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.034. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: ex-smoker  Vit D at visit: 17.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Cervical spine MRI date: February 01, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:25 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Renal disorders. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20.16 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on October 01, 2017. Comments on DMT: Avonex - Biotin. Vit D at visit: 51.2. MRI of brain or spine done. Cervical spine MRI date: May 25, 2018. The 25-foot walk done. 25-foot walk test time was 5.96 sec. SDMT done. SDMT numerator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.3 sec. 9-hole peg non-dominant:27.8 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2018. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 33. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.7 sec. 9-hole peg non-dominant:23.87 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation focal spasms. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25 sec. 9-hole peg non-dominant:25.68 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.09. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on June 01, 2017. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: November 01, 2021. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 1\/w. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 15, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.21 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.11 sec. 9-hole peg non-dominant:17.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:neurosarcoidosis. Has not converted to SPMS. Visit diagnosis:neurosarcoidosis. MRI of brain or spine done. Cervical spine MRI date: January 28, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2015. Comments on DMT: Betaferon- Tysabri. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 7 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 34. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.7 sec. 9-hole peg non-dominant:30.16 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.16 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.91 sec. 9-hole peg non-dominant:26.77 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on February 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 14. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 6.5 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.7 sec. 9-hole peg non-dominant:30 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.5 sec. 9-hole peg non-dominant:20 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:25.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Seizures\/convulsions. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:ris. Total relapses until visit: 0. DMT taken. Current DMT:avonex or cinnovex- im interferon on July 01, 2018. The 25-foot walk done. 25-foot walk test time was 3.68 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:21.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2011. Comments on DMT: Avonex Betaferon. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 17.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: December 27, 2019. The 25-foot walk done. 25-foot walk test time was 4 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 20, 2014. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.7 sec. 9-hole peg non-dominant:19.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Comments on DMT: Avonex. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: Copaxone - Betaferon - Mitoxantrone - Rebif. Vit D at visit: 29.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 28, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 16.83 sec. SDMT done. SDMT numerator: 11. SDMT denominator: 14. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:45.12 sec. 9-hole peg non-dominant:50.14 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:completely recovered from illness. Name of co-morbidity:Left breast cancer s\/p mastectomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 01, 2016. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 29.5. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: December 01, 2019. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:17.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar, cognitive dysfunction. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2013. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 21. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24 sec. 9-hole peg non-dominant:27.3 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:nmo. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 29, 2019. Tobacco smoker: ex-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: June 15, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.52 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:18.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.12. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2018. Tobacco smoker: current  Tobacco type: water-pipe. Exercise hrs per week:5. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:22 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:2.43. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2011. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 cigarette daily. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 6.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 48 months?",
        "output":"After 48 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:25.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2012. Comments on DMT: Betaferon. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 28. Vit D at visit: 46.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.25 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.4 sec. 9-hole peg non-dominant:19.26 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on September 05, 2016. Comments on DMT: Rebif (Jan 2015-Aug 2015) Tecfidera (Aug 2015-Aug 2016)  . MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: April 11, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 79. SDMT denominator: 79. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.7 sec. 9-hole peg non-dominant:18.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2012. Vit D at visit: 53.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 6. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 8.1 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.6 sec. 9-hole peg non-dominant:28.97 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 40 months?",
        "output":"After 40 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Hyperlipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2016. Vit D at visit: 109.0. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.7 sec. 9-hole peg non-dominant:19.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.83. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2014. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 3 HB\/Wk. Alcohol drinsk per week: 1. Vit D at visit: 33.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.64 sec. 9-hole peg non-dominant:20.47 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2020. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.6 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.83. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Skin disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Vit D at visit: 91.0. MRI of brain or spine done. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.53 sec. SDMT done. SDMT numerator: 81. SDMT denominator: 81. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.72 sec. 9-hole peg non-dominant:20.14 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:ocrevus - ocrelizumab on June 01, 2018. Comments on DMT: Avonex, Gilenya, Rituximab. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 1. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.6 sec. 9-hole peg non-dominant:75 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2016. The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:15.7 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:logistic issues to obtain the DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 21 months?",
        "output":"After 21 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.55. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on September 01, 2016. MRI of brain or spine done. Cervical spine MRI date: December 07, 2017. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: June 25, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.7 sec. 9-hole peg non-dominant:22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2016. Vit D at visit: 69.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: January 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:18.9 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:25.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2012. Comments on DMT: betaferon, . Tobacco smoker: ex-smoker  Coffee cups per week: 56. Exercise hrs per week:5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 110. SDMT denominator: 110. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.56 sec. 9-hole peg non-dominant:16.72 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on April 01, 2018. Comments on DMT: Betaferon; Gilenya. Vit D at visit: 55.8. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: May 24, 2019. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.47 sec. SDMT done. SDMT numerator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:19.2 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. OCBs in CSF:positive. IgG index in CSF:8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Anti-MOG Abs seropositivity: Negative. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 01, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:24 sec. 9-hole peg non-dominant:32 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:GERD. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia minor. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 01, 2018. Comments on DMT: previously took avonex. and failed rebi radiologically in 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 77. SDMT denominator: 77. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15.75 sec. 9-hole peg non-dominant:16.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2016. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 2.7 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.63 sec. 9-hole peg non-dominant:23.51 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on August 01, 2018. Vit D at visit: 66.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 80. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.56 sec. 9-hole peg non-dominant:18.94 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:logistic issues to obtain the DMT. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.98. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. There were new relapses since the previous visit. Tobacco smoker: non-smoker  Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.83. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2021. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 33. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:21.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: non-smoker  MRI of brain or spine done. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.85 sec. 9-hole peg non-dominant:22.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:69.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:arterial thrombosis. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:exploration of right hepatic mass with biopsy + cholecystectomy. Outcome:completely recovered from illness. Name of co-morbidity:PAD + arterial bypass. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:lumbar spondylosis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on January 28, 2019. Tobacco smoker: non-smoker  Vit D at visit: 23.7. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Cervical spine MRI date: June 27, 2019. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). Change in DMT or management done. Reason for DMT change:patient preference- convenience. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.9 sec. 9-hole peg non-dominant:32 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:3.61. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on November 01, 2019. Comments on DMT: Avonex. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 60.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: March 25, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 80. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. Vit D at visit: 47.9. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:22.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 1999. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.83 sec. 9-hole peg non-dominant:19.02 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 21 months?",
        "output":"After 21 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 8. Total T1 Gad-enhancing lesions in Brain: 2. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.31 sec. 9-hole peg non-dominant:28 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, optic neuritis, brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2016. Comments on DMT: None . MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.38. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on June 23, 2017. Comments on DMT: Rebif. Vit D at visit: 55.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 26, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:18.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, optic neuritis. Number of attacks until the first visit:3. Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on November 01, 2013. Vit D at visit: 50.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 04, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 10.1 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.83. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: November 29, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:20.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:ppms. Vit D at visit: 39.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: October 19, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 3. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 61.04 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.9 sec. 9-hole peg non-dominant:31.36 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 20 months?",
        "output":"After 20 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: Cladribine trial. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1.5 PPD. Vit D at visit: 8.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.65 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:20.47 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 38 months?",
        "output":"After 38 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.034. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2020. Tobacco smoker: ex-smoker  EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2014. Comments on DMT: Discontinued Gilenya in 2016 due to pregnancy . Tobacco smoker: non-smoker  MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 76. SDMT denominator: 77. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:15 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.61. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:endoxan- cyclophosphamide on April 27, 2016. Comments on DMT: Avonex (2011-2013) Gilenya (2013-2015) Tysabri (2015-2016). The 25-foot walk done. 25-foot walk test time was 9.51 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.3 sec. 9-hole peg non-dominant:56.59 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on November 01, 2022. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:23.64 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:T2 N0 M0, ER\/PR positive and HER-2 negative breast cancer. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteopenia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2016. Comments on DMT: gilenya, aubagio. Tobacco smoker: ex-smoker  Coffee cups per week: 7. Vit D at visit: 65.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: April 03, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Visit diagnosis:rrms. Comments on DMT: Betaferon. Vit D at visit: 46.4. The 25-foot walk done. 25-foot walk test time was 4.99 sec. SDMT done. SDMT numerator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.25 sec. 9-hole peg non-dominant:24.04 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. Vit D at visit: 14.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 01, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.86 sec. 9-hole peg non-dominant:20.71 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 26 months?",
        "output":"After 26 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2014. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: October 01, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:27 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:T2 N0 M0, ER\/PR positive and HER-2 negative breast cancer. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteopenia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 17, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 43. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:18.1 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar, incidental mri findings. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on January 18, 2016. Comments on DMT: gilenya. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 6 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.8 sec. 9-hole peg non-dominant:32.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Depression. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2016. Comments on DMT: Avonex (Sep 2014-Feb 2016). Tobacco smoker: non-smoker  Vit D at visit: 6.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 01, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.08 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.5 sec. 9-hole peg non-dominant:25.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:73.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on August 01, 2015. Comments on DMT: Rebif - Imuran - 5 sessions of plasma exchange in Oct 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 03, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 56.8 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:42.1 sec. 9-hole peg non-dominant:37.5 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 26 months?",
        "output":"After 26 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:negative. IgG index in CSF:0.51. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Allergies. More information on co-morbidity:Reactive airway disease. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: non-smoker  Vit D at visit: 17.7. Anti-MOG Abs seropositivity: Negative. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 4. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:24.78 sec. 9-hole peg non-dominant:20.86 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:ris. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 09, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.7 sec. 9-hole peg non-dominant:18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:trigeminal neuralgia s\/p balloon decompression. Outcome:ongoing illness. Name of co-morbidity:multinodular goiter. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on September 01, 2019. Comments on DMT: Intolerance to Avonex. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 6.8 sec. SDMT done. SDMT numerator: 26. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24 sec. 9-hole peg non-dominant:26.31 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:negative. IgG index in second:0.43. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 02, 2023. Comments on DMT: Rebif March 2021-Feb 2023 D\/c due to unavailability. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 7. The 25-foot walk done. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.9 sec. 9-hole peg non-dominant:15.58 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.56. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Vit D at visit: 13.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: May 10, 2016. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.43 sec. SDMT done. SDMT numerator: 22. SDMT denominator: 22. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.3 sec. 9-hole peg non-dominant:53.6 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Avonex or Cinnovex- IM Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2017. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Vit D at visit: 19.6. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:19.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 21 months?",
        "output":"After 21 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:75.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on October 02, 2018. Comments on DMT: Betaferon. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:nmo. DMT taken. Current DMT: mabthera- rituximab. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 02, 2016. The 25-foot walk done. 25-foot walk test time was 3.85 sec. SDMT done. SDMT numerator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.17 sec. 9-hole peg non-dominant:19.54 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis, cerebellar. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2014. Tobacco smoker: non-smoker  Vit D at visit: 45.5. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Cervical spine MRI date: April 04, 2016. The 25-foot walk done. 25-foot walk test time was 4.63 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.39 sec. 9-hole peg non-dominant:20.87 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2016. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: July 03, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.84 sec. 9-hole peg non-dominant:18.07 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.55. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. Total relapses until visit: 0. DMT taken. Current DMT:mabthera- rituximab on June 01, 2020. Tobacco smoker: non-smoker  Exercise hrs per week:10. MRI of brain or spine done. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 75 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Oral Candidiasis. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on May 29, 2017. Comments on DMT: Betaferon. The 25-foot walk done. 25-foot walk test time was 5.03 sec. SDMT done. SDMT numerator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.05 sec. 9-hole peg non-dominant:19.73 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2016. Comments on DMT: None . MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 6. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.9 sec. 9-hole peg non-dominant:21.1 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 18, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.2 sec. 9-hole peg non-dominant:16 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:1.45. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2015. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. 25-foot walk test time was 3.58 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.94 sec. 9-hole peg non-dominant:19.82 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. IgG index in CSF:1.33. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2017. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 50.3. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.37 sec. 9-hole peg non-dominant:18.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.16. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:RL fracture s\/p surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: March 01, 2016. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.44. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2017. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: January 05, 2018. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.4 sec. 9-hole peg non-dominant:18.1 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:pregnancy plans. New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 21 months?",
        "output":"After 21 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Comments on DMT: Betaferon. Vit D at visit: 53.7. The 25-foot walk done. 25-foot walk test time was 6.2 sec. SDMT done. SDMT numerator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.78 sec. 9-hole peg non-dominant:20.85 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:1. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 27, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2012. Comments on DMT: Rebif. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.08 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.14 sec. 9-hole peg non-dominant:18.63 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:tysabri- natalizumab on May 01, 2022. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: July 01, 2023. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:19.85 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Visit diagnosis:spms. Comments on DMT: Avonex. The 25-foot walk done. 25-foot walk test time was 50.12 sec. SDMT done. SDMT numerator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.8 sec. 9-hole peg non-dominant:31.9 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2016. Vit D at visit: 52.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 30, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:20.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Initial presentation incidental mri findings. Number of attacks until the first visit:0. OCBs in CSF:positive. IgG index in CSF:0.64. Visit diagnosis:ris. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2016. MRI of brain or spine done. Cervical spine MRI date: September 22, 2017. The 25-foot walk done. 25-foot walk test time was 3.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:17.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.55. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on September 01, 2016. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.62. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on July 01, 2019. Vit D at visit: 72.2. The 25-foot walk done. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:46 sec. 9-hole peg non-dominant:19.98 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:negative. OCBs in second CSF:positive. IgG index in second:0.71. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on May 01, 2017. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 25, 2022. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:7.97 sec. 9-hole peg non-dominant:32.7 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:77.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH . Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Disk disease. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Tinea versicolor. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 4. Comments on DMT: Rebif - Betaseron - Imuran - Po Prednisone. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 60 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.62 sec. 9-hole peg non-dominant:35.34 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2016. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: May 01, 2023. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:rrms. Comments on DMT: Avonex . MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:knee surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendenctomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 16, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.5ppd . Vit D at visit: 53.0. MRI of brain or spine done. Cervical spine MRI date: April 15, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.45 sec. SDMT done. SDMT numerator: 33. SDMT denominator: 35. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.07. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on October 01, 2018. Comments on DMT: Betaferon, Gilenya. Tobacco smoker: non-smoker  Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mayzent- Siponimod. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.64. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Total relapses until visit: 2. Vit D at visit: 25.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 01, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 10.5 sec. SDMT done. SDMT numerator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:38.4 sec. 9-hole peg non-dominant:29.1 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.13. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Vit D at visit: 15.6. MRI of brain or spine done. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24 sec. 9-hole peg non-dominant:22 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on October 01, 2017. MRI of brain or spine done. Thoracic spine MRI: T2 lesion, unknown enhancement (MRI without gad). Number of new T2 lesions in  Thoracic spine: 1. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on July 01, 2022. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 70. The 25-foot walk done. 25-foot walk test time was 6.2 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:10. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:epilepsy. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2011. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.4 sec. 9-hole peg non-dominant:28.4 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.47. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. Vit D at visit: 12.2. The 25-foot walk done. 25-foot walk test time was 4.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:18 sec. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:hydronephrosis . Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:sinusitis . Name of co-morbidity:Surgeries. More information on co-morbidity:c section, sinus surgery, external fixation of ankle fracture. Outcome:completely recovered from illness. Visit diagnosis:cis. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. Tobacco smoker: non-smoker  Vit D at visit: 51.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.56 sec. 9-hole peg non-dominant:15.54 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:71.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Number of attacks until the first visit:2. Visit diagnosis:spms. MRI of brain or spine done. No new lesions on Brain MRI. The patient is in NEDA. Will the patient be in NEDA or EDA after 20 months?",
        "output":"After 20 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2011. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: HB Weekly. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.37 sec. 9-hole peg non-dominant:20.24 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.11. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. The 25-foot walk done. 25-foot walk test time was 3.16 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.47 sec. 9-hole peg non-dominant:25.41 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 43 months?",
        "output":"After 43 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.77. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on April 01, 2022. Tobacco smoker: ex-smoker  Exercise hrs per week:8. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.24 sec. 9-hole peg non-dominant:19 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.69. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.89. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2019. Tobacco smoker: current  Tobacco type: water-pipe. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.88 sec. 9-hole peg non-dominant:15.53 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:1. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Rebif. The 25-foot walk done. 25-foot walk test time was 4.57 sec. SDMT done. SDMT numerator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.38 sec. 9-hole peg non-dominant:18.95 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 21 months?",
        "output":"After 21 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Rheumatoid Arthritis. Outcome:ongoing illness. Name of co-morbidity:Asthma. Outcome:ongoing illness. Name of co-morbidity:Essential Tremor. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on September 21, 2022. Tobacco smoker: non-smoker  Vit D at visit: 9.9. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.48. IgG index category in CSF:Normal (< 0.77). Total relapses until visit: 1. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: June 12, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.2 sec. 9-hole peg non-dominant:22.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.25. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 5.4 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.9 sec. 9-hole peg non-dominant:22.89 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on May 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 7.5 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:42.26 sec. 9-hole peg non-dominant:30.18 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in EDA due to relapses AND new EDSS findings. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2014. MRI of brain or spine done. No new lesions on Brain MRI. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:80.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Bronchitis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Tendinitis. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:endoxan- cyclophosphamide on June 10, 2013. Tobacco smoker: non-smoker  EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:18.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:GERD. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia minor. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 01, 2009. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 13, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 85. SDMT denominator: 85. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:21 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2014. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 1 HB\/d. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.45 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.09 sec. 9-hole peg non-dominant:21.22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2016. MRI of brain or spine done. Cervical spine MRI date: May 02, 2017. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:21.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 09, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.4 sec. 9-hole peg non-dominant:21.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:VZV Trigeminal neuritis. Outcome:completely recovered from illness. Visit diagnosis:varicella neuritis . Total relapses until visit: 2. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24 sec. 9-hole peg non-dominant:26 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on June 01, 2013. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 04, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 6. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: April 01, 2016. Cervical spine MRI: Not compared to previous spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.61 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.24 sec. 9-hole peg non-dominant:19.49 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.46. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:surgically-induced. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Rosacea . Outcome:ongoing illness. Name of co-morbidity:Hyperprolactinemia . Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2017. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 21. Exercise hrs per week:2. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.5 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:rrms. DMT taken. Current DMT: rebif and methotrexate on January 01, 2009. Comments on DMT: Avonex. The 25-foot walk done. 25-foot walk test time was 8.6 sec. SDMT done. SDMT numerator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28 sec. 9-hole peg non-dominant:35 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2017. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Visit diagnosis:rpms vs spms. Total relapses until visit: 3. Comments on DMT: betaferon. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 10.5 sec. SDMT done. SDMT numerator: 23. SDMT denominator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.91 sec. 9-hole peg non-dominant:27.45 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 21, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.37 sec. 9-hole peg non-dominant:18.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Plegridy (peginterferon beta 1-a). The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. Comments on DMT: rebif. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.58 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.93 sec. 9-hole peg non-dominant:22.41 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. IgG index in CSF:1.1. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: Betaferon. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.54 sec. 9-hole peg non-dominant:18.73 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.71. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: non-smoker  EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2013. Comments on DMT: Betaferon (2009-2011) (discontinued due to persistent pancytopenia) Avonex (2011-Nov 2013) (discontinued due to clinical and radiological failure)  . Vit D at visit: 63.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: April 01, 2022. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 1. The 25-foot walk done. 25-foot walk test time was 3.67 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.2 sec. 9-hole peg non-dominant:16.09 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2016. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:19 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on May 01, 2016. Comments on DMT: Avonex, Tysabri. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 6.2 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:20.2 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:gilenya- fingolimod on December 09, 2013. Comments on DMT: Avonex - Rebif. Tobacco smoker: non-smoker  Vit D at visit: 87.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.85 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.62 sec. 9-hole peg non-dominant:17.86 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. Total relapses until visit: 2. Comments on DMT: Cyclophosphamide - Syncathen. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 8. SDMT denominator: 10. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:154.31 sec. EDSS:9- helpless bed patient; can communicate and eat. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:6. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:BELL'S PALSY. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2012. Comments on DMT: Betaferon 2001-2003, Avonex 2003-2009, Rebif Apr 2010-2012, Cladribine Jan 2006-2009. Tobacco smoker: non-smoker  Vit D at visit: 33.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.25 sec. 9-hole peg non-dominant:23.19 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2019. Comments on DMT: tecfidera. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:17.74 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on November 04, 2011. The patient is in EDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.16. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2011. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 05, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 58 months?",
        "output":"After 58 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:cis. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on May 01, 2019. Comments on DMT: Avonex 07\/01\/2013 until May 2019. The 25-foot walk done. 25-foot walk test time was 3.25 sec. SDMT done. SDMT numerator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.7 sec. 9-hole peg non-dominant:16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.07. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on October 29, 2018. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: rebif, avonex. Vit D at visit: 54.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Cervical spine MRI date: November 01, 2017. Received Gadolinium for Cervical spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.9 sec. 9-hole peg non-dominant:27.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: None . Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. Cervical spine MRI date: May 01, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.68 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.2 sec. 9-hole peg non-dominant:18.1 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Avonex or Cinnovex- IM Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hepatic disorders. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.15 PPD. Coffee cups per week: 7. Alcohol drinsk per week: 1. Vit D at visit: 51.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.78 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:20.91 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:ocrevus - ocrelizumab on August 27, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.5 PPD. The 25-foot walk done. 25-foot walk test time was 6.9 sec. SDMT done. SDMT numerator: 23. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.2 sec. 9-hole peg non-dominant:33.11 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.8. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on February 26, 2019. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: April 01, 2021. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2008. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. The patient is in NEDA. Will the patient be in NEDA or EDA after 27 months?",
        "output":"After 27 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2015. Vit D at visit: 51.0. The 25-foot walk done. 25-foot walk test time was 3.89 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.46 sec. 9-hole peg non-dominant:16.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 28, 2019. The 25-foot walk done. 25-foot walk test time was 4.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Plegridy (peginterferon beta 1-a). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.96. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on September 01, 2021. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. IgG index in CSF:0.98. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.8. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 4. The 25-foot walk done. 25-foot walk test time was 4.32 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:7.8 sec. 9-hole peg non-dominant:20.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.94. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on July 22, 2022. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 14. Exercise hrs per week:7. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:23.6 sec. 9-hole peg non-dominant:18.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:0.91. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:opioid use disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2016. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 20. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: July 01, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.4 sec. 9-hole peg non-dominant:26.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.69. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.4 sec. 9-hole peg non-dominant:28.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on August 01, 2022. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 7. Alcohol drinsk per week: 1. Exercise hrs per week:1. Vit D at visit: 83.4. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 89. SDMT denominator: 89. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:20.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:11. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on March 01, 2008. Comments on DMT: Avonex - Rebif - Monthly IVIG. Vit D at visit: 68.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 21, 2015. The 25-foot walk done. 25-foot walk test time was 3.84 sec. SDMT done. SDMT numerator: 64. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.52 sec. 9-hole peg non-dominant:23.5 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2017. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:negative. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:tension headache. Outcome:completely recovered from illness. Name of co-morbidity:elevated LFTs. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 26, 2019. Tobacco smoker: non-smoker  Vit D at visit: 56.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: November 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.27 sec. 9-hole peg non-dominant:22.16 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT: tysabri- natalizumab. Comments on DMT: Betaferon. MRI of brain or spine done. Cervical spine MRI date: November 29, 2016. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 27.34 sec. SDMT done. SDMT numerator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:42.07 sec. 9-hole peg non-dominant:27.41 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2016. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: October 05, 2019. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.3 sec. 9-hole peg non-dominant:18.96 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:ris. Has not converted to SPMS. Initial presentation incidental mri findings. Name of co-morbidity:Anemia. More information on co-morbidity:Sickle Cell Anemia. Outcome:ongoing illness. Visit diagnosis:ris. Total relapses until visit: 0. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 90 months?",
        "output":"After 90 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis, cerebellar. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2014. Tobacco smoker: non-smoker  Vit D at visit: 58.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 04, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 5.23 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.02 sec. 9-hole peg non-dominant:28.01 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:T2 N0 M0, ER\/PR positive and HER-2 negative breast cancer. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteopenia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. Comments on DMT: gilenya. Tobacco smoker: ex-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 03, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.7 sec. 9-hole peg non-dominant:19.1 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Aubagio- Teriflunomide. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. There were new relapses since the previous visit. Comments on DMT: rebif, REFLEX trial, betaferon, aubagio. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: lighlt. Vit D at visit: 62.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 10. Total T1 Gad-enhancing lesions in Brain: 11. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: February 28, 2017. The 25-foot walk done. 25-foot walk test time was 5 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2003. Vit D at visit: 65.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. 25-foot walk test time was 4.33 sec. SDMT done. SDMT numerator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.07 sec. 9-hole peg non-dominant:18.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.98. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Endometriosis. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2012. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: August 15, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.45 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.31 sec. 9-hole peg non-dominant:21.43 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT: cellcept or imuxigen- mycophenolate. Comments on DMT: Betaferon - Mabthera - Monthly steroids. The 25-foot walk done. 25-foot walk test time was 7.5 sec. SDMT done. SDMT numerator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.98 sec. 9-hole peg non-dominant:22.4 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.43. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: non-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 2. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: May 01, 2023. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:22 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Visit diagnosis:rrms. MRI of brain or spine done. Cervical spine MRI date: January 05, 2012. The 25-foot walk done. 25-foot walk test time was 4.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.4 sec. 9-hole peg non-dominant:23 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 43 months?",
        "output":"After 43 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on April 01, 2016. Comments on DMT: Rebif. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:23.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1ppd. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:18.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2009. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 14, 2013. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.2 sec. 9-hole peg non-dominant:30.6 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation brainstem. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Alzheimer's. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Pityriasis versicolor. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:delayed gastric emptying. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 21, 2007. Comments on DMT:  + Imuran. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:subclinical hypothyroidism . Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:chronic idiopathic urticaria . Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on December 01, 2018. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 26, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.9 sec. 9-hole peg non-dominant:18.3 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:seizures . Name of co-morbidity:learning disability . Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 17, 2019. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 31, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 2.8 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:21.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Visit diagnosis:rrms. Total relapses until visit: 4. There were new relapses since the previous visit. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 54 months?",
        "output":"After 54 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:75.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation gtc seizures. Has experienced progressive symptoms since onset. Name of co-morbidity:Surgeries. More information on co-morbidity:cholecystectomy. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:scoliosis. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:DM2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:seizures. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:tronchanteric bursitis. Outcome:completely recovered from illness. Visit diagnosis:ppms. DMT taken. Current DMT: methotrexate on December 01, 2014. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 6.07 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.42 sec. 9-hole peg non-dominant:24.89 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.9. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2013. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 58.7. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Cervical spine MRI date: January 27, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.35 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.11 sec. 9-hole peg non-dominant:23.82 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:53.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Visit diagnosis:rrms. DMT taken. Current DMT:ocrevus - ocrelizumab on December 01, 2019. Comments on DMT: AVONEX, TYSABRI. The 25-foot walk done. 25-foot walk test time was 6.79 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:38 sec. 9-hole peg non-dominant:45 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2017. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 21. Alcohol drinsk per week: 1. Exercise hrs per week:3. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:aubagio- teriflunomide on September 01, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:20.7 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2016. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 20, 2019. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Lemtrada induced. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2016. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 21. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: December 01, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Lemtrada- Alemtuzumab. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. Comments on DMT: Avonex, Rebif, Tysabri. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 36.5 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:39.44 sec. 9-hole peg non-dominant:35.1 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT: betaferon, imuran-azathioprine on January 01, 2007. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 6.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.6 sec. 9-hole peg non-dominant:31.7 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on November 01, 2017. Comments on DMT: Avonex, betaferon, gilenya. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 57 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 38. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:100 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:73.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. Visit diagnosis:nmo. DMT taken. Current DMT:imuran-azathioprine on May 01, 2006. Comments on DMT: rebif, discontinued january 2014. MRI of brain or spine done. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.2 sec. 9-hole peg non-dominant:32.4 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in EDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:5. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on September 15, 2014. Comments on DMT: Betaferon June 2006-Aug 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: October 18, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.42 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.14 sec. 9-hole peg non-dominant:21.85 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:spms. There were new relapses since the previous visit. Comments on DMT: Avonex for 3m in 2003, Gilenya Mar 2012 till September 2012, Tysabri Feb 2013 till Mar 2013. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 110 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 53 months?",
        "output":"After 53 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Remarks about CSF: but the results of the LP were not known. Name of co-morbidity:Epilepsy . Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2017. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.83 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.53 sec. 9-hole peg non-dominant:25.26 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2015. Comments on DMT: Betaferon- Tysabri. Tobacco smoker: non-smoker  Vit D at visit: 44.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: December 09, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 8.4 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:36 sec. 9-hole peg non-dominant:34 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.17. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2014. Vit D at visit: 63.6. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: February 27, 2018. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:19.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:23.  Gender:male.  Diagnosis:mogad. Has not converted to SPMS. Initial presentation sensory, cerebellar. OCBs in CSF:positive. IgG index in CSF:1.38. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:mogad. Total relapses until visit: 1. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on July 03, 2022. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Exercise hrs per week:14. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: April 12, 2022. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.37 sec. 9-hole peg non-dominant:23.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:rrms. DMT taken. Current DMT: cellcept or imuxigen- mycophenolate. Comments on DMT: Avonex. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: April 16, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 74. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.8 sec. 9-hole peg non-dominant:19.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:ocrevus - ocrelizumab on August 01, 2018. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:tysabri- natalizumab on April 01, 2017. Comments on DMT: Avonex - cladrebine - stem cell transplant - tecfidera. Vit D at visit: 102.3. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 5.7 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 27. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.1 sec. 9-hole peg non-dominant:40.6 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. Comments on DMT: Rebif - Mitoxantrone - Imuran - Endoxan - Mesenchymal stem cell injection. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 11.27 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.39 sec. 9-hole peg non-dominant:20 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 34 months?",
        "output":"After 34 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: Rebif, Gilenya, Tecfidera. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:19.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.58. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 90 months?",
        "output":"After 90 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Hypnagogic myoclonus. Outcome:ongoing illness. Name of co-morbidity:Chronic hepatitis B. Outcome:ongoing illness. Visit diagnosis:ppms. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:10. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2014. Comments on DMT: Avonex, Mabthera. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:18.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:tysabri- natalizumab on October 01, 2017. Comments on DMT: Betaferon, Gilenya, Rebif, Tecfidera. Vit D at visit: 27.6. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.9 sec. 9-hole peg non-dominant:23.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.9. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2016. Tobacco smoker: current  Tobacco type: water-pipe. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:ocrevus - ocrelizumab on June 01, 2018. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 19, 2022. The 25-foot walk done. 25-foot walk test time was 7.1 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:45.3 sec. 9-hole peg non-dominant:20.1 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.62. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:ppms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on July 16, 2019. Tobacco smoker: non-smoker  Vit D at visit: 92.1. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 18, 2021. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 18.8 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:79 sec. 9-hole peg non-dominant:22.2 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 25 months?",
        "output":"After 25 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.4. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2015. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 46.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 19, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.21 sec. 9-hole peg non-dominant:21.89 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.33. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2017. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:21.86 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:completely recovered from illness. Name of co-morbidity:Left breast cancer s\/p mastectomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 33 months?",
        "output":"After 33 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:8. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2012. Comments on DMT: Imuran - Rebif, gilenya. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 21.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: June 01, 2013. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 3. The 25-foot walk done. 25-foot walk test time was 11.7 sec. SDMT done. SDMT numerator: 10. SDMT denominator: 13. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25 sec. 9-hole peg non-dominant:53.9 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 01, 2019. Vit D at visit: 45.0. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: February 01, 2023. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:19.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:1.89. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.58. Name of co-morbidity:Surgeries. More information on co-morbidity:achilles tendon repair. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:avonex or cinnovex- im interferon on August 20, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.6 sec. 9-hole peg non-dominant:16.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.3. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on January 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.42. Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2013. Comments on DMT: Avonex. The 25-foot walk done. 25-foot walk test time was 3.92 sec. SDMT done. SDMT numerator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.71 sec. 9-hole peg non-dominant:19.75 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:nmo. Total relapses until visit: 2. DMT taken. Current DMT: mabthera- rituximab. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. SDMT done. 9-HPT done. The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mavenclad- cladribine on March 01, 2020. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: August 01, 2021. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.42 sec. 9-hole peg non-dominant:16.7 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:nmo. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on July 01, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30 sec. 9-hole peg non-dominant:29 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 20, 2003. The 25-foot walk done. 25-foot walk test time was 5.18 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.3 sec. 9-hole peg non-dominant:21.48 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on September 01, 2017. Comments on DMT: Avonex, Rebif. Vit D at visit: 61.0. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 12.9 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.5 sec. 9-hole peg non-dominant:34.4 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.25. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: Avonex (2000-June 2005, July 2007-Apr 2008), Atacicept (July 2008-Sep 2009), Rebif (2000, Apr 2008-July 2008, Dec 2009-Mar 2013). Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: daily. Vit D at visit: 114.0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.1 sec. 9-hole peg non-dominant:19.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Brain Tumor. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on January 29, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. The 25-foot walk done. 25-foot walk test time was 4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.1 sec. 9-hole peg non-dominant:16.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:4. OCBs in CSF:negative. IgG index in CSF:1.047. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on February 01, 2016. Comments on DMT: Avonex 2013 (5 months), Gilenya Dec 2013-Feb 2016. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 40.3. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.2 sec. 9-hole peg non-dominant:18.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on May 01, 2016. Comments on DMT: Avonex, Betaferon. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5.3 sec. SDMT done. SDMT numerator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.7 sec. 9-hole peg non-dominant:26 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 06, 2016. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: Occasional. Alcohol drinsk per week: 1. Vit D at visit: 65.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 13, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.19 sec. 9-hole peg non-dominant:19.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2017. Comments on DMT: tecfidera. MRI of brain or spine done. The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2017. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:24 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.37 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.14 sec. 9-hole peg non-dominant:21.13 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:abortion. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: rebif. Tobacco smoker: non-smoker  Vit D at visit: 60.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.85 sec. 9-hole peg non-dominant:24.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:knee surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendenctomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2018. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 01, 2022. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 6 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:16 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on March 01, 2023. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:15.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. Comments on DMT: Rebif. The 25-foot walk done. 25-foot walk test time was 4.46 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: unable with both hands. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses AND new EDSS findings. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: gilenya- fingolimod. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 4. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 28, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:27.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.69. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on September 01, 2021. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:ocrevus - ocrelizumab on August 27, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1ppd. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: February 18, 2019. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 6.3 sec. SDMT done. SDMT numerator: 23. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30 sec. 9-hole peg non-dominant:33.45 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hashimoto thyroiditis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Vit D at visit: 45.0. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 20 months?",
        "output":"After 20 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:ocrevus - ocrelizumab on June 01, 2018. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: April 01, 2019. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 110 sec. SDMT done. SDMT numerator: 9. SDMT denominator: 9. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:70 sec. 9-hole peg non-dominant:43 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2016. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.4 sec. 9-hole peg non-dominant:15 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 24, 2016. Vit D at visit: 20.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: July 15, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.32 sec. 9-hole peg non-dominant:22.05 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:aubagio- teriflunomide on August 01, 2015. Vit D at visit: 49.7. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.5 sec. 9-hole peg non-dominant:23 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2001. Comments on DMT: Avonex - Rebif. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:20.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Initial presentation incidental mri findings. Number of attacks until the first visit:0. OCBs in CSF:positive. IgG index in CSF:0.64. Visit diagnosis:ris. Total relapses until visit: 0. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Comments on DMT: Stopped during preg and breastfeeding on july 2020. Tobacco smoker: ex-smoker  Vit D at visit: 48.4. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.6 sec. 9-hole peg non-dominant:17.56 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 25 months?",
        "output":"After 25 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Name of co-morbidity:Anxiety. Visit diagnosis:rrms. Total relapses until visit: 10. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2014. Comments on DMT: Rebif - Imuran - Gilenya. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 4. Total T1 Gad-enhancing lesions in Brain: 4. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: October 13, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:18.81 sec. 9-hole peg non-dominant:19.47 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2019. Tobacco smoker: non-smoker  Vit D at visit: 51.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 01, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 40 months?",
        "output":"After 40 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:22.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2020. Vit D at visit: 25.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.26 sec. 9-hole peg non-dominant:20.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on June 01, 2019. Comments on DMT: Rebif, Avonex, Tysabri. Tobacco smoker: ex-smoker  MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 5.7 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.1 sec. 9-hole peg non-dominant:16.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on December 05, 2019. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 12, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:22.87 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 07, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: December 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). Remarks about MRI:  . EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2017. Comments on DMT: Tecfidera. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 22, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.95 sec. 9-hole peg non-dominant:29.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.69. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on September 01, 2021. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: February 08, 2022. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.25. Visit diagnosis:ppms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on December 01, 2019. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 65 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.64 sec. 9-hole peg non-dominant:20.91 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on March 01, 2013. Vit D at visit: 65.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: August 22, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:17 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on September 01, 2015. Tobacco smoker: non-smoker  Exercise hrs per week:2. Vit D at visit: 43.6. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 29, 2016. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34.59 sec. 9-hole peg non-dominant:31.03 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:cis. Comments on DMT: None . MRI of brain or spine done. Cervical spine MRI date: November 25, 2013. The patient is in NEDA. Will the patient be in NEDA or EDA after 32 months?",
        "output":"After 32 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.54. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2018. Comments on DMT: avonex. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:18.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 25, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.41 sec. SDMT done. SDMT numerator: 74. SDMT denominator: 74. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.71 sec. 9-hole peg non-dominant:14.26 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2017. Comments on DMT: Avonex, Rebif, Gilenya. Tobacco smoker: current  Tobacco type: cigarette or cigar. Exercise hrs per week:5. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Has experienced progressive symptoms since onset. Name of co-morbidity:Spinal cord compression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 29, 2021. Tobacco smoker: current  Tobacco type: cigarette or cigar. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Initial presentation incidental mri findings. Number of attacks until the first visit:0. OCBs in CSF:positive. IgG index in CSF:0.64. Visit diagnosis:ris. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 5. Cervical spine MRI date: September 08, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.4 sec. 9-hole peg non-dominant:17.9 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Hidradenitis Suppurutiva. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT: biotin . Comments on DMT: Cellcept - Avonex -  Tysabri, Cycophosphamide. SDMT done. SDMT numerator: 21. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:62 sec. 9-hole peg non-dominant:84 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on August 26, 2016. Comments on DMT: patient preference : taking it once per year 500 mg . Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:29.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.8. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2013. Comments on DMT: Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.92. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Allergies. More information on co-morbidity:penicillin. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:lumpectomy. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:fibroid resection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.3 sec. 9-hole peg non-dominant:27.6 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:90.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Hysterectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:bilateral cataract surgery. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:PTCA stenting. Outcome:completely recovered from illness. Name of co-morbidity:Posterior capsular opasification of lens bilaterally. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:chronic nausea. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 103 sec. SDMT done. SDMT numerator: 15. SDMT denominator: 16. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:38.2 sec. 9-hole peg non-dominant:42.4 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 14. The 25-foot walk done. 25-foot walk test time was 2.6 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:19 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2013. Comments on DMT: Avonex March 2013 until Oct 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 25, 2018. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 78. SDMT denominator: 78. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:18.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2014. Comments on DMT: 2002-2005: Avonex; 2005 - dec 2013: Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 15.4 sec. SDMT done. SDMT numerator: 24. SDMT denominator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.1 sec. 9-hole peg non-dominant:68 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:abortion. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on June 18, 2015. Comments on DMT: rebif. Tobacco smoker: non-smoker  Vit D at visit: 59.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.07. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anxiety. More information on co-morbidity:GAD, Social anxiety. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 23.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:25.2 sec. 9-hole peg non-dominant:24.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.44 sec. 9-hole peg non-dominant:18.91 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Plegridy (peginterferon beta 1-a). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2017. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.08 sec. 9-hole peg non-dominant:19.02 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 33 months?",
        "output":"After 33 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 2. The 25-foot walk done. 25-foot walk test time was 3.92 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Brain Tumor. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on May 01, 2012. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 29, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:abortion. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. Tobacco smoker: non-smoker  Vit D at visit: 26.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: January 05, 2015. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 6.11 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.46 sec. 9-hole peg non-dominant:25.13 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 01, 2013. Tobacco smoker: non-smoker  Vit D at visit: 36.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 24, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Total relapses until visit: 4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. SDMT done. SDMT numerator: 39. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:80 sec. 9-hole peg non-dominant:65 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:25.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.35. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on July 01, 2021. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 1. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:21 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, optic neuritis, brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2016. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.5 PPD. Coffee cups per week: 21. Alcohol drinsk per week: 1. Vit D at visit: 4.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 4. Cervical spine MRI date: May 10, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:19.22 sec. 9-hole peg non-dominant:22.24 sec. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on December 01, 2016. Comments on DMT: Rebif June 2016 until Sept 2016. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:15.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Name of co-morbidity:hypoxic brain injury. Name of co-morbidity:strabismus. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2018. Comments on DMT: rebif. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 36.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.8 sec. 9-hole peg non-dominant:29.47 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.55. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 3.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.27 sec. 9-hole peg non-dominant:18 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. Comments on DMT: Rebif. Tobacco smoker: ex-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 29, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 3. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 6.47 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:36 sec. 9-hole peg non-dominant:293 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.034. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2021. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: December 01, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 1. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:19 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.56. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 08, 2016. Comments on DMT: avonex. Tobacco smoker: non-smoker  Vit D at visit: 63.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:36.6 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Uveitis. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Behcet Disease. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: imuran-azathioprine. Comments on DMT: Betaferon. The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:negative. OCBs in second CSF:positive. IgG index in second:0.71. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2002. Comments on DMT: None . MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 05, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 5.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.6 sec. 9-hole peg non-dominant:24.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on September 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 15, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.28 sec. SDMT done. SDMT numerator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.5 sec. 9-hole peg non-dominant:21.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.06. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2018. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. SDMT done. SDMT numerator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.49 sec. 9-hole peg non-dominant:18.12 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.89. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2021. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: one per week . Coffee cups per week: 21. Alcohol drinsk per week: 1. Exercise hrs per week:7. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.72. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2022. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. Alcohol drinsk per week: 1. Vit D at visit: 64.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: December 09, 2022. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:6. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:BELL'S PALSY. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 7. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2012. Comments on DMT: betaferon, avonex, rebif. Vit D at visit: 33.6. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: July 04, 2017. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 3. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Has experienced progressive symptoms since onset. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 01, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Total relapses until visit: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 11, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.93 sec. 9-hole peg non-dominant:20.05 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:GERD. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia minor. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2014. Comments on DMT: Avonex Sep 2009-July 2014. Tobacco smoker: non-smoker  Vit D at visit: 56.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 30, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.53 sec. SDMT done. SDMT numerator: 90. SDMT denominator: 90. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:16.07 sec. 9-hole peg non-dominant:15.03 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.58. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hashimoto Thyroiditis. Visit diagnosis:nmo. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:7. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 7. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on April 01, 2017. Comments on DMT: Rebif Oct 2000-July 2014, Tysabri Aug 2014-Feb 2017. Tobacco smoker: non-smoker  Coffee cups per week: 21. The 25-foot walk done. 25-foot walk test time was 8 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.8 sec. 9-hole peg non-dominant:53.3 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to relapses AND new EDSS findings. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.629. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on July 01, 2019. Tobacco smoker: ex-smoker  Vit D at visit: 75.2. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: June 24, 2021. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.26 sec. 9-hole peg non-dominant:19 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.92. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Allergies. More information on co-morbidity:penicillin. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:lumpectomy. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:fibroid resection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 32. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.7 sec. 9-hole peg non-dominant:22.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. IgG index in CSF:0.82. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on September 25, 2014. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 23, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 109. SDMT denominator: 110. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.39 sec. 9-hole peg non-dominant:25.81 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Visit diagnosis:nmo. DMT taken. Current DMT:imuran-azathioprine on January 01, 2013. MRI of brain or spine done. Cervical spine MRI date: September 08, 2015. The 25-foot walk done. 25-foot walk test time was 4.21 sec. SDMT done. SDMT numerator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.64 sec. 9-hole peg non-dominant:19.42 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 28 months?",
        "output":"After 28 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on March 01, 2018. Comments on DMT: Avonex - Gilenya. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 42. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 43 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Progression of disease. New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.11. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on April 01, 2020. Tobacco smoker: non-smoker  The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 19, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34.01 sec. 9-hole peg non-dominant:40.37 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:6. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on October 01, 2016. Tobacco smoker: non-smoker  Coffee cups per week: 21. Vit D at visit: 65.0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.13 sec. 9-hole peg non-dominant:20.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hepatic disorders. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Comments on DMT: Rebif Aubagio Gilenya. The 25-foot walk done. 25-foot walk test time was 3.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.5 sec. 9-hole peg non-dominant:17 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tysabri- Natalizumab. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.05. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. DMT taken. Current DMT: mabthera- rituximab. Comments on DMT: Betaferon. The 25-foot walk done. 25-foot walk test time was 27.4 sec. SDMT done. SDMT numerator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.8 sec. 9-hole peg non-dominant:45.1 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.22. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2014. Comments on DMT: REbif. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:44 sec. 9-hole peg non-dominant:21 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. Comments on DMT: betaferon, plegridy. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 06, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Plegridy (peginterferon beta 1-a). The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mavenclad- cladribine on February 01, 2023. Tobacco smoker: non-smoker  Alcohol drinsk per week: 2. Exercise hrs per week:4. The 25-foot walk done. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:17 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:7. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2014. Tobacco smoker: non-smoker  Coffee cups per week: 28. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.93 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.04 sec. 9-hole peg non-dominant:35.51 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. MRI of brain or spine done. Cervical spine MRI date: June 14, 2016. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.97 sec. 9-hole peg non-dominant:31.02 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:5. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2008. Comments on DMT: Rebif (2006-2008). Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 42. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 27, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.2 sec. 9-hole peg non-dominant:22.2 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2018. Comments on DMT: Aubagio; Betaferon. Vit D at visit: 48.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: February 01, 2019. SDMT done. SDMT numerator: 24. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:33.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.3. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on August 01, 2020. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: December 01, 2021. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:24 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Comments on DMT: Avonex, Rebif, gilenya. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5.1 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.8 sec. 9-hole peg non-dominant:21 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Hypnagogic myoclonus. Outcome:ongoing illness. Name of co-morbidity:Chronic hepatitis B. Outcome:ongoing illness. Visit diagnosis:ppms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on October 01, 2019. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 7.3 sec. SDMT done. SDMT numerator: 24. SDMT denominator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.5 sec. 9-hole peg non-dominant:33 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on November 17, 2017. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.5 sec. 9-hole peg non-dominant:24 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2013. Comments on DMT: Betaferon. Tobacco smoker: non-smoker  Exercise hrs per week:5. Vit D at visit: 78.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: November 03, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 2.9 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.74 sec. 9-hole peg non-dominant:21.9 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:78.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis, brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:right hip fracture. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 01, 2011. Comments on DMT: Avonex 2006, Rebif 2007, Mitoxantrone June 2011. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 ppd. Coffee cups per week: 28. Vit D at visit: 28.3. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 44.44 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.41 sec. 9-hole peg non-dominant:24.31 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT: tysabri- natalizumab. Comments on DMT: Rebif. Vit D at visit: 101.3. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.59 sec. 9-hole peg non-dominant:23.29 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2012. Tobacco smoker: non-smoker  Vit D at visit: 61.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 9.79 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.03 sec. 9-hole peg non-dominant:22.4 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2010. Comments on DMT: cladribine. Tobacco smoker: current  Tobacco type: water-pipe. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:18.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.629. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on July 01, 2021. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 73.6. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 01, 2022. The 25-foot walk done. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.92. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:nmo. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on September 01, 2014. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 06, 2017. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.8 sec. 9-hole peg non-dominant:17.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2012. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 21. Exercise hrs per week:3. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 76. SDMT denominator: 76. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:18.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Visit diagnosis:spms. Total relapses until visit: 8. DMT taken. Current DMT:mabthera- rituximab on February 01, 2018. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 21. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.82. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:hearing problem. Name of co-morbidity:thrombocytopenia medication induced. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2006. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Cellcept or Imuxigen- Mycophenolate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.607. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:16.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.47. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: September 01, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:22.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2017. Comments on DMT: Gilenya was taken from Dec 2014 to Dec 2015 then stopped due to pregnancy. Tobacco smoker: non-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: March 24, 2023. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on September 01, 2019. Comments on DMT: rebif, gilenya, tysabri. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 9.2 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.96 sec. 9-hole peg non-dominant:23.3 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:schizoaffective. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on November 30, 2012. Comments on DMT: Rebif, Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). SDMT done. SDMT numerator: 25. SDMT denominator: 26. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:33 sec. 9-hole peg non-dominant:42.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2016. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.7 sec. 9-hole peg non-dominant:22.1 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mavenclad- cladribine on January 01, 2020. Vit D at visit: 43.6. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:20.28 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.16. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:RL fracture s\/p surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 21, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 1. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:19.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:pregnancy plans. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on November 01, 2017. Comments on DMT: Avonex. Vit D at visit: 57.5. The 25-foot walk done. Assistance required for 25-foot walk test: Unilateral assistance by a person. 25-foot walk test time was 22.33 sec. SDMT done. SDMT numerator: 47. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:176.19 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on July 05, 2005. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: January 08, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.8 sec. 9-hole peg non-dominant:20.6 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.9. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on December 23, 2019. Comments on DMT: Avonex Rebif. Vit D at visit: 38.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 01, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:18 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2011. The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:hydronephrosis . Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:sinusitis . Name of co-morbidity:Surgeries. More information on co-morbidity:c section, sinus surgery, external fixation of ankle fracture. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on December 01, 2018. Comments on DMT: Rebif, Gilenya, Tecfidera. The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:18.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on December 01, 2014. The 25-foot walk done. 25-foot walk test time was 6.65 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.94 sec. 9-hole peg non-dominant:20.87 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Surgeries. More information on co-morbidity:oophorectomy for ovrian teratoma. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on August 01, 2020. Vit D at visit: 37.7. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: March 01, 2023. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:24 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on November 01, 2014. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 15.2 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mavenclad- Cladribine. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Visit diagnosis:spms. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Cervical spine MRI date: February 11, 2020. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 3. The 25-foot walk done. 25-foot walk test time was 10.8 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.4 sec. 9-hole peg non-dominant:30 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:10. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:spms. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. Assistance required for 25-foot walk test: Unilateral assistance by a person. 25-foot walk test time was 29.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.9 sec. 9-hole peg non-dominant:18.8 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on September 01, 2019. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:19 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on June 01, 2010. Tobacco smoker: non-smoker  Vit D at visit: 19.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.6 sec. 9-hole peg non-dominant:20.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 36 months?",
        "output":"After 36 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on August 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.06 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.63 sec. 9-hole peg non-dominant:19.66 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Rebif . MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 4. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 46 months?",
        "output":"After 46 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. OCBs in CSF:positive. IgG index in CSF:1.27. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on March 16, 2018. Tobacco smoker: non-smoker  Coffee cups per week: 21. The 25-foot walk done. 25-foot walk test time was 7.9 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on October 01, 2012. Comments on DMT: Rebif - Avonex. MRI of brain or spine done. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 06, 2019. Cervical spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.38 sec. 9-hole peg non-dominant:19.47 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:imuran-azathioprine on November 12, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 06, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 36 months?",
        "output":"After 36 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:20.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2021. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: May 01, 2022. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 2. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.21 sec. 9-hole peg non-dominant:20.03 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:8. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:47.7 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2014. Comments on DMT: 2002-2005: Avonex; 2005 - dec 2013: Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 1. Vit D at visit: 107.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 29, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 23 sec. SDMT done. SDMT numerator: 26. SDMT denominator: 26. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:49 sec. 9-hole peg non-dominant:49.7 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:spms. Comments on DMT: Avonex -Rebif - Aubagio -Tysabri. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 24, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 41 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:52.63 sec. 9-hole peg non-dominant:34.18 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on November 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:22 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. Comments on DMT: Avonex (Jan 2015 - Mar 2015) failed with an attack Rebif (Mar 2015 - July 2015) failed with an attack Gilenya (Aug 2015 - April 2017) due to pregnancy was D\/C  . EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Psychiatric disorders. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:avonex or cinnovex- im interferon on July 01, 2015. Comments on DMT: Tecfidera (Jan 2015-May 2015\/0 Avonex (July 2015-Aug 2016) Rebif (Aug 2016-Dec 2016). The 25-foot walk done. 25-foot walk test time was 6.3 sec. SDMT done. SDMT numerator: 19. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:78.95 sec. 9-hole peg non-dominant:96.71 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:Severe lesion load. New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on October 01, 2018. Comments on DMT: Tysabri. The 25-foot walk done. 25-foot walk test time was 6.3 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:58 sec. 9-hole peg non-dominant:27.5 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2017. Tobacco smoker: ex-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 84. SDMT denominator: 84. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:17.83 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 01, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 29, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:16.1 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2013. Comments on DMT: Rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: December 20, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Remarks about MRI: Increase in the size of a right frontal lesion with evidence of enhancement consistent with active demyelination. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 19. SDMT denominator: 19. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.9 sec. 9-hole peg non-dominant:22.33 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Name of co-morbidity:Anxiety. Visit diagnosis:rrms. Total relapses until visit: 12. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on June 01, 2016. Comments on DMT: Rebif Imuran Gilenya. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 07, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:16 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Solumedrol- IV Methylprednisolone. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 09, 2013. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 26, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.8 sec. 9-hole peg non-dominant:20.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Has experienced progressive symptoms since onset. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 01, 2013. Comments on DMT: imuran 2004-Apr 2013. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:spms. Total relapses until visit: 8. DMT taken. Current DMT:mabthera- rituximab on July 01, 2017. Comments on DMT: Avonex, Rebif, Gilenya, Tecfidera. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:16.7 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:78.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis, brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:right hip fracture. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:osteopenia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT: mitoxantrone on July 01, 2011. Comments on DMT: Avonex 2006, Rebif 2007. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 ppd. Coffee cups per week: 42. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 13, 2011. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 10.9 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Anterior Uveitis. Name of co-morbidity:Migraine. Name of co-morbidity:Depression. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on April 01, 2011. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 4. Alcohol drinsk per week: 21. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:23 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:T2 N0 M0, ER\/PR positive and HER-2 negative breast cancer. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2016. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 49.3. The 25-foot walk done. 25-foot walk test time was 8.1 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.2 sec. 9-hole peg non-dominant:20.4 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation incidental mri findings. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. The 25-foot walk done. 25-foot walk test time was 3.38 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2014. Comments on DMT: Avonex, Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: November 26, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 21.8 sec. SDMT done. SDMT numerator: 19. SDMT denominator: 19. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:40.8 sec. 9-hole peg non-dominant:58.8 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. IgG index in CSF:0.82. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 23, 2014. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2013. Comments on DMT: Imuran, Rebif, Betaferon. MRI of brain or spine done. The patient is in EDA. Will the patient be in NEDA or EDA after 49 months?",
        "output":"After 49 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.83. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2016. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.3 sec. 9-hole peg non-dominant:22.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female. . Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.84. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on April 01, 2017. Comments on DMT: rebif, avonex. Vit D at visit: 70.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: September 25, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.2 sec. 9-hole peg non-dominant:30.5 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 01, 2013. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:15 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.72. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 33 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:23.2 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar, incidental mri findings. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2012. Comments on DMT: tried Rebif for 7 months in 2014 for financial reasons. Tobacco smoker: non-smoker  Vit D at visit: 50.3. MRI of brain or spine done. Cervical spine MRI date: January 13, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 6.3 sec. SDMT done. SDMT numerator: 22. SDMT denominator: 23. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:26.9 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2002. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.9 sec. 9-hole peg non-dominant:19.9 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2013. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Cervical spine MRI date: May 21, 2018. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 14. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:23.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on December 01, 2018. Comments on DMT: Rebif. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.6 sec. 9-hole peg non-dominant:17.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 PPD. Alcohol drinsk per week: 1. Vit D at visit: 20.0. MRI of brain or spine done. Cervical spine MRI date: April 23, 2013. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 1. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.6 sec. 9-hole peg non-dominant:19.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Avonex or Cinnovex- IM Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2017. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 14. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: May 01, 2022. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:tecfidera-dimethylfumarate on September 01, 2015. Comments on DMT: Avonex, Gilenya. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 10. Total T1 Gad-enhancing lesions in Brain: 5. Cervical spine MRI date: May 16, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 1. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.38 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.09 sec. 9-hole peg non-dominant:22.41 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Remarks about CSF: but the results of the LP were not known. Name of co-morbidity:Epilepsy . Visit diagnosis:rrms. Total relapses until visit: 4. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.66 sec. 9-hole peg non-dominant:25.56 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:10. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2011. MRI of brain or spine done. Cervical spine MRI date: March 30, 2012. The 25-foot walk done. 25-foot walk test time was 8.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:22.6 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:10. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:epilepsy. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2011. Tobacco smoker: non-smoker  SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.2 sec. 9-hole peg non-dominant:24 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Visit diagnosis:rrms. Total relapses until visit: 8. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2008. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.99 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.25 sec. 9-hole peg non-dominant:24.04 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:65.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Visit diagnosis:spms. Total relapses until visit: 3. Comments on DMT: Avonex (2010-2018), Rituximab (2019). Tobacco smoker: non-smoker  Coffee cups per week: 21. Alcohol drinsk per week: 2. Exercise hrs per week:1. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 59 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.5 sec. 9-hole peg non-dominant:22.4 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 7. DMT taken. Current DMT:mabthera- rituximab on February 01, 2019. Comments on DMT: Rebif, Tysabri, Gilenya. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 01, 2019. The 25-foot walk done. 25-foot walk test time was 7.7 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.89 sec. 9-hole peg non-dominant:23.47 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.28. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Asthma. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2014. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.97 sec. 9-hole peg non-dominant:18.9 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.54. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2018. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 23, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18.9 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on March 01, 2017. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: May 11, 2012. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The patient is in EDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2014. Comments on DMT: Rebif + REFLEX trial. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: occasional. Vit D at visit: 72.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 01, 2014. The 25-foot walk done. 25-foot walk test time was 4.33 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.54 sec. 9-hole peg non-dominant:22.42 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. IgG index in CSF:0.82. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 25, 2014. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 110. SDMT denominator: 110. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:17.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2017. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. SDMT done. SDMT numerator: 24. SDMT denominator: 26. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:24 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.3. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2014. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 6. Total T1 Gad-enhancing lesions in Brain: 4. Cervical spine MRI date: June 15, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.39 sec. 9-hole peg non-dominant:18.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hepatic disorders. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on January 16, 2018. MRI of brain or spine done. Cervical spine MRI date: October 26, 2018. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Name of co-morbidity:Anxiety. Visit diagnosis:rrms. Total relapses until visit: 9. There were new relapses since the previous visit. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.58. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2016. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:15.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Name of co-morbidity:hypoxic brain injury. Name of co-morbidity:strabismus. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. There were new relapses since the previous visit. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2018. Comments on DMT: rebif. Tobacco smoker: ex-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 10, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.5 sec. 9-hole peg non-dominant:33 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:observation period. The patient is in EDA due to relapses AND new EDSS findings. Will the patient be in NEDA or EDA after 38 months?",
        "output":"After 38 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2014. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.8 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:17.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Asthma. Visit diagnosis:rrms. Total relapses until visit: 6. There were new relapses since the previous visit. DMT taken. Current DMT:tysabri- natalizumab on May 01, 2017. Comments on DMT: Rebif. The 25-foot walk done. 25-foot walk test time was 4.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.15 sec. 9-hole peg non-dominant:17.5 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:gastric sleeve. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2019. Comments on DMT: Rebif. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 01, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.32 sec. SDMT done. SDMT numerator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:19.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.81. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Name of co-morbidity:Asthma. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on July 04, 2018. Comments on DMT: Aubagio. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: June 10, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.35 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25 sec. 9-hole peg non-dominant:26.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 25, 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 05, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:1. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on September 16, 2015. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.8 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.4 sec. 9-hole peg non-dominant:20.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on December 01, 2015. Comments on DMT: Avonex 2010-Dec 2015. Tobacco smoker: non-smoker  Coffee cups per week: 1. Alcohol drinsk per week: 2. Vit D at visit: 45.2. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:21.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:spms. Total relapses until visit: 9. DMT taken. Current DMT:mabthera- rituximab on July 01, 2017. Comments on DMT: Avonex, Rebif, Gilenya, Tecfidera. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 53.7. The 25-foot walk done. 25-foot walk test time was 9.3 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:16.85 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.69. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2019. Comments on DMT: Rebif. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 85. SDMT denominator: 85. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:17 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mavenclad- cladribine on August 01, 2021. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 6.2 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.6 sec. 9-hole peg non-dominant:36 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, brainstem. Visit diagnosis:spms. Several relapses until this visit. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 104 sec. SDMT done. SDMT numerator: 21. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28 sec. 9-hole peg non-dominant:36 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:17.9 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2017. Comments on DMT: Betaferon, Gilenya. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 16, 2019. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 61 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:26.4 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on October 01, 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 29.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 81. SDMT denominator: 82. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:19 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. IgG index in CSF:1.17. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on March 01, 2023. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: March 01, 2022. The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25 sec. 9-hole peg non-dominant:26.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Bipolar disorder. Visit diagnosis:rrms. Total relapses until visit: 2. Coffee cups per week: 7. MRI of brain or spine done. No new lesions on Brain MRI. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2012. The 25-foot walk done. 25-foot walk test time was 9.43 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.43 sec. 9-hole peg non-dominant:21.55 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:2.43. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on April 25, 2019. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 16, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on December 18, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:nmo. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14 sec. 9-hole peg non-dominant:16.57 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2018. MRI of brain or spine done. Cervical spine MRI date: August 20, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.06 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.3 sec. 9-hole peg non-dominant:23.46 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:75.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH s\/p TURP. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Constipation. Outcome:ongoing illness. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. Comments on DMT: Rebif - Avonex. Tobacco smoker: non-smoker  Vit D at visit: 28.32. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:42.24 sec. EDSS:8- essentially restricted to bed or chair or perambulated in wheelchair but out of bed most of day; retains many self-care functions; generally has effective use of arms. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2017. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.46 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.4 sec. 9-hole peg non-dominant:22.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on February 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:24.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on April 01, 2017. Comments on DMT: 2012-Imuran \/ 2012-2015 Betaferon\/ 2015 Rebif\/ 2015-Mar2017 Betaferon. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 34.78 sec. SDMT done. SDMT numerator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:27.24 sec. 9-hole peg non-dominant:48.21 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on September 01, 2017. Vit D at visit: 59.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.05 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.59 sec. 9-hole peg non-dominant:23.13 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.47. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on November 01, 2018. Comments on DMT: Betaferon, Gilenya, Tysabri. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.9 sec. 9-hole peg non-dominant:23.45 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2020. Comments on DMT: Betaferon, Plegridy. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 24, 2021. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.4 sec. 9-hole peg non-dominant:18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:1.58. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on September 23, 2019. Comments on DMT: Rebif, Gilenya, Avonex, Aubagio. Tobacco smoker: ex-smoker  The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.06. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:1.01. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on August 01, 2019. Comments on DMT: avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: February 20, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:19 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2003. Vit D at visit: 47.5. The 25-foot walk done. 25-foot walk test time was 4.19 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30 sec. 9-hole peg non-dominant:39.6 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:ocrevus - ocrelizumab on January 08, 2020. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:25 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on December 09, 2013. Comments on DMT: Avonex - Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 21. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 01, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on November 01, 2017. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: March 05, 2022. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 43 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:84 sec. 9-hole peg non-dominant:55 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:0.93. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on January 01, 2017. Comments on DMT: None . MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on February 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: September 15, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 9.6 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.88 sec. 9-hole peg non-dominant:18.46 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.3. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 4.41 sec. SDMT done. SDMT numerator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.61 sec. 9-hole peg non-dominant:21.33 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on July 01, 2020. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.5 sec. 9-hole peg non-dominant:21 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mavenclad- Cladribine. The patient is in NEDA. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. More information on co-morbidity:herpes zoster ophthalmicus. Outcome:completely recovered from illness. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:endoxan- cyclophosphamide on May 02, 2014. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 34.17 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:33.13 sec. 9-hole peg non-dominant:35.46 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Visit diagnosis:rrms. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2017. Vit D at visit: 33.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. The 25-foot walk done. 25-foot walk test time was 4.18 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.12 sec. 9-hole peg non-dominant:20.69 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:negative. IgG index in second:0.46. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:anterior uveitis. Outcome:completely recovered from illness. Name of co-morbidity:iridocorneal adhesions. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Name of co-morbidity:Sciatica. Outcome:ongoing illness. Name of co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:prolactinemia 2ry to Tegretol. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Klebsiella pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on October 01, 2017. Comments on DMT: Tysabri (August 2015-June 2017). EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. IgG index in CSF:1.33. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 16, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.4 sec. 9-hole peg non-dominant:17.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2011. MRI of brain or spine done. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2017. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). SDMT done. SDMT numerator: 44. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2013. Comments on DMT: Betaferon (2009-2011) (discontinued due to persistent pancytopenia) Avonex (2011-Nov 2013) (discontinued due to clinical and radiological failure)  . Vit D at visit: 60.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:17 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:2.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2009. Comments on DMT: Rebif, atacicept. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 33. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.29 sec. 9-hole peg non-dominant:34.95 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.17. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2014. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 ppd. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 2.3 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.15 sec. 9-hole peg non-dominant:23.14 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.83. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 4.62 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.3 sec. 9-hole peg non-dominant:20.6 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Tobacco smoker: ex-smoker  Vit D at visit: 49.5. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14 sec. 9-hole peg non-dominant:14.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:5. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 8. There were new relapses since the previous visit. DMT taken. Current DMT:mavenclad- cladribine on February 01, 2020. Comments on DMT: avonex, betaferon, gilenya, tysabri, tecfidera. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.93 sec. 9-hole peg non-dominant:17.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Blood and lymphatic disorders. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on September 01, 2020. The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.7 sec. 9-hole peg non-dominant:16 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.25. Visit diagnosis:ppms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on December 01, 2019. Tobacco smoker: non-smoker  The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:cis. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on May 01, 2019. SDMT done. SDMT numerator: 75. SDMT denominator: 77. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:16.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:5. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on April 29, 2015. Comments on DMT: avonex. Vit D at visit: 54.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.8 sec. 9-hole peg non-dominant:26.5 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Vitamin B 12 deficiency. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 10.8 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.3 sec. 9-hole peg non-dominant:31.2 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2014. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Vit D at visit: 68.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 09, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:20.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:completely recovered from illness. Visit diagnosis:cis. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 26, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 5.1 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:18.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Cervical spine MRI date: February 14, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.7 sec. SDMT done. SDMT numerator: 19. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.7 sec. 9-hole peg non-dominant:31.9 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2013. Comments on DMT: Avonex. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.9 sec. 9-hole peg non-dominant:23.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Visit diagnosis:rrms vs spms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2013. Tobacco smoker: ex-smoker  Vit D at visit: 100.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 26, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. SDMT done. SDMT numerator: 23. SDMT denominator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.91 sec. 9-hole peg non-dominant:27.45 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Bipolar disorder. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2014. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:20.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 4. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.5 sec. 9-hole peg non-dominant:21.9 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT: endoxan- cyclophosphamide. Comments on DMT: Rebif. Vit D at visit: 67.2. The 25-foot walk done. 25-foot walk test time was 8.4 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 4.32 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.68 sec. 9-hole peg non-dominant:22.58 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 47 months?",
        "output":"After 47 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:negative. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:tension headache. Outcome:completely recovered from illness. Name of co-morbidity:elevated LFTs. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 11, 2019. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 22, 2022. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.96 sec. 9-hole peg non-dominant:20 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.9. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: Avonex . MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:19.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on November 01, 2015. Comments on DMT: Dec 2013-Feb 2014 Gilenya, Jan 2015-Nov 2015 Avonex. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: May 30, 2017. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.74 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.94 sec. 9-hole peg non-dominant:33.04 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:3.41. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 06, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 2.8 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.81 sec. 9-hole peg non-dominant:17.85 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:18.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Plegridy (peginterferon beta 1-a). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Comments on DMT: rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 21, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.58. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Comments on DMT: Rebif, Tecfidera. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 91. SDMT denominator: 92. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:18.8 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.12. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2018. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 03, 2019. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:23 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on August 08, 2019. Comments on DMT: avonex, rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 47.2. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 01, 2020. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:21.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:76.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Disk surgery. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Right ear congenital hearing loss. Outcome:ongoing illness. Name of co-morbidity:Tooth abscess + extraction. Outcome:completely recovered from illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total Left hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on April 05, 2012. Comments on DMT: rebif, atoricept trial. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 40. The 25-foot walk done. 25-foot walk test time was 32.63 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. OCBs in CSF:positive. IgG index in CSF:1.04. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. MRI of brain or spine done. Cervical spine MRI date: May 01, 2022. Thoracic spine MRI: Not compared to previous spine MRI. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:38 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2001. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 30, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on May 01, 2016. Comments on DMT: Avonex, Tysabri. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.2 sec. 9-hole peg non-dominant:20 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.98. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. Tobacco smoker: non-smoker  Coffee cups per week: 15. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: November 01, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.8 sec. 9-hole peg non-dominant:19.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Rheumatoid arhritis. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: tysabri- natalizumab. Comments on DMT: Gilenya - Cyclophosphamide. Vit D at visit: 68.8. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: December 29, 2016. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2017. The 25-foot walk done. 25-foot walk test time was 3.49 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.36 sec. 9-hole peg non-dominant:20.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:logistic issues to obtain the DMT. New DMT:Lemtrada- Alemtuzumab. The patient is in EDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.47. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2020. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 03, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.58 sec. 9-hole peg non-dominant:18 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1ppd. The 25-foot walk done. 25-foot walk test time was 3.84 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.65 sec. 9-hole peg non-dominant:17.81 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:59.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:1.5. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Imuran. MRI of brain or spine done. Cervical spine MRI date: April 28, 2015. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.82 sec. 9-hole peg non-dominant:19.09 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.04. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Rosacea. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on May 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 27, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.37 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:19.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:ocrevus - ocrelizumab on September 01, 2022. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: December 12, 2022. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 1. SDMT denominator: 34. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.14 sec. 9-hole peg non-dominant:29 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Visit diagnosis:rrms. DMT taken. Current DMT: mabthera- rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT: tysabri- natalizumab. MRI of brain or spine done. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2012. Tobacco smoker: non-smoker  MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:22 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2021. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: September 01, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:17.09 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2013. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Vit D at visit: 67.6. SDMT done. SDMT numerator: 93. SDMT denominator: 93. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.93 sec. 9-hole peg non-dominant:22.75 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.64. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on January 01, 2015. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 01, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:22.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.94. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on June 01, 2021. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: December 21, 2021. Cervical spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.8 sec. 9-hole peg non-dominant:23 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:5. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on March 13, 2017. Comments on DMT: Betaferon Gilenya Tysabri. The 25-foot walk done. 25-foot walk test time was 15.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:113 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2015. Comments on DMT: Gilenya December 2013 - February 2014. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. Vit D at visit: 49.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: December 03, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.63 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.3 sec. 9-hole peg non-dominant:27.4 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on October 01, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: July 03, 2020. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.2 sec. 9-hole peg non-dominant:18.04 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.3 sec. 9-hole peg non-dominant:19.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:ris. Has not converted to SPMS. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ris. Total relapses until visit: 0. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 7. Vit D at visit: 33.6. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 07, 2022. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 2.9 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15.9 sec. 9-hole peg non-dominant:18.55 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:75.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation gtc seizures. Has experienced progressive symptoms since onset. Name of co-morbidity:Surgeries. More information on co-morbidity:cholecystectomy. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:scoliosis. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:DM2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:seizures. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:tronchanteric bursitis. Outcome:completely recovered from illness. Visit diagnosis:ppms. DMT taken. Current DMT: methotrexate on December 01, 2014. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 28.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 11.3 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.1 sec. 9-hole peg non-dominant:32 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.71. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Comments on DMT: rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 33.7. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.8 sec. 9-hole peg non-dominant:19.1 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:nmo. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on July 01, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:23 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2006. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: May 01, 2018. Cervical spine MRI: T2 lesions, not gad-enhancing. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Visit diagnosis:ppms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on September 01, 2018. The 25-foot walk done. 25-foot walk test time was 34.8 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31.56 sec. 9-hole peg non-dominant:22.33 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on September 01, 2018. Comments on DMT: Avonex Gilenya Tecfidera Tysabri. Vit D at visit: 30.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. Remarks about CSF: CSF studies done outside AUBMC in 2016 for diagnosis. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on June 04, 2018. Comments on DMT: Rebif from 2016 until June 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: January 14, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 19.21 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:43.64 sec. 9-hole peg non-dominant:59.64 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: non-smoker  MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: March 31, 2023. Cervical spine MRI: T2 lesion, unknown enhancement (MRI without gad). Number of new T2 lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 74. SDMT denominator: 74. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:14.81 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 26, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.7 sec. 9-hole peg non-dominant:15.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 01, 2013. Tobacco smoker: non-smoker  Vit D at visit: 32.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 19, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.8 sec. 9-hole peg non-dominant:18.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:spms. There were new relapses since the previous visit. Comments on DMT: Avonex for 3m in 2003, Gilenya Mar 2012 till September 2012, Tysabri Feb 2013 till Mar 2013. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 5.5 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. Name of co-morbidity:Absence Seizures. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2018. Tobacco smoker: non-smoker  Coffee cups per week: 7. Alcohol drinsk per week: 1. Exercise hrs per week:2. Vit D at visit: 36.9. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:18 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:GERD. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia minor. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: tecfidera-dimethylfumarate. Comments on DMT: Avonex; Rebif. Vit D at visit: 34.9. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: June 01, 2019. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 91. SDMT denominator: 92. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation brainstem. Has experienced progressive symptoms since onset. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:OCD. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on March 01, 2019. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 7.5 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:55 sec. 9-hole peg non-dominant:53 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. OCBs in CSF:positive. IgG index in CSF:1.13. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 6. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 09, 2019. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 24, 2020. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2015. Comments on DMT: Betaferon. Tobacco smoker: non-smoker  Vit D at visit: 83.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.95 sec. SDMT done. SDMT numerator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.84 sec. 9-hole peg non-dominant:20.89 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:spms. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 74 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:67.86 sec. 9-hole peg non-dominant:46.15 sec. EDSS:8- essentially restricted to bed or chair or perambulated in wheelchair but out of bed most of day; retains many self-care functions; generally has effective use of arms. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:2. OCBs in second CSF:positive. OCBs in third CSF:positive. IgG index in third CSF:0.52. IgG index category in third CSF:Normal (< 0.77). Name of co-morbidity:schizoaffective. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2011. Comments on DMT: Betaferon. The 25-foot walk done. 25-foot walk test time was 5.09 sec. SDMT done. SDMT numerator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:33.7 sec. 9-hole peg non-dominant:37.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 2 times\/week. Coffee cups per week: 7. Vit D at visit: 6.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: June 19, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 4. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 4. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.4 sec. 9-hole peg non-dominant:23.3 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Avonex or Cinnovex- IM Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.98. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 10, 2018. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 26, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.43 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.64 sec. 9-hole peg non-dominant:18.27 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2012. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 68.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 30, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.2 sec. 9-hole peg non-dominant:20.31 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on March 01, 2009. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. Vit D at visit: 70.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 6.4 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.2 sec. 9-hole peg non-dominant:42.6 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:cis. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.6 sec. 9-hole peg non-dominant:21.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.72. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on June 24, 2022. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. Exercise hrs per week:4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: April 13, 2022. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:21 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2015. Vit D at visit: 19.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: November 18, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.22 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:67.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis, sarcoidosis. OCBs in CSF:negative. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 3. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on January 01, 2011. Comments on DMT: Cellcept, Other. The patient is in EDA. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, incidental mri findings. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2018. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 3. Vit D at visit: 75.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 06, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 3. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 3. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.06 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.09 sec. 9-hole peg non-dominant:22.87 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. OCBs in CSF:positive. IgG index in CSF:1.27. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on March 01, 2022. Tobacco smoker: non-smoker  Coffee cups per week: 35. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:27 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:17.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:999. Visit diagnosis:nmo. Total relapses until visit: 2. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.83. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2014. Vit D at visit: 50.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:21.88 sec. 9-hole peg non-dominant:22.35 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:8. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: Imuran ,Rebif, gilenya, endoxam cellcept. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 102 sec. SDMT done. SDMT numerator: 10. SDMT denominator: 10. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.03 sec. 9-hole peg non-dominant:133 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on September 01, 2019. Comments on DMT: Avonex. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.27 sec. 9-hole peg non-dominant:18.86 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:25.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.35. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2018. Vit D at visit: 33.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.5 sec. 9-hole peg non-dominant:21.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Avonex. Tobacco smoker: ex-smoker  EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on September 01, 2019. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:patient preference- convenience. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.95. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on July 01, 2013. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 31, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.5 sec. 9-hole peg non-dominant:23.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.864. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Essential tremor. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2015. Comments on DMT: Avonex Mar 2014\/Oct 2015. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 3.46 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.53 sec. 9-hole peg non-dominant:23.81 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:disc disease. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on May 18, 2018. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 41.2. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 9.41 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.5 sec. 9-hole peg non-dominant:27 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation brainstem. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Alzheimer's. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Pityriasis versicolor. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:delayed gastric emptying. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 21, 2007. Comments on DMT: Imuran. Tobacco smoker: non-smoker  Vit D at visit: 62.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 13.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:38.88 sec. 9-hole peg non-dominant:37.98 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:27.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on July 01, 2021. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.47 sec. 9-hole peg non-dominant:19.44 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on July 01, 2018. Vit D at visit: 46.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 15, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.94 sec. 9-hole peg non-dominant:24 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Blood and lymphatic disorders. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2019. Comments on DMT: Rebif- Tecfidera. Vit D at visit: 44.0. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.37 sec. 9-hole peg non-dominant:16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on November 01, 2016. Comments on DMT: Avonex Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 28. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.89 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2007. Comments on DMT: Avonex. Vit D at visit: 15.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.74 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.44 sec. 9-hole peg non-dominant:24.83 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 40 months?",
        "output":"After 40 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on October 02, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Hidradenitis Suppurutiva. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. Comments on DMT: Cellcept - Avonex - Gilenya, Tysabri, Cycophosphamide. EDSS:7.5- unable to take more than a few steps; restricted to wheelchair; may need some help in transferring and in wheeling self. The patient is in NEDA. Will the patient be in NEDA or EDA after 33 months?",
        "output":"After 33 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2003. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 26. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.9 sec. 9-hole peg non-dominant:21 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.44. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2019. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:0.79. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Comments on DMT: Rebif (pregnancy). Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:negative. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on May 01, 2013. Comments on DMT: betaferon. Tobacco smoker: non-smoker  Vit D at visit: 18.0. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 76.14 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.83 sec. 9-hole peg non-dominant:42.42 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:2.43. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 02, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 3.85 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.19 sec. 9-hole peg non-dominant:21.41 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:positive. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 7. Alcohol drinsk per week: 1. Vit D at visit: 7.5. MRI of brain or spine done. Presence of new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:20.52 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on September 01, 2016. Tobacco smoker: non-smoker  Coffee cups per week: 5. Vit D at visit: 26.02. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: January 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.9 sec. 9-hole peg non-dominant:27.9 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT: betaferon on January 01, 2007. Comments on DMT: Imuran-Azathioprine, Betaferon. Tobacco smoker: non-smoker  Vit D at visit: 5.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 5.22 sec. SDMT done. SDMT numerator: 33. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.07 sec. 9-hole peg non-dominant:30.94 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2017. Tobacco smoker: ex-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 98. SDMT denominator: 98. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.7 sec. 9-hole peg non-dominant:16.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on February 01, 2018. Vit D at visit: 45.36. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.9 sec. 9-hole peg non-dominant:18.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 28 months?",
        "output":"After 28 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Number of attacks until the first visit:1. Visit diagnosis:ppms. Total relapses until visit: 1. DMT taken. Current DMT: methotrexate on July 01, 2012. The 25-foot walk done. 25-foot walk test time was 5.4 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.8 sec. 9-hole peg non-dominant:21 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 20 months?",
        "output":"After 20 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. The 25-foot walk done. 25-foot walk test time was 29.9 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory. Has experienced progressive symptoms since onset. OCBs in CSF:positive. Visit diagnosis:ppms. Total relapses until visit: 0. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. Tobacco smoker: current  The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on October 01, 2019. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:20 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2016. Comments on DMT: rebif until May 2016, d\/c due to a relapse. Vit D at visit: 94.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 71. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.1 sec. 9-hole peg non-dominant:16.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Comments on DMT: Rebif. Tobacco smoker: ex-smoker  Vit D at visit: 59.8. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 14, 2019. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.14 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.58 sec. 9-hole peg non-dominant:18.59 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 7. DMT taken. Current DMT:ocrevus - ocrelizumab on May 25, 2021. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2017. Vit D at visit: 79.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 01, 2018. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:999. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: February 10, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 99. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.12 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.83 sec. 9-hole peg non-dominant:26.29 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 45 months?",
        "output":"After 45 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.91. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2017. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 23, 2020. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.94 sec. SDMT done. SDMT numerator: 88. SDMT denominator: 88. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.7 sec. 9-hole peg non-dominant:20 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:6. Visit diagnosis:rrms. Total relapses until visit: 9. DMT taken. Current DMT:mabthera- rituximab on March 01, 2019. Comments on DMT: Avonex, betaferon, Rebif, Gilenya. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.7 sec. 9-hole peg non-dominant:28.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on June 01, 2018. Comments on DMT: avonex, gilenya. mabthera. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. Assistance required for 25-foot walk test: Unilateral assistance by a person. 25-foot walk test time was 18.6 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.85 sec. 9-hole peg non-dominant:66 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2014. Comments on DMT: Avonex, Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: April 16, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 95. SDMT denominator: 95. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.1 sec. 9-hole peg non-dominant:22.04 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:86.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation myelitis. Number of attacks until the first visit:3. Name of co-morbidity:Diffuse cystic mastopathy s\/p subtotal mastectomy. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonitis. Outcome:completely recovered from illness. Name of co-morbidity:Sepsis. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:hemorrhage. Outcome:death due to illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2010. Comments on DMT: Mitoxantrone  - Avonex - Mabthera  -. The 25-foot walk done. 25-foot walk test time was 22.8 sec. SDMT done. SDMT numerator: 13. SDMT denominator: 13. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:43.46 sec. 9-hole peg non-dominant:82.93 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2016. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on October 01, 2019. Vit D at visit: 60.3. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:18 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hepatic disorders. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. The patient is in EDA. Will the patient be in NEDA or EDA after 23 months?",
        "output":"After 23 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:LABILE HTN. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. Comments on DMT: Rebif. The patient is in EDA. Will the patient be in NEDA or EDA after 37 months?",
        "output":"After 37 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:gastric sleeve. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.8 sec. 9-hole peg non-dominant:21 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:nmosd. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on April 01, 2018. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:180 sec. 9-hole peg non-dominant:17.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.034. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. There were new relapses since the previous visit. DMT taken. Current DMT:tysabri- natalizumab on April 21, 2020. Comments on DMT: Tecfidera. The 25-foot walk done. 25-foot walk test time was 4.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 50 months?",
        "output":"After 50 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 11. DMT taken. Current DMT:mabthera- rituximab on May 01, 2016. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 6.6 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.58 sec. 9-hole peg non-dominant:27.18 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. IgG index in CSF:0.82. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:avonex or cinnovex- im interferon on July 01, 2012. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: February 21, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 83. SDMT denominator: 84. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.4 sec. 9-hole peg non-dominant:18.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2014. Comments on DMT: Rebif, REFLEX. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 3HB\/wk. The 25-foot walk done. 25-foot walk test time was 8.4 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.34 sec. 9-hole peg non-dominant:20.29 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:negative. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:ppms. Comments on DMT: Betaferon, cellcept, cyclophosphamide. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 49 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:OCD. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2019. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: December 30, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 2. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 2. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.79 sec. 9-hole peg non-dominant:22.94 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Has experienced progressive symptoms since onset. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:ppms. Total relapses until visit: 0. Comments on DMT: Rebif. Vit D at visit: 89.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: June 05, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. IgG index in CSF:0.87. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.76. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2016. Vit D at visit: 53.6. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2016. Comments on DMT: Avonex. Vit D at visit: 57.6. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 15, 2016. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.91 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.57 sec. 9-hole peg non-dominant:18.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2004. Comments on DMT: None . MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 5.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.6 sec. 9-hole peg non-dominant:21.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2002. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2016. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:21.6 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. OCBs in CSF:positive. IgG index in CSF:1.13. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2019. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2013. Comments on DMT: Betaferon, Gilenya. Tobacco smoker: non-smoker  Exercise hrs per week:5. Vit D at visit: 88.7. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.45 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.12 sec. 9-hole peg non-dominant:17.47 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Has experienced progressive symptoms since onset. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on April 01, 2013. Comments on DMT: Imuran: 2004-Apr 2013, Avonex Apr 2013-June 2015. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.95 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.19 sec. 9-hole peg non-dominant:16.54 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on February 01, 2018. Comments on DMT: Tecfidera. Tobacco smoker: non-smoker  Vit D at visit: 34.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). SDMT done. SDMT numerator: 49. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:23 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2020. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:19.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2010. Tobacco smoker: current  Tobacco type: water-pipe. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.49 sec. 9-hole peg non-dominant:19.3 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. More information on co-morbidity:herpes zoster ophthalmicus. Outcome:completely recovered from illness. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: Cyclophosphamide, rebif, avonex. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 32 sec. SDMT done. SDMT numerator: 25. SDMT denominator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34 sec. 9-hole peg non-dominant:32 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on October 11, 2011. Comments on DMT: Avonex Sep 2010-Mar 2011, Betaferon May 2011-Sep 2011. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: occassionally. Coffee cups per week: 14. The 25-foot walk done. 25-foot walk test time was 4.47 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:21.52 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 1. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.77 sec. 9-hole peg non-dominant:15.5 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.96. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2020. Comments on DMT: Rebif, Aubagio. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:19 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:1. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 16, 2015. Comments on DMT: Betaferon - Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.58 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.54 sec. 9-hole peg non-dominant:16.97 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.47. IgG index category in CSF:Normal (< 0.77). SDMT done. SDMT numerator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.89 sec. 9-hole peg non-dominant:22.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2002. MRI of brain or spine done. No new lesions on Brain MRI. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:cis. DMT taken. Current DMT:avonex or cinnovex- im interferon on July 01, 2013. The 25-foot walk done. 25-foot walk test time was 2.8 sec. SDMT done. SDMT numerator: 87. SDMT denominator: 89. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.74 sec. 9-hole peg non-dominant:16.68 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.16. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on December 06, 2017. MRI of brain or spine done. The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2013. Tobacco smoker: non-smoker  Vit D at visit: 139.0. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:20.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on December 01, 2018. Vit D at visit: 50.1. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:17.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.82. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:hearing problem. Name of co-morbidity:thrombocytopenia medication induced. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 01, 2011. Comments on DMT: betaferon, rituximab. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 172.8. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:22 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Anemia. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 35.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 14, 2014. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.91 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.83 sec. 9-hole peg non-dominant:21.74 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Avonex or Cinnovex- IM Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Visit diagnosis:nmo. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on March 01, 2014. Tobacco smoker: non-smoker  The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 8. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on May 09, 2014. Comments on DMT: Betaferon, imuran, mabthera, endoxan. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 15, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 28.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:37.4 sec. 9-hole peg non-dominant:28.8 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar, cognitive dysfunction. Number of attacks until the first visit:4. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2007. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31.7 sec. 9-hole peg non-dominant:37.33 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 25 months?",
        "output":"After 25 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: February 18, 2019. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on April 01, 2018. Comments on DMT: Betaferon Gilenya. Vit D at visit: 44.1. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.34 sec. 9-hole peg non-dominant:19 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.47. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 4. Cervical spine MRI date: October 07, 2013. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Thoracic spine: 4. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.1 sec. 9-hole peg non-dominant:22.5 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. IgG index in CSF:0.87. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.76. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on October 01, 2021. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.52 sec. 9-hole peg non-dominant:18.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:3.04. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:vascular malformation in right forearm. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2013. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 77.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 5. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.01 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:19.7 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.17. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2018. Vit D at visit: 68.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 09, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:17.24 sec. 9-hole peg non-dominant:19.33 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on May 01, 2017. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 56 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:51.63 sec. 9-hole peg non-dominant:46.38 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:4. OCBs in CSF:negative. IgG index in CSF:1.047. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on February 01, 2016. Comments on DMT: Avonex. Vit D at visit: 40.3. MRI of brain or spine done. No new lesions on Brain MRI. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:77.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Prostatitis. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 2. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 18.75 sec. SDMT done. SDMT numerator: 19. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:40.59 sec. 9-hole peg non-dominant:45.5 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 54 months?",
        "output":"After 54 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:3.04. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:vascular malformation in right forearm. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on September 01, 2017. Comments on DMT: Gilenya, Rebif, Tysabri. Tobacco smoker: non-smoker  Vit D at visit: 39.4. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.6 sec. 9-hole peg non-dominant:21.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 16, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:18.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.47. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2016. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 1. Exercise hrs per week:5. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 04, 2021. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:23.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 29 months?",
        "output":"After 29 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.75 sec. 9-hole peg non-dominant:21.94 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem. OCBs in CSF:positive. IgG index in CSF:0.55. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Coffee cups per week: 35. Vit D at visit: 18.0. Anti-MOG Abs seropositivity: Negative. MRI of brain or spine done. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Avonex, Mitoxantrone. The 25-foot walk done. 25-foot walk test time was 6.09 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.19 sec. 9-hole peg non-dominant:23.59 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cognitive dysfunction. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Anti-MOG Abs seropositivity: Negative. The 25-foot walk done. 25-foot walk test time was 4.7 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:GERD. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia minor. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2014. Comments on DMT: Avonex Sep 2009-July 2014. Tobacco smoker: non-smoker  Coffee cups per week: 21. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: March 13, 2017. The 25-foot walk done. 25-foot walk test time was 3.65 sec. SDMT done. SDMT numerator: 91. SDMT denominator: 91. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:16.8 sec. 9-hole peg non-dominant:15.33 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:T2 N0 M0, ER\/PR positive and HER-2 negative breast cancer. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on October 18, 2017. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 75.4. The 25-foot walk done. 25-foot walk test time was 12.3 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.83. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Skin disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Vit D at visit: 33.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 10, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 94. SDMT denominator: 95. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.49 sec. 9-hole peg non-dominant:20.06 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.12. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on November 01, 2020. Vit D at visit: 61.0. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness.  Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:ocrevus - ocrelizumab on January 01, 2020. Tobacco smoker: ex-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 1. Exercise hrs per week:4. The 25-foot walk done. 25-foot walk test time was 6.5 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:73 sec. 9-hole peg non-dominant:23 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on December 02, 2015. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.2 sec. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:16 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2016. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Asthma. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:tysabri- natalizumab on May 01, 2017. Comments on DMT: rebif. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: December 04, 2019. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:18 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on February 02, 2021. Comments on DMT: Rebif . Vit D at visit: 58.49. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: August 11, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:18 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:financial difficulties to get the DMT. New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. Comments on DMT: Gilenya, Rebif, Avonex since Nov17. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Cervical spine MRI date: March 31, 2018. Cervical spine MRI: Not compared to previous spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 5.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.4 sec. 9-hole peg non-dominant:33.67 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:71.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, optic neuritis, brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:spms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2011. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.9 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.4 sec. 9-hole peg non-dominant:29.2 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:change in diagnosis. New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:78.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis, brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:right hip fracture. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on July 01, 2011. Comments on DMT: Avonex - Rebif - Mitoxantrone. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 45.88 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.25 sec. 9-hole peg non-dominant:25.69 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT: gilenya- fingolimod. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2012. Comments on DMT: Avonex - Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: April 27, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 2. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.35 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands.  9-hole peg dominant:20.46 sec. 9-hole peg non-dominant:20.05 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:papillary urothelial cancer . Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on January 01, 2015. Tobacco smoker: ex-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: January 01, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 6.2 sec. SDMT done. SDMT numerator: 19. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.28 sec. 9-hole peg non-dominant:24.8 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. Comments on DMT: Tysabri, Betaferon, Aubagio, Cyclophosphamide. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 14 sec. SDMT done. SDMT numerator: 24. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:33 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.88. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2014. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: March 16, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.49 sec. 9-hole peg non-dominant:20.36 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on March 01, 2019. Comments on DMT: rebif. Tobacco smoker: ex-smoker  Vit D at visit: 44.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:17.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on September 01, 2020. Tobacco smoker: ex-smoker  Exercise hrs per week:4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: February 19, 2021. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:spms. Comments on DMT: None . MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. The patient is in EDA. Will the patient be in NEDA or EDA after 31 months?",
        "output":"After 31 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem, cerebellar. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2012. The 25-foot walk done. 25-foot walk test time was 5.9 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29 sec. 9-hole peg non-dominant:28.7 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:knee surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendenctomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.4 sec. 9-hole peg non-dominant:18.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:62.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on May 01, 2018. SDMT done. SDMT numerator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.6 sec. 9-hole peg non-dominant:24.5 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 31 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.5 sec. 9-hole peg non-dominant:29.72 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on March 25, 2019. Comments on DMT: Rebif, Avonex, Tecfidera. The 25-foot walk done. 25-foot walk test time was 5.06 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.2 sec. 9-hole peg non-dominant:22 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Lemtrada induced. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2016. Tobacco smoker: ex-smoker  Vit D at visit: 63.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 22, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.04 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.6 sec. 9-hole peg non-dominant:15.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on January 01, 2016. Comments on DMT: Betaferon 2013-2016. Vit D at visit: 64.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 19, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 22. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.3 sec. 9-hole peg non-dominant:36.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:53.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2006. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Cervical spine MRI date: March 05, 2018. Cervical spine MRI: Not compared to previous spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 25. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.3 sec. 9-hole peg non-dominant:29 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.06 sec. 9-hole peg non-dominant:17.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Bilateral deafness. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: November 26, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:21.26 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 89. SDMT denominator: 89. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.87 sec. 9-hole peg non-dominant:15.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:73.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. Vit D at visit: 68.0. The 25-foot walk done. 25-foot walk test time was 16.5 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.75 sec. 9-hole peg non-dominant:24.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2011. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: September 08, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 5.52 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.74 sec. 9-hole peg non-dominant:24.31 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:23.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on September 01, 2021. Tobacco smoker: non-smoker  Coffee cups per week: 7. Exercise hrs per week:6. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:19.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.54. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14 sec. 9-hole peg non-dominant:16 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Hypnagogic myoclonus. Outcome:ongoing illness. Name of co-morbidity:Chronic hepatitis B. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on October 01, 2019. The 25-foot walk done. 25-foot walk test time was 6.1 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 32. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.4 sec. 9-hole peg non-dominant:25.3 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:1. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on September 01, 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 14. Exercise hrs per week:2. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:19.73 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. There were new relapses since the previous visit. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2019. Comments on DMT: rebif. The 25-foot walk done. 25-foot walk test time was 11.89 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.64. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on January 01, 2015. The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.08 sec. 9-hole peg non-dominant:20.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.47. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on August 01, 2021. Tobacco smoker: ex-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2013. Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.684. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:avonex or cinnovex- im interferon on November 01, 2019. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 7. Exercise hrs per week:7. Vit D at visit: 70.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.48 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.42 sec. 9-hole peg non-dominant:19.44 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Brain Tumor. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on July 01, 2018. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:16.7 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:86.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation myelitis. Number of attacks until the first visit:3. Name of co-morbidity:Diffuse cystic mastopathy s\/p subtotal mastectomy. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonitis. Outcome:completely recovered from illness. Name of co-morbidity:Sepsis. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:hemorrhage. Outcome:death due to illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on January 08, 2009. Comments on DMT: Mitoxantrone (1991) - Avonex . EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.64. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on August 01, 2018. Comments on DMT: Recigen. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: April 30, 2020. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:19.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. MRI of brain or spine done. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.42 sec. 9-hole peg non-dominant:20 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Plegridy (peginterferon beta 1-a). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:25.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Seizures\/convulsions. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:ris. Total relapses until visit: 0. DMT taken. Current DMT:avonex or cinnovex- im interferon on July 01, 2018. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:22.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.22. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2014. Comments on DMT: Rebif. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32 sec. 9-hole peg non-dominant:23.4 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on December 01, 2015. Comments on DMT: Avonex. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:17 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:spms. The 25-foot walk done. 25-foot walk test time was 20.2 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. New DMT:Cellcept or Imuxigen- Mycophenolate. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness.  Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 25, 2014. Tobacco smoker: ex-smoker  Coffee cups per week: 14. Exercise hrs per week:4. Vit D at visit: 25.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 20, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.1 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.6 sec. 9-hole peg non-dominant:27.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on November 01, 2016. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: August 01, 2023. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:20.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on July 01, 2012. Vit D at visit: 41.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: June 30, 2012. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Visit diagnosis:rrms. Total relapses until visit: 8. DMT taken. Current DMT:mabthera- rituximab on April 01, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 28. The 25-foot walk done. 25-foot walk test time was 6.2 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:21 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. There were new relapses since the previous visit. Comments on DMT: Cinnovex (May 2012-December 2012)(Gilenya (Dec 2012 )Tysabri (Jan 2013-april 2013). MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 3. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 10.99 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:39.35 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Bipolar disorder. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2017. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 7. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Cervical spine MRI date: January 05, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.5 sec. 9-hole peg non-dominant:23.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem. Number of attacks until the first visit:4. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: Avonex - Betaferon - Recigen - Mitoxantrone. Vit D at visit: 32.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: March 07, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 6.5 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.06. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Sciatica. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2019. Comments on DMT: Aubagio. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 24, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.63 sec. 9-hole peg non-dominant:24.7 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: Hb weekly. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 05, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.37 sec. 9-hole peg non-dominant:20.24 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:subclinical hypothyroidism . Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:chronic idiopathic urticaria . Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 13, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:18.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:tysabri- natalizumab on October 01, 2017. Comments on DMT: betaferon, gilenya, tecfidera, rebif. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 7. Vit D at visit: 29.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.2 sec. 9-hole peg non-dominant:19.3 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on August 15, 2016. Comments on DMT: Tecfidera. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.8 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.3 sec. 9-hole peg non-dominant:22.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Has experienced progressive symptoms since onset. Name of co-morbidity:Spinal cord compression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2021. Vit D at visit: 18.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 01, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 5. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.4 sec. 9-hole peg non-dominant:30 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:6. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:BELL'S PALSY. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2012. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Rheumatoid arhritis. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on July 01, 2014. Comments on DMT: Gilenya - Cyclophosphamide. Vit D at visit: 50.5. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 6.6 sec. SDMT done. SDMT numerator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.9 sec. 9-hole peg non-dominant:23.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2018. Vit D at visit: 39.7. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:20.21 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:stop DMT due to stability. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Visit diagnosis:nmo. DMT taken. Current DMT:solumedrol- iv methylprednisolone on February 01, 2018. Comments on DMT: None . MRI of brain or spine done. Cervical spine MRI date: February 19, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.91. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on September 01, 2021. Vit D at visit: 84.6. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 01, 2023. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 95. SDMT denominator: 95. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.5 sec. 9-hole peg non-dominant:18.5 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:76.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Disk surgery. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Right ear congenital hearing loss. Outcome:ongoing illness. Name of co-morbidity:Tooth abscess + extraction. Outcome:completely recovered from illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total Left hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on April 05, 2012. Comments on DMT:  rebif and Atacicept. The 25-foot walk done. 25-foot walk test time was 13.25 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:tysabri- natalizumab on August 31, 2017. Comments on DMT: Rebif Avonex Tysabri. Vit D at visit: 63.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 25, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.85 sec. 9-hole peg non-dominant:17.25 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.48. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on December 28, 2017. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 07, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 2.82 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.52 sec. 9-hole peg non-dominant:20.28 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Vit D at visit: 75.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 31, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 71. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:16.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:1.04. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:cis. DMT taken. Current DMT:avonex or cinnovex- im interferon on August 01, 2012. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 74. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:27.7 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:prolactinoma. Outcome:ongoing illness. Name of co-morbidity:degenrative disk disease. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:chronic constipation. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Vit D at visit: 16.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: December 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.5 sec. 9-hole peg non-dominant:16.41 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:autoimmune alopecia universalis. Outcome:ongoing illness. Name of co-morbidity:congenital vision loss in right eye. Outcome:ongoing illness. Name of co-morbidity:nail dystrophy. Outcome:ongoing illness. Name of co-morbidity:hereditary senosry motor demyelinating neuropathy. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on May 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 07, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 5. Comments on DMT: Betaferon, Gilenya, Tecfidera, Rebif, Tysabri. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 5.3 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.8 sec. 9-hole peg non-dominant:23.2 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Name of co-morbidity:Anxiety. Visit diagnosis:rrms. Total relapses until visit: 7. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 05, 2003. Comments on DMT: Imuran. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 26 months?",
        "output":"After 26 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.73. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on January 01, 2021. Tobacco smoker: ex-smoker  Vit D at visit: 59.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 01, 2021. Received Gadolinium for Cervical spine MRI. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Has experienced progressive symptoms since onset. Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:s\/p thyroidectomy. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:disc repair. Outcome:completely recovered from illness. Visit diagnosis:ppms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on May 01, 2017. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 14.3 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34 sec. 9-hole peg non-dominant:31.7 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.55. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on October 27, 2016. Tobacco smoker: non-smoker  EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness.  Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: Rebif Gilenya. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: September 26, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Rheumatoid arhritis. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on January 01, 2019. Vit D at visit: 51.4. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 13, 2022. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 6.69 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:20 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2021. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.95 sec. 9-hole peg non-dominant:23 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mavenclad- cladribine on November 01, 2019. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 01, 2020. Received Gadolinium for Cervical spine MRI. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 88. SDMT denominator: 88. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:19 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 24, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Anterior Uveitis. Name of co-morbidity:Migraine. Name of co-morbidity:Depression. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on April 01, 2011. Comments on DMT: Rebid Avonex. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:17 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2015. Comments on DMT: betaferon. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:20.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. Name of co-morbidity:Absence Seizures. Outcome:completely recovered from illness. Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.68 sec. 9-hole peg non-dominant:22.97 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 2.7 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.629. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on July 01, 2019. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: July 01, 2020. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:19 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:cis. There were new relapses since the previous visit. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1\/4 PPD. Coffee cups per week: 14. MRI of brain or spine done. Cervical spine MRI date: May 19, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:24 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:abortion. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on January 20, 2021. Comments on DMT: Gilenya 0.5mg PO QD (June 18, 2015- October 2020) Rebif  (Jan 2015-April 2015). Vit D at visit: 45.0. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.98 sec. 9-hole peg non-dominant:26 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: Rebif\u00c2\u00a0(2016-2017) Tecfidera (2017-2018) Gilenya (2018-2019). MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: April 28, 2023. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 1. Evidence of LETM. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 2.8 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:11.8 sec. 9-hole peg non-dominant:15 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2016. Comments on DMT: Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 2.6 sec. SDMT done. SDMT numerator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.26 sec. 9-hole peg non-dominant:23.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.4. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2015. Vit D at visit: 31.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 06, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.66 sec. 9-hole peg non-dominant:18.67 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2012. Comments on DMT: Rebif. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.2 sec. 9-hole peg non-dominant:25 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Renal disorders. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2017. Comments on DMT: Avonex and Gilenya. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.79. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on July 01, 2015. Tobacco smoker: non-smoker  Vit D at visit: 30.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 27. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.9 sec. 9-hole peg non-dominant:23.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis, brainstem. Number of attacks until the first visit:1. IgG index in CSF:3.2. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2014. Comments on DMT: Cladribine trial. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.68 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.97 sec. 9-hole peg non-dominant:18.74 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on October 01, 2016. Vit D at visit: 23.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 13, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.22 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.99 sec. 9-hole peg non-dominant:23.74 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on October 22, 2018. Comments on DMT: rebif, tecfidera. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: May 09, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:14.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Visit diagnosis:cis. Total relapses until visit: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.85 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:17.42 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation brainstem. OCBs in CSF:positive. IgG index in CSF:1.49. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 01, 2014. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 18.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). SDMT done. SDMT numerator: 49. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.4 sec. 9-hole peg non-dominant:18.09 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 59 months?",
        "output":"After 59 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem, cerebellar. Number of attacks until the first visit:3. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on May 01, 2017. Comments on DMT: Avonex - Rebif - Gilenya. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 42.06 sec. SDMT done. SDMT numerator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands.  9-hole peg dominant:22.35 sec. 9-hole peg non-dominant:24.67 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Brain Tumor. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on July 01, 2015. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 49.3. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15.2 sec. 9-hole peg non-dominant:13.74 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:off dmt. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.95. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on July 01, 2013. Tobacco smoker: non-smoker  Vit D at visit: 70.0. MRI of brain or spine done. Cervical spine MRI date: August 04, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 1. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 4.09 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.95 sec. 9-hole peg non-dominant:19.93 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:1.42. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Right breast cancer. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:right shoulder tendinitis. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2020. Comments on DMT: took gilenya from dec 2017- june 2020. Tobacco smoker: ex-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: May 01, 2021. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.5 sec. 9-hole peg non-dominant:22.54 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. More information on co-morbidity:FMF. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on October 01, 2018. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:22 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on March 01, 2020. The 25-foot walk done. 25-foot walk test time was 8.8 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:21 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in EDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT: gilenya- fingolimod. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 03, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:67.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis, sarcoidosis. OCBs in CSF:negative. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 3. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:nmo. Several relapses until this visit. DMT taken. Current DMT: cellcept and monthly ivig on May 01, 2011. Comments on DMT: Mabthera, monthly IVMP. MRI of brain or spine done. No new lesions on Brain MRI. The patient is in EDA. Will the patient be in NEDA or EDA after 48 months?",
        "output":"After 48 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2017. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 48.9. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.1 sec. 9-hole peg non-dominant:16.17 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:6. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:BELL'S PALSY. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2012. Comments on DMT: Betaferon 2001-2003, Avonex 2003-2009, Rebif Apr 2010-2012, Cladribine Jan 2006-2009. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 8 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:27 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, optic neuritis, brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mavenclad- cladribine on November 01, 2020. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 01, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15.36 sec. 9-hole peg non-dominant:15.83 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.804. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:low back pain. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2017. Tobacco smoker: non-smoker  Vit D at visit: 31.2. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.12. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on June 04, 2015. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 34.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 16, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:20 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.82. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:hearing problem. Name of co-morbidity:thrombocytopenia medication induced. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 01, 2011. Comments on DMT: beatferon, rituximab. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 92.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 01, 2019. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 7.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.6 sec. 9-hole peg non-dominant:20.8 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.5. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Right breast nodule resection. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Lower back cyst resection. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Laser surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 01, 2017. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:21 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation incidental mri findings, seizures. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Comments on DMT: None . The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation lhermitte . Number of attacks until the first visit:2. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Endocrine disorders. Name of co-morbidity:Depression. Visit diagnosis:nmo. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on February 01, 2010. Comments on DMT: Avonex - Rebif - Imuran. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.17 sec. 9-hole peg non-dominant:21.64 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:T2 N0 M0, ER\/PR positive and HER-2 negative breast cancer. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on October 18, 2017. Comments on DMT: gilenya, augbaio, tecfidera. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 61.0. The 25-foot walk done. 25-foot walk test time was 8.9 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20.7 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:1.89. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on November 10, 2017. Comments on DMT: Rebif. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: July 01, 2019. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.94 sec. 9-hole peg non-dominant:22.68 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:25.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Seizures\/convulsions. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:ris. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on June 01, 2023. Vit D at visit: 29.2. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.5 sec. 9-hole peg non-dominant:17.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on June 01, 2018. Vit D at visit: 29.5. The 25-foot walk done. 25-foot walk test time was 6.02 sec. SDMT done. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.73 sec. 9-hole peg non-dominant:20.53 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:2.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 9. DMT taken. Current DMT:mabthera- rituximab on April 01, 2023. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 01, 2023. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.5 sec. 9-hole peg non-dominant:33 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Bipolar disorder. Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 5.1 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.55 sec. 9-hole peg non-dominant:22.28 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. OCBs in CSF:positive. IgG index in CSF:1.01. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2020. Vit D at visit: 70.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 01, 2020. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 1. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.2 sec. 9-hole peg non-dominant:16.85 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2008. Comments on DMT: Avonex (2005). Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:22.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2011. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.58 sec. 9-hole peg non-dominant:19.1 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:6. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:BELL'S PALSY. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 6. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2012. Comments on DMT: Betaferon 2001-2003, Avonex 2003-2009, Rebif Apr 2010-2012, Cladribine Jan 2006-2009. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.25 sec. 9-hole peg non-dominant:23.19 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:71.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, optic neuritis, brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on September 01, 2017. Comments on DMT: Betaferon. The 25-foot walk done. 25-foot walk test time was 7.46 sec. SDMT done. SDMT numerator: 11. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.28 sec. 9-hole peg non-dominant:36.22 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:copaxone- glatiramer acetate on January 01, 2007. Comments on DMT: Avonex. The patient is in EDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. There were new relapses since the previous visit. Comments on DMT: Cinnovex - Gilenya - Tysabri - Rebif. Vit D at visit: 20.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 6. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 7.43 sec. 9-HPT done. 9-HPT ability: unable with both hands. Dominant hand:Right. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:endoxan- cyclophosphamide on January 01, 2017. Comments on DMT: Betaferon - Tysabri - Aubagio. Vit D at visit: 47.0. The 25-foot walk done. 25-foot walk test time was 10.02 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.39 sec. 9-hole peg non-dominant:29 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS . Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:ocrevus - ocrelizumab on March 01, 2022. Tobacco smoker: non-smoker  Vit D at visit: 45.85. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:5. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 7. DMT taken. Current DMT:mabthera- rituximab on March 01, 2018. Comments on DMT: Avonex, Gilneya . MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: March 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 38 months?",
        "output":"After 38 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2012. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 01, 2014. The 25-foot walk done. 25-foot walk test time was 8.92 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.63 sec. 9-hole peg non-dominant:23.42 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 19, 2016. Vit D at visit: 57.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: January 05, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 2.5 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.4 sec. 9-hole peg non-dominant:17.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on May 01, 2022. Comments on DMT: REbif Tecfidera. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: June 01, 2023. Cervical spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:17.41 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Name of co-morbidity:Anxiety. Visit diagnosis:rrms. Total relapses until visit: 12. DMT taken. Current DMT:mabthera- rituximab on June 01, 2016. Comments on DMT: Rebif Imuran Gilenya. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:15.2 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation incidental mri findings. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Vit D at visit: 63.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: December 28, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:19.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2009. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 44.2. SDMT done. SDMT numerator: 43. SDMT denominator: 43. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.67. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:27.71 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:5. OCBs in second CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2014. Comments on DMT: Avonex; Betaferon; Gilenya. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.4 sec. 9-hole peg non-dominant:22.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.92. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Allergies. More information on co-morbidity:penicillin. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:lumpectomy. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:fibroid resection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5.1 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.6 sec. 9-hole peg non-dominant:24.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 16, 2012. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.25 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 70. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2012. MRI of brain or spine done. Cervical spine MRI date: September 08, 2015. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.75 sec. 9-hole peg non-dominant:17.97 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Coffee cups per week: 1. Exercise hrs per week:2. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:19.6 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2016. Vit D at visit: 38.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 13, 2016. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.7 sec. 9-hole peg non-dominant:23.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.44. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2017. Vit D at visit: 44.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.6 sec. 9-hole peg non-dominant:16.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Renal disorders. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on October 01, 2021. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 6.5 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:20.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2012. Tobacco smoker: non-smoker  Coffee cups per week: 21. Vit D at visit: 33.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 06, 2013. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.8 sec. 9-hole peg non-dominant:23.4 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.64. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on August 01, 2018. Vit D at visit: 26.2. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.4 sec. 9-hole peg non-dominant:19 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on October 01, 2016. Comments on DMT: She discontinued Avonex during pregnancy ( December 2015 - November 2016). Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.07 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.72 sec. 9-hole peg non-dominant:19.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:negative. IgG index in CSF:0.32. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Sinusitis. Outcome:ongoing illness. Visit diagnosis:ppms. Several relapses until this visit. DMT taken. Current DMT:ocrevus - ocrelizumab on May 01, 2020. Comments on DMT: Aubagio (July 2018 - February 2020)  . The 25-foot walk done. 25-foot walk test time was 7.5 sec. SDMT done. SDMT numerator: 17. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30 sec. 9-hole peg non-dominant:27.75 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:ocrevus - ocrelizumab on August 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 6.7 sec. SDMT done. SDMT numerator: 23. SDMT denominator: 23. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30 sec. 9-hole peg non-dominant:33 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 20.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 5. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: January 25, 2023. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 5. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.87 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:22.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: August 08, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.24 sec. 9-hole peg non-dominant:21.12 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:5. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2015. Comments on DMT: Avonex - Betaseron. Vit D at visit: 27.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 29, 2017. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 71. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.5 sec. 9-hole peg non-dominant:14.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness.  Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:ocrevus - ocrelizumab on January 22, 2020. Comments on DMT: Rebif, Gilenya. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:36.4 sec. 9-hole peg non-dominant:21.5 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:1.45. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2017. Vit D at visit: 37.6. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: February 01, 2022. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:23 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. IgG index in CSF:0.82. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 23, 2014. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. Vit D at visit: 59.5. The 25-foot walk done. 25-foot walk test time was 3.56 sec. SDMT done. SDMT numerator: 110. SDMT denominator: 110. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.04 sec. 9-hole peg non-dominant:17.11 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Visit diagnosis:ris. The 25-foot walk done. 25-foot walk test time was 4.26 sec. SDMT done. SDMT numerator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.98 sec. 9-hole peg non-dominant:18.18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2020. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.5 sec. 9-hole peg non-dominant:24 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:logistic issues to obtain the DMT. New DMT:Gilenya- Fingolimod. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2016. Comments on DMT: Rebif. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:20.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on November 01, 2015. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.66 sec. 9-hole peg non-dominant:22.16 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:ocrevus - ocrelizumab on May 01, 2021. Tobacco smoker: ex-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: November 01, 2021. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:23.5 sec. 9-hole peg non-dominant:19.96 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2014. Comments on DMT: Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: February 18, 2015. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:24.96 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.25. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: Avonex - Atacicept trial - Rebif. Vit D at visit: 40.8. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:17.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:8. Visit diagnosis:spms. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on July 01, 2018. Comments on DMT: Betaferon. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 17, 2019. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 6.67 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.4 sec. 9-hole peg non-dominant:25.49 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 38 months?",
        "output":"After 38 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2016. Comments on DMT: Cinnovex. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.9 sec. 9-hole peg non-dominant:20.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. More information on co-morbidity:FMF. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2017. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Alcohol abuse disorder. Name of co-morbidity:Migraine. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 56. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 14, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.4 sec. 9-hole peg non-dominant:22.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.72. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:ACL repair. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:L4-5 laminectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:corrective eye surgery. Outcome:completely recovered from illness. Visit diagnosis:ppms. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 03, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.8 sec. 9-hole peg non-dominant:20.8 sec. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:positive. IgG index in CSF:1.42. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on July 01, 2016. Comments on DMT: Avonex - Gilenya. Vit D at visit: 63.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 8.15 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.33 sec. 9-hole peg non-dominant:25.3 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:nmo. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on April 01, 2018. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:18.5 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:1.45. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2015. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 24, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:21.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.3. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:tysabri- natalizumab on July 28, 2016. Tobacco smoker: non-smoker  Vit D at visit: 27.2. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.4 sec. 9-hole peg non-dominant:16.1 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 01, 2015. The 25-foot walk done. 25-foot walk test time was 4.95 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.34 sec. 9-hole peg non-dominant:26.51 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2017. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 100. SDMT denominator: 100. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 23, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:21 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on February 01, 2020. Tobacco smoker: ex-smoker  Coffee cups per week: 49. The 25-foot walk done. 25-foot walk test time was 18 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.4 sec. 9-hole peg non-dominant:29.6 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2012. Tobacco smoker: current  Tobacco type: IQOS. Coffee cups per week: 7. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 71. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:17.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on February 01, 2017. Comments on DMT: Tecfidera. Vit D at visit: 23.4. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.7 sec. 9-hole peg non-dominant:16.7 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:tysabri- natalizumab on December 11, 2020. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 6.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:17.5 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on November 01, 2021. Vit D at visit: 57.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: May 01, 2022. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:24 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2011. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 39.8. Anti-MOG Abs seropositivity: Negative. Anti-MOG Abs denominator titer: 1:10. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: October 01, 2020. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 2. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:18.23 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:negative. OCBs in second CSF:positive. IgG index in second:0.71. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 5.91 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.1 sec. 9-hole peg non-dominant:34.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2016. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 58.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.5 sec. 9-hole peg non-dominant:23.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on April 01, 2014. Comments on DMT: Betaferon, Imuran. Vit D at visit: 50.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: December 08, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.1 sec. 9-hole peg non-dominant:24.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:67.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:nmo. DMT taken. Current DMT:imuran-azathioprine on January 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 09, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2011. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:19 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on February 01, 2014. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 18, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 6.18 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 34. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.56 sec. 9-hole peg non-dominant:34.71 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on September 01, 2012. Comments on DMT: Betaferon. Tobacco smoker: non-smoker  Vit D at visit: 44.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.86 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:26.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:10. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on June 01, 2017. Comments on DMT: Betaferon, Arava. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 10, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 32. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.9 sec. 9-hole peg non-dominant:25.7 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on October 02, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.25 sec. 9-hole peg non-dominant:20.15 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:76.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Disk surgery. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Right ear congenital hearing loss. Outcome:ongoing illness. Name of co-morbidity:Tooth abscess + extraction. Outcome:completely recovered from illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total Left hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on April 05, 2012. Comments on DMT: rebif, atoricept. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 30. Vit D at visit: 15.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 17, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 17 sec. SDMT done. SDMT numerator: 28. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25 sec. 9-hole peg non-dominant:37 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy . Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: Mabthera, Aubagio, Rebif. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:18.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on June 01, 2013. Comments on DMT: Imuran - Rebif - Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Renal disorders. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on October 01, 2021. The 25-foot walk done. 25-foot walk test time was 5.47 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.49 sec. 9-hole peg non-dominant:21 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.79. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on July 01, 2015. Vit D at visit: 41.0. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.58 sec. 9-hole peg non-dominant:26.22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on February 01, 2022. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 01, 2023. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.39 sec. 9-hole peg non-dominant:14.52 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in second CSF:positive. IgG index in second:2.08. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on July 01, 2015. Vit D at visit: 8.0. The 25-foot walk done. 25-foot walk test time was 3.17 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:18.86 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.79. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on July 01, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.6 sec. 9-hole peg non-dominant:19.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 01, 2015. The 25-foot walk done. 25-foot walk test time was 13.09 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 34. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.66 sec. 9-hole peg non-dominant:27.86 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.75. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on December 09, 2013. Comments on DMT: Rebif, Avonex, Imuran. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.4 sec. 9-hole peg non-dominant:18 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.25. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: Avonex (2000-June 2005, July 2007-Apr 2008), Atacicept (July 2008-Sep 2009), Rebif (2000, Apr 2008-July 2008, Dec 2009-Mar 2013). Tobacco smoker: ex-smoker  Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.62 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.34 sec. 9-hole peg non-dominant:18.36 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.8. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2013. Comments on DMT: Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.76 sec. SDMT done. SDMT numerator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.66 sec. 9-hole peg non-dominant:20.19 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.4 sec. 9-hole peg non-dominant:14.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:unavailability of plegridy. New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.67. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 11, 2021. Tobacco smoker: ex-smoker  Vit D at visit: 22.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: June 01, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2016. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 84. SDMT denominator: 84. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.8 sec. 9-hole peg non-dominant:24.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:hydronephrosis . Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:sinusitis . Name of co-morbidity:Surgeries. More information on co-morbidity:c section, sinus surgery, external fixation of ankle fracture. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on December 26, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:18.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 23 months?",
        "output":"After 23 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 8. DMT taken. Current DMT:tysabri- natalizumab on December 01, 2016. Comments on DMT: Avonex. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.1 sec. 9-hole peg non-dominant:33.9 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:balo's concentric sclerosis. Has not converted to SPMS. Visit diagnosis:balo's concentric sclerosis. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on December 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:25 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 44 months?",
        "output":"After 44 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. Comments on DMT: gilenya. Tobacco smoker: non-smoker  The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.69. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on June 01, 2016. Comments on DMT: rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 26, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.2 sec. 9-hole peg non-dominant:27.4 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Comments on DMT: Avonex. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.3 sec. 9-hole peg non-dominant:16 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mavenclad- Cladribine. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.95. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on August 01, 2012. Tobacco smoker: non-smoker  Vit D at visit: 88.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 21, 2013. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 2. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 3.82 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.35 sec. 9-hole peg non-dominant:24.36 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, brainstem. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:avonex or cinnovex- im interferon on February 01, 2014. The 25-foot walk done. 25-foot walk test time was 40.2 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2014. Comments on DMT: stopped treatment between DEc 2015 and Feb 2017. The 25-foot walk done. 25-foot walk test time was 3.87 sec. SDMT done. SDMT numerator: 97. SDMT denominator: 97. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.5 sec. 9-hole peg non-dominant:13.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 8. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on May 01, 2014. The 25-foot walk done. Assistance required for 25-foot walk test: Rollator. 25-foot walk test time was 84 sec. SDMT done. SDMT numerator: 22. SDMT denominator: 22. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:49.6 sec. 9-hole peg non-dominant:44.5 sec. EDSS:7.5- unable to take more than a few steps; restricted to wheelchair; may need some help in transferring and in wheeling self. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 34 months?",
        "output":"After 34 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:abortion. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on February 28, 2018. Comments on DMT: Rebif, gilenya (2015-2018). Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 6.19 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.49 sec. 9-hole peg non-dominant:26.33 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Initial presentation incidental mri findings. OCBs in CSF:positive. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:ris. Total relapses until visit: 0. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2019. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 2\/w. Vit D at visit: 40.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.12 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:6.2 sec. 9-hole peg non-dominant:18.3 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:2. OCBs in second CSF:positive. OCBs in third CSF:positive. IgG index in third CSF:0.52. IgG index category in third CSF:Normal (< 0.77). Name of co-morbidity:schizoaffective. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2011. Comments on DMT: Betaferon. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.35 sec. 9-hole peg non-dominant:33.76 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2014. Comments on DMT: Avonex. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.7 sec. 9-hole peg non-dominant:26 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Visit diagnosis:cis. Comments on DMT: None . Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: Occasional. Alcohol drinsk per week: 1. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Name of co-morbidity:Anxiety. Visit diagnosis:spms. Total relapses until visit: 13. DMT taken. Current DMT:mabthera- rituximab on June 01, 2016. SDMT done. SDMT numerator: 48. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:16.8 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2011. Comments on DMT: Avonex. Vit D at visit: 30.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.68 sec. SDMT done. SDMT numerator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.8 sec. 9-hole peg non-dominant:19.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.25. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. Comments on DMT: solumedrol . MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 26, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 6.16 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 39 months?",
        "output":"After 39 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.58. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2016. Vit D at visit: 20.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 14, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.08 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.6 sec. 9-hole peg non-dominant:18.05 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:papillary urothelial cancer . Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on January 01, 2019. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Hypnagogic myoclonus. Outcome:ongoing illness. Name of co-morbidity:Chronic hepatitis B. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on October 31, 2019. Tobacco smoker: non-smoker  Coffee cups per week: 7. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 7 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:28 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.69. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 11, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Obstructive Sleep Apnea. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on December 01, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 14, 2016. The 25-foot walk done. 25-foot walk test time was 4.68 sec. SDMT done. SDMT numerator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.66 sec. 9-hole peg non-dominant:19.66 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:56.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2016. Comments on DMT: avonex, rebif. Tobacco smoker: ex-smoker  Vit D at visit: 36.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: August 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:19.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:cis. Total relapses until visit: 1. The 25-foot walk done. 25-foot walk test time was 4.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.8 sec. 9-hole peg non-dominant:23.12 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Visit diagnosis:rpms vs spms. Total relapses until visit: 3. DMT taken. Current DMT:ocrevus - ocrelizumab on December 28, 2015. Comments on DMT: betaferon. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 10.43 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.73. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: June 29, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.4 sec. 9-hole peg non-dominant:21.3 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:disc disease. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on May 18, 2018. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 41.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 7.6 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.39 sec. 9-hole peg non-dominant:27.78 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.98. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Endometriosis. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on August 25, 2014. Comments on DMT: Betaferon. Tobacco smoker: non-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:19.77 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2018. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 7. Vit D at visit: 65.9. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:17.7 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on June 01, 2018. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2020. Comments on DMT: Tysabri. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: May 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). SDMT done. SDMT numerator: 56. SDMT denominator: 56. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.38. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on June 23, 2017. Comments on DMT: Rebif. Vit D at visit: 57.6. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 77. SDMT denominator: 77. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.7 sec. 9-hole peg non-dominant:17.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on September 01, 2021. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. Vit D at visit: 104.0. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: June 22, 2023. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.84 sec. 9-hole peg non-dominant:25 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:67.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.95. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2014. Comments on DMT: Avonex, Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1.5ppd. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:23.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:6. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2012. The 25-foot walk done. 25-foot walk test time was 4.32 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.16 sec. 9-hole peg non-dominant:29.51 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on September 01, 2015. Vit D at visit: 24.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 05, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:38.26 sec. 9-hole peg non-dominant:38.83 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.16. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:ocrevus - ocrelizumab on September 01, 2020. The 25-foot walk done. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:19.4 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on March 01, 2017. Comments on DMT: Rebif, Betaferon, Aubagio. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.58. Name of co-morbidity:Surgeries. More information on co-morbidity:achilles tendon repair. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 52.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: July 24, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 2. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.3 sec. 9-hole peg non-dominant:19.75 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.64. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.64. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.63 sec. 9-hole peg non-dominant:25.18 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on October 01, 2017. MRI of brain or spine done. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:cis. Total relapses until visit: 1. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 99. SDMT denominator: 99. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.57 sec. 9-hole peg non-dominant:15 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Total relapses until visit: 4. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:24.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Bilateral deafness. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 09, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. MRI of brain or spine done. Cervical spine MRI: T2 lesion, unknown enhancement (MRI without gad). The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.3 sec. 9-hole peg non-dominant:28.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2016. Comments on DMT: Tecfidera . Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Vit D at visit: 14.9. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.6 sec. 9-hole peg non-dominant:20.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:imuran-azathioprine on January 01, 2011. MRI of brain or spine done. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: December 21, 2018. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.39 sec. 9-hole peg non-dominant:25.9 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Tobacco smoker: non-smoker  Vit D at visit: 30.8. MRI of brain or spine done. Cervical spine MRI date: August 23, 2022. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24 sec. 9-hole peg non-dominant:28 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 3.72 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.5 sec. 9-hole peg non-dominant:23 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT: monthly ivig on October 18, 2016. Comments on DMT: Avonex (2005-2007), Rebif (2007-2008), Betaferon (Sep 2009-July 2010), Tysabri (Aug 2010-Aug 2011), Gilenya (Nov 2012-June 2013), Mabthera (July 2013-July 2016). Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.01 PPD. Coffee cups per week: 14. Alcohol drinsk per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.4 sec. 9-hole peg non-dominant:21 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 3.42 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.4 sec. 9-hole peg non-dominant:16.85 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2011. Vit D at visit: 50.5. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: July 27, 2017. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.15 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:22.99 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.83. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Skin disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: Rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 19, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 84. SDMT denominator: 84. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.69 sec. 9-hole peg non-dominant:20.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:pituitary adenoma . Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT: mabthera- rituximab. Comments on DMT: 2019-01-12 00:00:00. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 01, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 33. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:22.5 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: May 01, 2020. Cervical spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.98 sec. 9-hole peg non-dominant:19.54 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:24.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2019. Comments on DMT: Rebif. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. Vit D at visit: 16.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 01, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.98 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.74 sec. 9-hole peg non-dominant:21.12 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.64. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on July 01, 2018. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Vit D at visit: 43.0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:18 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Total relapses until visit: 0. Vit D at visit: 25.26. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: No lesions. Cervical spine MRI date: April 01, 2014. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 35 months?",
        "output":"After 35 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.4. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2015. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 24.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: May 25, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.5 sec. 9-hole peg non-dominant:19.4 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Blood and lymphatic disorders. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 14.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: November 12, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.85 sec. 9-hole peg non-dominant:17.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.98. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Endometriosis. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on July 01, 2016. Comments on DMT: Betaferon. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 27, 2020. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.2 sec. 9-hole peg non-dominant:18.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.25. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 11. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2021. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: hubble bubble. Vit D at visit: 30.1. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:17.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Has experienced progressive symptoms since onset. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 01, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 2. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:20.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2021. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 3. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: February 01, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 90. SDMT denominator: 91. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Visit diagnosis:rrms. Several relapses until this visit. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2011. Comments on DMT: avonex, rebif. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.1 sec. 9-hole peg non-dominant:27.2 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Visit diagnosis:spms. Total relapses until visit: 7. DMT taken. Current DMT:mabthera- rituximab on November 01, 2018. The 25-foot walk done. 25-foot walk test time was 13.2 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.5 sec. 9-hole peg non-dominant:28.4 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2011. Comments on DMT: Avonex Sep 2010-Mar 2011, Betaferon May 2011-Sep 2011. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 5.54 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.1 sec. 9-hole peg non-dominant:26.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 01, 2013. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Cervical spine MRI date: August 01, 2021. Received Gadolinium for Cervical spine MRI. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on October 01, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 6.7 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:75 sec. 9-hole peg non-dominant:26.32 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on November 01, 2017. Vit D at visit: 98.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 22, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.73 sec. SDMT done. SDMT numerator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.81 sec. 9-hole peg non-dominant:24.94 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.51. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 23, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:17.83 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:ris. The 25-foot walk done. 25-foot walk test time was 3.42 sec. SDMT done. SDMT numerator: 76. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.08 sec. 9-hole peg non-dominant:18.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on August 01, 2015. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.65 sec. SDMT done. SDMT numerator: 77. SDMT denominator: 77. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.57 sec. 9-hole peg non-dominant:21.39 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:ocrevus - ocrelizumab on December 27, 2019. Comments on DMT: Tysabri. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 15.7 sec. SDMT done. SDMT numerator: 25. SDMT denominator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:54 sec. 9-hole peg non-dominant:32 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on July 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 20, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on January 01, 2017. Comments on DMT: Betaferon. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: June 08, 2017. The 25-foot walk done. 25-foot walk test time was 28 sec. SDMT done. SDMT numerator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34.09 sec. 9-hole peg non-dominant:83.61 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: February 17, 2009. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 51 months?",
        "output":"After 51 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: Occasional. Alcohol drinsk per week: 1. MRI of brain or spine done. Cervical spine MRI date: October 21, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:18.67 sec. 9-hole peg non-dominant:16.82 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.42. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:nmo. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on August 24, 2021. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Coffee cups per week: 21. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2015. The 25-foot walk done. 25-foot walk test time was 3.83 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:19.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 15, 2014. Comments on DMT: avonex, betaferon. Tobacco smoker: non-smoker  MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.32 sec. 9-hole peg non-dominant:23.41 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:76.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Disk surgery. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Right ear congenital hearing loss. Outcome:ongoing illness. Name of co-morbidity:Tooth abscess + extraction. Outcome:completely recovered from illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total Left hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 13, 2008. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Atoricept trial. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:74.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on April 09, 2013. Comments on DMT: rebif, avonex. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1ppd. Vit D at visit: 59.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 23.2 sec. SDMT done. SDMT numerator: 25. SDMT denominator: 27. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.7 sec. 9-hole peg non-dominant:21.5 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: January 01, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. OCBs in CSF:positive. IgG index in CSF:1.01. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2020. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:15 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.91. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2017. Tobacco smoker: non-smoker  Vit D at visit: 44.2. The 25-foot walk done. 25-foot walk test time was 3.91 sec. SDMT done. SDMT numerator: 87. SDMT denominator: 87. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:17.74 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Anterior Uveitis. Name of co-morbidity:Migraine. Name of co-morbidity:Depression. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on April 01, 2011. Comments on DMT: Rebid Avonex. Vit D at visit: 70.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 20, 2015. Received Gadolinium for Cervical spine MRI. Whole spinal cord lesion load on MRI: No lesions. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2014. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 2 HB\/wk. Coffee cups per week: 7. Vit D at visit: 25.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.12 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.48 sec. 9-hole peg non-dominant:25.48 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on February 01, 2017. Comments on DMT: tecfidera. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. Vit D at visit: 50.5. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:17.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 30 months?",
        "output":"After 30 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2018. Comments on DMT: avonex, rebif, betaferon, tysabri, gilenya, rituximab, ivig. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: April 24, 2020. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.77 sec. 9-hole peg non-dominant:20.94 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 0. There were new relapses since the previous visit. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 03, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 6.4 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.7 sec. 9-hole peg non-dominant:33.7 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:8. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on April 01, 2015. Comments on DMT: Imuran - Rebif. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.21 sec. 9-hole peg non-dominant:101.2 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. Change in DMT or management done. Reason for DMT change:patient preference- convenience. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.64. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on January 01, 2015. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 10, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 3.18 sec. SDMT done. SDMT numerator: 66. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:21.16 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Tonsillectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Varicocele. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:imuran-azathioprine on November 27, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: December 12, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.09 sec. 9-hole peg non-dominant:17.23 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 44 months?",
        "output":"After 44 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2018. Comments on DMT: betaferon,tecfidera. Tobacco smoker: non-smoker  Vit D at visit: 41.7. SDMT done. SDMT numerator: 60. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:16.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.61. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on July 06, 2005. Comments on DMT: Avonex. Vit D at visit: 70.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 04, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 14.17 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:41.12 sec. 9-hole peg non-dominant:55.09 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:abortion. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on January 20, 2021. Comments on DMT: Gilenya 0.5mg PO QD (June 18, 2015- October 2020) Rebif  (Jan 2015-April 2015). Vit D at visit: 37.06. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: July 01, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.78 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:25.3 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:1.58. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. DMT taken. Current DMT:aubagio- teriflunomide on October 01, 2018. Comments on DMT: Avonex, Gilenya, Rebif. The 25-foot walk done. 25-foot walk test time was 23.4 sec. SDMT done. SDMT numerator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:42.54 sec. 9-hole peg non-dominant:41.97 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:ACID REFLUX . Outcome:ongoing illness. Visit diagnosis:cis. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:16.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:8. OCBs in CSF:positive. IgG index in CSF:0.58. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on June 01, 2016. The 25-foot walk done. 25-foot walk test time was 4.83 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.44 sec. 9-hole peg non-dominant:19.69 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, seizure. Number of attacks until the first visit:3. Remarks about CSF: CSF studies done outside AUBMC for diagnosis. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: Stopped Rituximab 3 months ago because of pregnancy. Tobacco smoker: non-smoker  EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:25.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2012. Comments on DMT: betaferon. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 18.0. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 88. SDMT denominator: 88. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2010. Comments on DMT: avonex. Tobacco smoker: non-smoker  Coffee cups per week: 21. Vit D at visit: 108.3. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 14, 2013. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 18. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:24 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Gilenya- Fingolimod. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:VZV Trigeminal neuritis. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Comments on DMT: rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 16, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.54 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.95 sec. 9-hole peg non-dominant:24.31 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 35 months?",
        "output":"After 35 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:74.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Transurethra resenction of bladder tumor. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Right double J insertion and laser stone fragmentation. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Colonic polyps and diverticula. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on January 06, 2016. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Vit D at visit: 77.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2014. Comments on DMT: 2002-2005: Avonex; 2005 - dec 2013: Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 01, 2015. The 25-foot walk done. 25-foot walk test time was 18.7 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 23. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:42.2 sec. 9-hole peg non-dominant:59.4 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Hyperlipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2016. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 01, 2019. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.8 sec. 9-hole peg non-dominant:18.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.3. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:tysabri- natalizumab on July 28, 2016. Tobacco smoker: non-smoker  Vit D at visit: 43.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 21, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:17.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:endoxan- cyclophosphamide on October 13, 2013. Comments on DMT: rebif. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. The 25-foot walk done. 25-foot walk test time was 29 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.48 sec. 9-hole peg non-dominant:28.93 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Rheumatoid arhritis. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on July 25, 2014. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: daily. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Visit diagnosis:spms. Total relapses until visit: 8. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 5.62 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 27. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:32 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT: monthly ivig on October 18, 2016. Comments on DMT: Avonex (2005-2007), Rebif (2007-2008), Betaferon (Sep 2009-July 2010), Tysabri (Aug 2010-Aug 2011), Gilenya (Nov 2012-June 2013), Mabthera (July 2013-July 2016). Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.01 PPD. Coffee cups per week: 14. Alcohol drinsk per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 6.1 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.01 sec. 9-hole peg non-dominant:22.24 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Monthly IV Ig. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:tysabri- natalizumab on December 01, 2015. Comments on DMT: Avonex - Gilenya- Mitoxantrone. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 37.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 20, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 21. SDMT denominator: 22. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30 sec. 9-hole peg non-dominant:30.55 sec. EDSS:8- essentially restricted to bed or chair or perambulated in wheelchair but out of bed most of day; retains many self-care functions; generally has effective use of arms. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 31, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.4 sec. 9-hole peg non-dominant:19.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on December 28, 2015. Comments on DMT: Betaferon. Tobacco smoker: ex-smoker  Vit D at visit: 34.6. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 12.6 sec. SDMT done. SDMT numerator: 24. SDMT denominator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.3 sec. 9-hole peg non-dominant:30 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2018. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:5. Visit diagnosis:spms. Total relapses until visit: 5. The 25-foot walk done. 25-foot walk test time was 16.64 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:18.16 sec. 9-hole peg non-dominant:20.46 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Imuran-Azathioprine. The patient is in EDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:5. OCBs in second CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 8. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2012. Comments on DMT: avonex (2007-2009), betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 28, 2014. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.1 sec. 9-hole peg non-dominant:25.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:negative. IgG index in CSF:0.72. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:suclinical hypothyrodism. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:ocrevus - ocrelizumab on August 20, 2018. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 27, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 15.52 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.64 sec. 9-hole peg non-dominant:28.04 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.12. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2015. Tobacco smoker: ex-smoker  Coffee cups per week: 14. Vit D at visit: 36.1. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: No lesions. Cervical spine MRI date: June 20, 2022. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:18.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. There were new relapses since the previous visit. DMT taken. Current DMT:aubagio- teriflunomide on June 01, 2022. Vit D at visit: 27.9. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:19 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, incidental mri findings. OCBs in CSF:negative. IgG index in CSF:999. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:ocrevus - ocrelizumab on November 01, 2021. Tobacco smoker: non-smoker  Coffee cups per week: 5. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:22.5 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. Visit diagnosis:rrms. Total relapses until visit: 3. Vit D at visit: 55.0. The 25-foot walk done. 25-foot walk test time was 3.78 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.6 sec. 9-hole peg non-dominant:16.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Comments on DMT: Rebif. Tobacco smoker: ex-smoker  Coffee cups per week: 7. Exercise hrs per week:7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 03, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:18.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:90.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Hysterectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:bilateral cataract surgery. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:PTCA stenting. Outcome:completely recovered from illness. Name of co-morbidity:Posterior capsular opasification of lens bilaterally. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:chronic nausea. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 66 sec. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. IgG index in CSF:1.33. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. Tobacco smoker: current  Tobacco type: cigarette or cigar. Exercise hrs per week:7. Vit D at visit: 26.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 25, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.85 sec. 9-hole peg non-dominant:24.18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2017. Vit D at visit: 44.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.6 sec. 9-hole peg non-dominant:16.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on September 01, 2015. Tobacco smoker: non-smoker  Exercise hrs per week:2. Vit D at visit: 57.7. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 03, 2017. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 6.1 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:46.1 sec. 9-hole peg non-dominant:29.2 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT: tysabri- natalizumab. Comments on DMT: Betaferon -Gilenya -Tecfidera - Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 19, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.79 sec. SDMT done. SDMT numerator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.21 sec. 9-hole peg non-dominant:19.38 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2018. Comments on DMT: Rebif, gilenya. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:19 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.47. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2016. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 46.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: December 06, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.804. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:low back pain. Outcome:ongoing illness. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2017. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.88 sec. 9-hole peg non-dominant:17 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:78.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis, brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:right hip fracture. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 11, 2011. Comments on DMT: Avonex 2006, Rebif 2007, Mitoxantrone June 2011. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 ppd. Coffee cups per week: 42. Vit D at visit: 24.6. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 28.15 sec. SDMT done. SDMT numerator: 25. SDMT denominator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.22 sec. 9-hole peg non-dominant:28.47 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, lightheadedness. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:ocrevus - ocrelizumab on October 01, 2018. Comments on DMT: avonex. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 37.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 01, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.54 sec. 9-hole peg non-dominant:19.96 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation incidental mri findings. Visit diagnosis:rrms. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 26, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:20.97 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:3.41. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on December 01, 2017. Comments on DMT: rebif. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Initial presentation incidental mri findings. Number of attacks until the first visit:0. OCBs in CSF:positive. IgG index in CSF:0.64. Visit diagnosis:ris. MRI of brain or spine done. Cervical spine MRI date: December 08, 2015. The 25-foot walk done. 25-foot walk test time was 3.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.6 sec. 9-hole peg non-dominant:17.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:3. Visit diagnosis:spms. Total relapses until visit: 12. DMT taken. Current DMT:mabthera- rituximab on August 01, 2017. Comments on DMT: Betaferon - Rebif. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 14, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.6 sec. 9-hole peg non-dominant:22.6 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mavenclad- cladribine on December 01, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Presence of new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: November 01, 2020. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.44 sec. 9-hole peg non-dominant:15 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on November 01, 2015. Comments on DMT: Dec 2013-Feb 2014 Gilenya, Jan 2015-Nov 2015 Avonex. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. Vit D at visit: 52.6. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.5 sec. 9-hole peg non-dominant:29.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Positive JCV for 2 years. New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Vit D at visit: 17.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 27, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.6 sec. 9-hole peg non-dominant:21.5 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:5. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. Comments on DMT: Was on Rebif discontinued 3 month before visit. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 5. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: May 08, 2010. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Thoracic spine: 1. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 36 months?",
        "output":"After 36 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:15 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. OCBs in CSF:negative. Name of co-morbidity:Anemia. More information on co-morbidity:Normocytic anemia- Thallasemia ?. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Comments on DMT: tecfidera. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 7. Vit D at visit: 25.2. The 25-foot walk done. 25-foot walk test time was 3.35 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.2 sec. 9-hole peg non-dominant:14.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 1999. Tobacco smoker: non-smoker  Coffee cups per week: 7. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.15 sec. 9-hole peg non-dominant:18.64 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on November 01, 2012. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 1 HB \/ Wk. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 01, 2013. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:19 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:GERD. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia minor. Outcome:ongoing illness. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 01, 2009. Tobacco smoker: non-smoker  Coffee cups per week: 11. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 24, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. SDMT done. SDMT numerator: 80. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.57 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, bowel\/bladder dysfunction. OCBs in CSF:positive. IgG index in CSF:1.64. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:TB. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Exercise hrs per week:1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Cervical spine MRI date: March 15, 2022. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 2. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:rrms. Comments on DMT: None . MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.83. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2020. Comments on DMT: Rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: May 27, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:17 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:GERD. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia minor. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 01, 2018. Tobacco smoker: non-smoker  Vit D at visit: 33.0. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: No lesions. Cervical spine MRI date: June 22, 2023. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 80. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:14.78 sec. 9-hole peg non-dominant:15.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:completely recovered from illness. Name of co-morbidity:Left breast cancer s\/p mastectomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. MRI of brain or spine done. The patient is in NEDA. Will the patient be in NEDA or EDA after 35 months?",
        "output":"After 35 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 25, 2012. Tobacco smoker: non-smoker  Coffee cups per week: 28. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 27, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.13 sec. SDMT done. SDMT numerator: 77. SDMT denominator: 77. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.47 sec. 9-hole peg non-dominant:19.24 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:76.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Vertebral fracture. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteopenia. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Hemothorax. Visit diagnosis:spms. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1ppd. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 6. SDMT denominator: 11. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.07 sec. 9-hole peg non-dominant:28.68 sec. EDSS:8- essentially restricted to bed or chair or perambulated in wheelchair but out of bed most of day; retains many self-care functions; generally has effective use of arms. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on June 01, 2019. Comments on DMT: Rebif, GIlenya. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: June 27, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.5 sec. 9-hole peg non-dominant:18.59 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on February 01, 2018. Comments on DMT: Tecfidera. Tobacco smoker: non-smoker  Vit D at visit: 22.6. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: August 01, 2019. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:21 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:66.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 1995. Comments on DMT: Betaferon - Endoxan. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 103 sec. SDMT done. SDMT numerator: 9. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:45.19 sec. 9-hole peg non-dominant:60.34 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. Change in DMT or management done. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 27 months?",
        "output":"After 27 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on July 01, 2017. MRI of brain or spine done. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:asthma. Outcome:completely recovered from illness. Name of co-morbidity:Keratoconus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: July 01, 2019. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 76. SDMT denominator: 79. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.5 sec. 9-hole peg non-dominant:16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Brain Tumor. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on July 01, 2015. Vit D at visit: 49.3. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2008. Comments on DMT: Rebif. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2011. Vit D at visit: 68.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.38 sec. 9-hole peg non-dominant:24.36 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2016. Vit D at visit: 34.4. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.58 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.69 sec. 9-hole peg non-dominant:16.74 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:ocrevus - ocrelizumab on June 01, 2018. The 25-foot walk done. Assistance required for 25-foot walk test: AFO. 25-foot walk test time was 48 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:30 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hashimoto. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: Aubagio (only 1 month in July 2020) d\/c due to itchiness and patient preference. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.79. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on July 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:86.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation myelitis. Number of attacks until the first visit:3. Name of co-morbidity:Diffuse cystic mastopathy s\/p subtotal mastectomy. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonitis. Outcome:completely recovered from illness. Name of co-morbidity:Sepsis. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:hemorrhage. Outcome:death due to illness. Visit diagnosis:rrms vs spms. DMT taken. Current DMT:avonex or cinnovex- im interferon on June 17, 2004. Comments on DMT: Mitoxantrone . EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on October 21, 2021. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, incidental mri findings. OCBs in CSF:negative. IgG index in CSF:999. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Vit D at visit: 24.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: May 06, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.85 sec. 9-hole peg non-dominant:22.5 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT: tysabri- natalizumab. Vit D at visit: 66.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 8.4 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.8 sec. 9-hole peg non-dominant:24.4 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.28. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Asthma. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Reflex trial, Rebif, Aubagio. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 28 months?",
        "output":"After 28 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:10. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:epilepsy. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on October 01, 2022. The 25-foot walk done. 25-foot walk test time was 4.19 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.2 sec. 9-hole peg non-dominant:24 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Name of co-morbidity:asthma. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 30, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.4 sec. 9-hole peg non-dominant:23.3 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2018. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 7. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.7 sec. 9-hole peg non-dominant:25.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 8. DMT taken. Current DMT:mabthera- rituximab on February 01, 2020. Comments on DMT: Avonex, Tysabri. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 7.2 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35 sec. 9-hole peg non-dominant:35 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2022. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 01, 2023. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.12 sec. SDMT done. SDMT numerator: 83. SDMT denominator: 83. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14 sec. 9-hole peg non-dominant:16 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:ris. Total relapses until visit: 0. MRI of brain or spine done. Cervical spine MRI date: November 12, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 1. The 25-foot walk done. 25-foot walk test time was 4.39 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.6 sec. 9-hole peg non-dominant:22.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.91. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2021. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: October 01, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:26.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on April 01, 2020. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.5 sec. 9-hole peg non-dominant:14.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on July 01, 2018. Comments on DMT: Rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.4 sec. 9-hole peg non-dominant:20 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation brainstem. Has experienced progressive symptoms since onset. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:OCD. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on March 01, 2019. Comments on DMT: Rebif (2019). EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on October 01, 2012. MRI of brain or spine done. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: non-smoker  Vit D at visit: 20.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:23.83 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 0. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 2. Vit D at visit: 9.6. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:24 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: ex-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 10, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 4. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 80. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.4 sec. 9-hole peg non-dominant:17.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2015. Vit D at visit: 6.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 18, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.03 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.54 sec. 9-hole peg non-dominant:17.54 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT: hsct in march 2022 on March 01, 2022. Comments on DMT: Avonex (January 2016 - December 2016) Multiple attacks - Tysabri every 4wk (December 2016 - November 2019) Clinical and radiological failure - Rituximab (February 2020, 3rd cycle in August 2021)  . The 25-foot walk done. 25-foot walk test time was 7.7 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:37 sec. 9-hole peg non-dominant:43 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female. . Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.84. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on March 01, 2019. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 25. SDMT denominator: 23. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28 sec. 9-hole peg non-dominant:31.5 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:6. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2012. Comments on DMT: Betaferon, Avonex, Atoricept, Rebif. MRI of brain or spine done. Cervical spine MRI date: June 16, 2014. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.7 sec. 9-hole peg non-dominant:46.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:pregnancy plans. New DMT:Solumedrol- IV Methylprednisolone. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.34. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2011. MRI of brain or spine done. Cervical spine MRI date: March 08, 2018. The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:80.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Bronchitis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Tendinitis. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 26, 2015. Comments on DMT: endoxan. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Rollator. 25-foot walk test time was 30 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands.  9-hole peg dominant:25.4 sec. 9-hole peg non-dominant:34 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on March 01, 2017. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 5.1 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.7 sec. 9-hole peg non-dominant:18 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:23.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on February 01, 2018. Comments on DMT: tecfidera. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.28 sec. 9-hole peg non-dominant:22 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:balo's concentric sclerosis. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on December 01, 2018. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.2 sec. 9-hole peg non-dominant:31.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.96. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2016. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. Alcohol drinsk per week: 1. Vit D at visit: 31.2. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: December 10, 2018. The 25-foot walk done. 25-foot walk test time was 3.76 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.47 sec. 9-hole peg non-dominant:21.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:gastric sleeve. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2012. The 25-foot walk done. 25-foot walk test time was 3.55 sec. SDMT done. SDMT numerator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.7 sec. 9-hole peg non-dominant:22 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:5. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 7. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on February 16, 2017. Comments on DMT: Avonex. Vit D at visit: 61.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: March 20, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.1 sec. 9-hole peg non-dominant:25.1 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2018. Comments on DMT: Avonex. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:16.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2009. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34.8 sec. 9-hole peg non-dominant:29 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:5. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 14, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:75.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH s\/p TURP. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Constipation. Outcome:ongoing illness. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on May 12, 2017. Comments on DMT: Rebif - Avonex- Betaseron. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:39.9 sec. 9-hole peg non-dominant:67.8 sec. EDSS:8- essentially restricted to bed or chair or perambulated in wheelchair but out of bed most of day; retains many self-care functions; generally has effective use of arms. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Renal disorders. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2014. Tobacco smoker: current  Tobacco type: water-pipe. Exercise hrs per week:4. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Name of co-morbidity:Depression. Name of co-morbidity:PTSD. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2012. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:18.1 sec. 9-hole peg non-dominant:23.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mavenclad- Cladribine. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on August 01, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 37 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:side effects of current DMT. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Name of co-morbidity:hypoxic brain injury. Name of co-morbidity:strabismus. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. There were new relapses since the previous visit. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2018. Comments on DMT: rebif. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.5 sec. 9-hole peg non-dominant:33 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA due to relapses AND new EDSS findings. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on July 01, 2017. Comments on DMT: Failed Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 40. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:18 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.91. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2020. Comments on DMT: Rebif stopped due to non compliance and respiratory failure. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 92. SDMT denominator: 92. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.22 sec. 9-hole peg non-dominant:19.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:ACID REFLUX . Outcome:ongoing illness. Visit diagnosis:cis. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2011. Comments on DMT: Betaferon. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.2 sec. 9-hole peg non-dominant:18.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 19, 2015. Vit D at visit: 44.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: April 14, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). Change in DMT or management done. Reason for DMT change:pregnancy plans. New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.864. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Essential tremor. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on February 01, 2023. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:20 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Blood and lymphatic disorders. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2016. Comments on DMT: Rebif; Tecfidera. Vit D at visit: 43.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 07, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.7 sec. 9-hole peg non-dominant:14.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on July 01, 2018. SDMT done. SDMT numerator: 57. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:19.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on December 01, 2022. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:39 sec. 9-hole peg non-dominant:32 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2017. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: July 14, 2020. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 76. SDMT denominator: 76. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.3 sec. 9-hole peg non-dominant:18.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness, brainstem. Number of attacks until the first visit:6. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on May 01, 2018. Comments on DMT: Avonex, Recigen. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 12 sec. SDMT done. SDMT numerator: 15. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:24 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2014. Comments on DMT: Avonex, Rebif. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.71 sec. SDMT done. SDMT numerator: 100. SDMT denominator: 100. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.6 sec. 9-hole peg non-dominant:23.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:male. . Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.79. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 14.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 23.2 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.5 sec. 9-hole peg non-dominant:30.46 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on August 01, 2021. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: February 01, 2022. Cervical spine MRI: T2 lesion, unknown enhancement (MRI without gad). Number of new T2 lesions in Cervical spine: 1. The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:41 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.42. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 1. Alcohol drinsk per week: 1. Exercise hrs per week:3. Vit D at visit: 32.7. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: February 25, 2022. Whole spinal cord lesion load on MRI: No lesions. SDMT done. SDMT numerator: 71. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:21 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:cis. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: April 02, 2022. The 25-foot walk done. 25-foot walk test time was 4.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.1 sec. 9-hole peg non-dominant:20.26 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.81 sec. 9-hole peg non-dominant:28.28 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.034. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on April 01, 2020. Comments on DMT: Tecfidera. Tobacco smoker: current  Tobacco type: water-pipe. Alcohol drinsk per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 16, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.13 sec. 9-hole peg non-dominant:19.47 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.07. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on October 01, 2018. Comments on DMT: betaferon, gilenya. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 102 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:94 sec. 9-hole peg non-dominant:95 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:67.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on August 27, 2015. Comments on DMT: None . MRI of brain or spine done. Cervical spine MRI date: September 29, 2016. The 25-foot walk done. 25-foot walk test time was 6.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.4 sec. 9-hole peg non-dominant:26.2 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:81.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem. Name of co-morbidity:Trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Cellulitis. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:osteoporosis. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 7. Comments on DMT: Rebif 1999-2007, avonex. Tobacco smoker: non-smoker  The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on June 15, 2015. Comments on DMT: Cinnovex Rebif Mycophenolate. Vit D at visit: 34.5. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: July 03, 2019. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:19.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on November 05, 2015. Comments on DMT: Betaferon (Dec 2012-June 2013), Tysabri (June 2013-Aug 2015). Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 1 per day. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: May 02, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.01 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.49 sec. 9-hole peg non-dominant:27.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Alemtuzumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on December 01, 2016. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 26, 2018. Comments on DMT: Avonex Rebif Tysabri. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 37.7 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:46.4 sec. 9-hole peg non-dominant:38.8 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on July 10, 2020. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 48.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 22, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:19 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 33 months?",
        "output":"After 33 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2016. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2004. Comments on DMT: Avonex (2004), Betaferon (2004). Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 14.95 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.2 sec. 9-hole peg non-dominant:36.4 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:change in diagnosis. New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem, cerebellar. Number of attacks until the first visit:4. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT: mabthera- rituximab. Comments on DMT: Gilenya. Vit D at visit: 15.6. The 25-foot walk done. 25-foot walk test time was 6.51 sec. SDMT done. SDMT numerator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:23.94 sec. 9-hole peg non-dominant:28.83 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 27 months?",
        "output":"After 27 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.31. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Adenoidectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Bartholin gland excision . Outcome:completely recovered from illness. Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: non-smoker  Vit D at visit: 18.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: April 01, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.75 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.81 sec. 9-hole peg non-dominant:21 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:spms. Total relapses until visit: 8. DMT taken. Current DMT:mabthera- rituximab on July 01, 2017. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 9.8 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.97 sec. 9-hole peg non-dominant:17.8 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation lhermitte . Number of attacks until the first visit:2. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Endocrine disorders. Name of co-morbidity:Depression. Visit diagnosis:nmo. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on February 01, 2010. Comments on DMT: Avonex Rebif Imuran. Tobacco smoker: non-smoker  Vit D at visit: 75.8. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:19.4 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 01, 2018. Comments on DMT: Betaferon. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 21. Alcohol drinsk per week: 3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 17, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.78 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.98 sec. 9-hole peg non-dominant:19.76 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:rrms. DMT taken. Current DMT: cellcept or imuxigen- mycophenolate. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.73 sec. SDMT done. SDMT numerator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.5 sec. 9-hole peg non-dominant:20.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:3. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2014. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.55 sec. 9-hole peg non-dominant:15.97 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on June 01, 2017. Comments on DMT: betaferon, gilenya, tysabri. Tobacco smoker: current  Tobacco type: water-pipe. Exercise hrs per week:10. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis, incidental mri findings. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on June 01, 2009. Tobacco smoker: non-smoker  Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: February 01, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.91 sec. 9-hole peg non-dominant:25.93 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Brain Tumor. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on July 01, 2015. Tobacco smoker: non-smoker  Vit D at visit: 54.1. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:14.6 sec. 9-hole peg non-dominant:15 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:ocrevus - ocrelizumab on August 01, 2021. The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 26. SDMT denominator: 26. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.5 sec. 9-hole peg non-dominant:55 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2014. The patient is in NEDA. Will the patient be in NEDA or EDA after 43 months?",
        "output":"After 43 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:5. Visit diagnosis:spms. Total relapses until visit: 5. DMT taken. Current DMT:imuran-azathioprine on February 01, 2016. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 28 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:20.4 sec. 9-hole peg non-dominant:22.7 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:rrms. DMT taken. Current DMT: tysabri- natalizumab. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 5. Total T1 Gad-enhancing lesions in Brain: 1. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:8. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. Comments on DMT: Imuran - Rebif. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:46.88 sec. 9-hole peg non-dominant:115.84 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:78.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis, brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:right hip fracture. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on July 01, 2011. Comments on DMT: Avonex 2006, Rebif 2007, Mitoxantrone June 2011. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 PPD. Coffee cups per week: 28. Vit D at visit: 78.44. The 25-foot walk done. 25-foot walk test time was 6.7 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.68 sec. 9-hole peg non-dominant:24.06 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2009. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 37 months?",
        "output":"After 37 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. Name of co-morbidity:Absence Seizures. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:avonex or cinnovex- im interferon on October 10, 2014. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.9 sec. 9-hole peg non-dominant:20.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Bilateral deafness. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 1. SDMT done. SDMT numerator: 69. SDMT denominator: 69. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on November 14, 2017. Comments on DMT: Avonex; Betaferon; Gilenya. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: June 21, 2019. The 25-foot walk done. 25-foot walk test time was 18.4 sec. SDMT done. SDMT numerator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:112 sec. 9-hole peg non-dominant:101 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:spms. DMT taken. Current DMT:tysabri- natalizumab on October 01, 2016. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 5.9 sec. SDMT done. SDMT numerator: 18. SDMT denominator: 18. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:39.2 sec. 9-hole peg non-dominant:34.55 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.81. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Anti-MOG Abs seropositivity: Negative. Anti-MOG Abs denominator titer: 1:10. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: May 03, 2022. Cervical spine MRI: Not compared to previous spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2015. Vit D at visit: 32.3. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:19.2 sec. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Asthma. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on June 08, 2020. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 88. SDMT denominator: 88. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:18.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar, cognitive dysfunction. Has experienced progressive symptoms since onset. Visit diagnosis:ppms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2012. MRI of brain or spine done. Cervical spine MRI date: November 18, 2013. The 25-foot walk done. Assistance required for 25-foot walk test: Unilateral assistance by a person. 25-foot walk test time was 26 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 20 months?",
        "output":"After 20 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:6. Visit diagnosis:rrms. There were new relapses since the previous visit. Comments on DMT: Was on Gilenya since August 2012 stopped in June 2024 to get pregnant. The 25-foot walk done. 25-foot walk test time was 4.05 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.14 sec. 9-hole peg non-dominant:39.38 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.25. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 11. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: avonex, atacicept, rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: hubble bubble. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 27. DMT taken. Current DMT:mabthera- rituximab on August 01, 2015. Comments on DMT: Rebif Avonex Immuran Gilenya. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.2 sec. 9-hole peg non-dominant:18 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT: tysabri- natalizumab. Comments on DMT: Avonex. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.8 sec. 9-hole peg non-dominant:24.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar, cognitive dysfunction. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on February 01, 2018. Comments on DMT: Avonex from August 2016 to January 2017  Avonex from December 2017 to January 2018 . Tobacco smoker: current  Tobacco type: cigarette or cigar. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2015. Comments on DMT: rebif. Tobacco smoker: non-smoker  Vit D at visit: 35.4. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.4 sec. 9-hole peg non-dominant:20 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:2. Visit diagnosis:rrms. Comments on DMT: Avonex, Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: October 29, 2014. Cervical spine MRI: Not compared to previous spine MRI. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT: gilenya- fingolimod. Comments on DMT: Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 24, 2016. The 25-foot walk done. 25-foot walk test time was 3.61 sec. SDMT done. SDMT numerator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.19 sec. 9-hole peg non-dominant:24.57 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on September 01, 2016. Tobacco smoker: non-smoker  Vit D at visit: 23.26. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: November 14, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.68 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.88 sec. 9-hole peg non-dominant:23.43 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Asthma. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on May 18, 2017. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Cervical spine MRI date: October 25, 2018. The 25-foot walk done. 25-foot walk test time was 4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.6 sec. 9-hole peg non-dominant:21.3 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, incidental mri findings. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.91. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.2 sec. 9-hole peg non-dominant:20.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.81. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Name of co-morbidity:Asthma. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on July 01, 2018. Tobacco smoker: non-smoker  The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:67.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.95. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: Avonex, Rebif, Gilenya. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). SDMT done. SDMT numerator: 37. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:21.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2017. Comments on DMT: Tecfidera. The 25-foot walk done. 25-foot walk test time was 7.2 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.65 sec. 9-hole peg non-dominant:35.15 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:5. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2016. Comments on DMT: Betaferon. The 25-foot walk done. 25-foot walk test time was 12.9 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:logistic issues to obtain the DMT. New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:73.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on August 17, 2020. Comments on DMT: avonex . Vit D at visit: 38.8. The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.11. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 02, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 64. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:22.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: Rebif . MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: December 21, 2013. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.3 sec. 9-hole peg non-dominant:20.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2019. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:19.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:negative. OCBs in second CSF:positive. IgG index in second:0.71. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2002. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.1 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:21.16 sec. 9-hole peg non-dominant:33.12 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 19 sec. SDMT done. SDMT numerator: 26. SDMT denominator: 27. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24 sec. 9-hole peg non-dominant:30 sec. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. The 25-foot walk done. 25-foot walk test time was 6.78 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:41.07 sec. 9-hole peg non-dominant:29.08 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:1.63. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2016. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:17.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Depression. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2016. Comments on DMT: avonex. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.9 sec. 9-hole peg non-dominant:20.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. Remarks about CSF: CSF done in Iraq and reported at visit, no reports on chart.. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on December 01, 2019. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 10.6 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:24.9 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: REFLEX trial. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: February 03, 2017. The 25-foot walk done. 25-foot walk test time was 3.67 sec. SDMT done. SDMT numerator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:19.42 sec. 9-hole peg non-dominant:19.48 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:completely recovered from illness. Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2014. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 40.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.41 sec. SDMT done. SDMT numerator: 87. SDMT denominator: 87. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.95 sec. 9-hole peg non-dominant:19.89 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.25. Visit diagnosis:ppms. Total relapses until visit: 1. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 10.2 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.69 sec. 9-hole peg non-dominant:24.59 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on June 01, 2017. Comments on DMT: Betaferon (Oct 2007-Jan 2012); Gilenya (Mar 2012-Nov 2013); Tysabri (Jan 2013-Apr 2017). Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: occasionally. Coffee cups per week: 35. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 28, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 2.9 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.5 sec. 9-hole peg non-dominant:20.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on August 01, 2014. Tobacco smoker: non-smoker  Vit D at visit: 7.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 10. Total T1 Gad-enhancing lesions in Brain: 4. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:23.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy . Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2017. MRI of brain or spine done. Cervical spine MRI date: March 02, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:18.7 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2015. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.46 sec. 9-hole peg non-dominant:18.76 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on July 01, 2019. The 25-foot walk done. 25-foot walk test time was 4.03 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.2 sec. 9-hole peg non-dominant:17 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem. Number of attacks until the first visit:1. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.18 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.34 sec. 9-hole peg non-dominant:18.44 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 65 months?",
        "output":"After 65 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). IgG index in second:0.99. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 28, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:21.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 42 months?",
        "output":"After 42 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.69. Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.7 sec. 9-hole peg non-dominant:17.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2017. Comments on DMT: Avonex. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:20.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: REFLEX trial. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 3.67 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:19.42 sec. 9-hole peg non-dominant:19.32 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 27 months?",
        "output":"After 27 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.71. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 16, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on May 01, 2017. Comments on DMT: Gilenya February 2014 to March 2017 Rebif March 2013 to January 2014 Betaferon September 2012 to March 2013  . Vit D at visit: 70.0. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.8 sec. 9-hole peg non-dominant:25.6 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:20.  Gender:female.  Diagnosis:mog disease. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:congenital aortic stenosis and regurge. Outcome:ongoing illness. Visit diagnosis:mog disease. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on December 04, 2019. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: December 27, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 2. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Both enhancing and non-enhancing lesions. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 7.6 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.02 sec. 9-hole peg non-dominant:26.74 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar, cognitive dysfunction. Number of attacks until the first visit:1. Name of co-morbidity:Allergies. More information on co-morbidity:Asthma. Outcome:ongoing illness. Visit diagnosis:adem. Total relapses until visit: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: October 10, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:76.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Disk surgery. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Right ear congenital hearing loss. Outcome:ongoing illness. Name of co-morbidity:Tooth abscess + extraction. Outcome:completely recovered from illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total Left hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on April 05, 2012. Comments on DMT: rebif, atoricept trial . MRI of brain or spine done. Cervical spine MRI date: May 03, 2012. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 14.97 sec. SDMT done. SDMT numerator: 15. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.28 sec. 9-hole peg non-dominant:28.5 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Has experienced progressive symptoms since onset. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 01, 2013. Comments on DMT: imuran 2004-Apr 2013. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:17.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:83.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:osteoporosis. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:hallux valgus surgery. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total abdominal hysterectomy + bilateral salpingoopherectomy. Outcome:completely recovered from illness. Name of co-morbidity:Cataract surgery. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Cataract surgery. Outcome:completely recovered from illness. Name of co-morbidity:Head trauma. Outcome:completely recovered from illness. Name of co-morbidity:Right shoulder trauma. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Left wrist fracture. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on December 01, 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 10 sec. SDMT done. SDMT numerator: 19. SDMT denominator: 19. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:36 sec. 9-hole peg non-dominant:37 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation incidental mri findings. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  MRI of brain or spine done. Cervical spine MRI date: February 22, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:22 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar, incidental mri findings. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on January 18, 2016. Comments on DMT: gilenya. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5.4 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:29 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2014. Comments on DMT: Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 7.1 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on February 01, 2018. Comments on DMT: Gilenya, Avonex, Tysabri. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 1. Exercise hrs per week:2. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:26.3 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:73.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. Visit diagnosis:nmo. Several relapses until this visit. Comments on DMT: Imuran, Other, Rebif. The 25-foot walk done. 25-foot walk test time was 52.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:39.44 sec. 9-hole peg non-dominant:35.52 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 48 months?",
        "output":"After 48 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.54 sec. 9-hole peg non-dominant:25.24 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:3.04. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:vascular malformation in right forearm. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2015. Comments on DMT: rebif. Tobacco smoker: non-smoker  Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Remarks about MRI: BASELINE MRI ON GILENYA. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.7 sec. 9-hole peg non-dominant:18.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 1999. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.85 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.97 sec. 9-hole peg non-dominant:21.07 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 10. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on May 01, 2016. Comments on DMT: avonex, betaferon. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24 sec. 9-hole peg non-dominant:26.8 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Solumedrol- IV Methylprednisolone. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2016. Tobacco smoker: non-smoker  Exercise hrs per week:4. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:15.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on April 30, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 16, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.78 sec. SDMT done. SDMT numerator: 82. SDMT denominator: 84. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.19 sec. 9-hole peg non-dominant:23.19 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.83. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Skin disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 29, 2016. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.13 sec. SDMT done. SDMT numerator: 87. SDMT denominator: 87. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.64 sec. 9-hole peg non-dominant:17.89 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2012. Vit D at visit: 37.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.09 sec. 9-hole peg non-dominant:29.82 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2015. Comments on DMT: Betaferon. Vit D at visit: 26.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.91 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.6 sec. 9-hole peg non-dominant:19.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:endoxan- cyclophosphamide on October 16, 2012. Comments on DMT: rebif. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 7.7 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Uveitis. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Behcet Disease. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2018. Comments on DMT: Betaferon, Immuran, Gilenya. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 6.5 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.6 sec. 9-hole peg non-dominant:24.3 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. Vit D at visit: 33.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:18.94 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mavenclad- cladribine on December 15, 2020. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 95. SDMT denominator: 95. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.6 sec. 9-hole peg non-dominant:18.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2012. Comments on DMT: Rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 11, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.25 sec. 9-hole peg non-dominant:16.47 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:patient preference- convenience. New DMT:Avonex or Cinnovex- IM Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on April 08, 2013. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 01, 2017. The 25-foot walk done. 25-foot walk test time was 9.8 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:39.3 sec. 9-hole peg non-dominant:35.8 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:23.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: non-smoker  Vit D at visit: 19.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: August 15, 2016. Received Gadolinium for Cervical spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.3 sec. 9-hole peg non-dominant:27.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:3.41. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on December 01, 2017. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.48 sec. 9-hole peg non-dominant:17.7 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation brainstem. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Alzheimer's. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Pityriasis versicolor. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:delayed gastric emptying. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 21, 2007. Comments on DMT:  + Imuran. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:spms. Total relapses until visit: 5. DMT taken. Current DMT:ocrevus - ocrelizumab on August 01, 2021. Comments on DMT: Avonex, Tysabri, Gilenya. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 7.8 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25 sec. 9-hole peg non-dominant:20.1 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Bipolar disorder. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2017. MRI of brain or spine done. Cervical spine MRI date: July 03, 2018. The 25-foot walk done. 25-foot walk test time was 5.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:24.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2019. Vit D at visit: 66.74. The 25-foot walk done. 25-foot walk test time was 6 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:59.6 sec. 9-hole peg non-dominant:93.3 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:5. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on October 01, 2012. Comments on DMT: Avonex Sep 2010-Sep 2011, Betaferon Oct 2011-Feb 2012, Gilenya Mar 2010-Oct 2012. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.3 sec. 9-hole peg non-dominant:15.7 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:tysabri- natalizumab on December 01, 2020. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.77 sec. 9-hole peg non-dominant:20.4 sec. Change in DMT or management done. Reason for DMT change:pregnancy plans. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:spms. Total relapses until visit: 8. DMT taken. Current DMT:mabthera- rituximab on August 01, 2017. Comments on DMT: avonex, rebif, gilenya. The 25-foot walk done. 25-foot walk test time was 7.5 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.31 sec. 9-hole peg non-dominant:16.1 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: Gilenya Jan 2015 until 10\/Dec\/2015. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 90. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.23 sec. 9-hole peg non-dominant:15.95 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.11. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2017. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.6 sec. 9-hole peg non-dominant:17.25 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. OCBs in CSF:positive. IgG index in CSF:1.27. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: non-smoker  Coffee cups per week: 21. Vit D at visit: 12.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 8.9 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.7 sec. 9-hole peg non-dominant:25.6 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. Vit D at visit: 13.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 4. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.8 sec. 9-hole peg non-dominant:26 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on February 01, 2018. Comments on DMT: mitoxantrone. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 25.74 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.9 sec. 9-hole peg non-dominant:21.5 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. The 25-foot walk done. 25-foot walk test time was 11.37 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.7 sec. 9-hole peg non-dominant:33.4 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on November 01, 2018. Comments on DMT: Rebif. Vit D at visit: 38.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: April 17, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 1. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.73 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.54 sec. 9-hole peg non-dominant:23.83 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on December 01, 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 78. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:17.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:1.89. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on September 01, 2021. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 01, 2023. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.8 sec. 9-hole peg non-dominant:18.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:nmo. Total relapses until visit: 1. DMT taken. Current DMT: mabthera- rituximab. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. The patient is in EDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:1. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Rebif. Vit D at visit: 49.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 13, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.55 sec. SDMT done. SDMT numerator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.37 sec. 9-hole peg non-dominant:19.12 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 42 months?",
        "output":"After 42 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:5. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:tecfidera-dimethylfumarate on December 13, 2019. Comments on DMT: Betaferon Gilenya. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2017. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:19.97 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 21 months?",
        "output":"After 21 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2011. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 26. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.1 sec. 9-hole peg non-dominant:33.9 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:positive. IgG index in CSF:0.69. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on May 28, 2019. MRI of brain or spine done. Thoracic spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: No lesions. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.61. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: gilenya- fingolimod. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 8.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.5 sec. 9-hole peg non-dominant:50.2 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.25. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: Avonex (2000-June 2005, July 2007-Apr 2008), Atacicept (July 2008-Sep 2009), Rebif (2000, Apr 2008-July 2008, Dec 2009-Mar 2013). Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: daily. Coffee cups per week: 21. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.11 sec. 9-hole peg non-dominant:21.23 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. IgG index in CSF:0.98. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.8. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:rrms. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.07 sec. 9-hole peg non-dominant:20.17 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Brain Tumor. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on July 01, 2015. Comments on DMT: Rebif. Vit D at visit: 50.2. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:74.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Transurethra resenction of bladder tumor. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Right double J insertion and laser stone fragmentation. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Colonic polyps and diverticula. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on October 01, 2014. Vit D at visit: 36.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 01, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.9 sec. 9-hole peg non-dominant:26.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. Visit diagnosis:spms. Total relapses until visit: 3. Comments on DMT: Avonex - Cyclophosphamide. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 79.5 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.8 sec. 9-hole peg non-dominant:88.1 sec. EDSS:8- essentially restricted to bed or chair or perambulated in wheelchair but out of bed most of day; retains many self-care functions; generally has effective use of arms. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:5. OCBs in CSF:positive. Name of co-morbidity:Asthma. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on January 04, 2012. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 PPD. Coffee cups per week: 14. Alcohol drinsk per week: 1. Vit D at visit: 95.0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.5 sec. 9-hole peg non-dominant:19.42 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:10. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 11. The 25-foot walk done. Assistance required for 25-foot walk test: Rollator. 25-foot walk test time was 18.4 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.73 sec. 9-hole peg non-dominant:18.35 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.64. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 43 months?",
        "output":"After 43 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.77. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on May 17, 2021. Tobacco smoker: ex-smoker  Anti-MOG Abs seropositivity: Negative. Anti-MOG Abs denominator titer: 1:10. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 99. Cervical spine MRI date: May 16, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 2. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:21.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2013. Comments on DMT: Betaseron - Mabthera - Sandoglobulin. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 10, 2014. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The patient is in EDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation brainstem. OCBs in CSF:positive. IgG index in CSF:1.49. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:ocrevus - ocrelizumab on May 01, 2022. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 70. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Cervical spine MRI date: September 01, 2022. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 6 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:22 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, bowel\/bladder dysfunction. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT: aubagio- teriflunomide. Vit D at visit: 50.3. MRI of brain or spine done. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: May 09, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:19 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: November 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.01 sec. 9-hole peg non-dominant:22.94 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 15. Vit D at visit: 14.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:16.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 01, 2013. Tobacco smoker: current  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.05 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.71 sec. 9-hole peg non-dominant:15.67 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. Name of co-morbidity:Absence Seizures. Outcome:completely recovered from illness. Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.7 sec. 9-hole peg non-dominant:19.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:asthma. Outcome:completely recovered from illness. Name of co-morbidity:Keratoconus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. The 25-foot walk done. 25-foot walk test time was 3.51 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:17.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis, cerebellar. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2014. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.9 sec. 9-hole peg non-dominant:22.17 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2017. Vit D at visit: 60.0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:17 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. Vit D at visit: 8.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: June 13, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T1 lesions, gad-enhancing. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Both enhancing and non-enhancing lesions. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.88 sec. 9-hole peg non-dominant:26.38 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.62. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:43.5 sec. 9-hole peg non-dominant:20.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.3. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Comments on DMT: aubagio, rebif. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:18.7 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2012. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.5 ppd. The 25-foot walk done. 25-foot walk test time was 5.15 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.71 sec. 9-hole peg non-dominant:29.68 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on November 11, 2011. Comments on DMT: Avone 2009 Rebif(2009) Betaferon(2009-2010) Methotrexate(2009-2010) Tysabri(2010-2011). MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 17, 2012. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2011. Tobacco smoker: non-smoker  Vit D at visit: 63.1. MRI of brain or spine done. No new lesions on Brain MRI. SDMT done. SDMT numerator: 74. SDMT denominator: 74. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.45 sec. 9-hole peg non-dominant:22.91 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2015. Comments on DMT: Avonex, Betaferon. Tobacco smoker: non-smoker  Vit D at visit: 12.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.74 sec. 9-hole peg non-dominant:24.79 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2011. Comments on DMT: Avonex. Vit D at visit: 8.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 13, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.87 sec. 9-hole peg non-dominant:19 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 89 months?",
        "output":"After 89 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:22.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 2. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 33.4 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:19.37 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.64. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on December 01, 2016. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: August 01, 2019. Received Gadolinium for Cervical spine MRI. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 9.7 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.7 sec. 9-hole peg non-dominant:24 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2018. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. Exercise hrs per week:2. Vit D at visit: 36.7. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.4 sec. 9-hole peg non-dominant:18.5 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2012. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1\/2 PPD. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 10, 2015. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.09 sec. 9-hole peg non-dominant:29.82 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness.  Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2015. Tobacco smoker: ex-smoker  Exercise hrs per week:4. Vit D at visit: 62.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 21, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.4 sec. 9-hole peg non-dominant:23.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on December 02, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 09, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.8 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:19.3 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:abortion. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on June 18, 2015. Comments on DMT: Rebif. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:negative. IgG index in second:0.43. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2021. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 80. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.8 sec. 9-hole peg non-dominant:17.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:76.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Disk surgery. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Right ear congenital hearing loss. Outcome:ongoing illness. Name of co-morbidity:Tooth abscess + extraction. Outcome:completely recovered from illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total Left hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on April 05, 2012. Comments on DMT: rebif, atoricpet trial. The 25-foot walk done. 25-foot walk test time was 15.8 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.2 sec. 9-hole peg non-dominant:33.3 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. IgG index in CSF:0.98. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.8. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2016. Vit D at visit: 58.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.96 sec. SDMT done. SDMT numerator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.76 sec. 9-hole peg non-dominant:19.94 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on January 01, 2022. Vit D at visit: 40.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: April 01, 2022. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 2. Remarks about MRI: the cervical spine was compared to 2018. The 25-foot walk done. 25-foot walk test time was 7 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:40 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2002. MRI of brain or spine done. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 4.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:19.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Tonsillectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Varicocele. Outcome:completely recovered from illness. Visit diagnosis:cis. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.8 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:20.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2011. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 PPD. Coffee cups per week: 10. Alcohol drinsk per week: 4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. Visit diagnosis:spms. Total relapses until visit: 3. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. EDSS:8- essentially restricted to bed or chair or perambulated in wheelchair but out of bed most of day; retains many self-care functions; generally has effective use of arms. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on August 01, 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. Exercise hrs per week:2. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:22 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. There were new relapses since the previous visit. Comments on DMT: Rebif . MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 4. Cervical spine MRI date: June 30, 2014. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Both enhancing and non-enhancing lesions. Total T1 Gad-enhancing lesions in Cervical spine: 2. The 25-foot walk done. 25-foot walk test time was 4.23 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.34 sec. 9-hole peg non-dominant:29.66 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 21 months?",
        "output":"After 21 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Anti phospholipid syndrome. Outcome:ongoing illness. Name of co-morbidity:Familial Mediteranean Fever. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2013. Tobacco smoker: non-smoker  Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.1 sec. 9-hole peg non-dominant:35.78 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:1. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. Comments on DMT: Rebif. MRI of brain or spine done. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.86 sec. 9-hole peg non-dominant:20.5 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2017. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 47.0. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:mogad. Has not converted to SPMS. Initial presentation brainstem. OCBs in CSF:negative. Visit diagnosis:mog. Total relapses until visit: 1. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on September 06, 2022. Tobacco smoker: ex-smoker  Anti-MOG Abs seropositivity: Positive. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands.  9-hole peg dominant:41 sec. 9-hole peg non-dominant:28 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Visit diagnosis:rpms vs spms. Total relapses until visit: 2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 7.4 sec. SDMT done. SDMT numerator: 26. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.9 sec. 9-hole peg non-dominant:32.2 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Asthma. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on June 01, 2020. Comments on DMT: Rebif and Tysrabi. Clinical relapse. Tobacco smoker: current  Tobacco type: cigarette or cigar. Exercise hrs per week:8. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Rheumatoid arhritis. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: tysabri- natalizumab. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 23 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31.9 sec. 9-hole peg non-dominant:30.9 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on March 01, 2013. Vit D at visit: 93.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 21, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:19 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:avonex or cinnovex- im interferon on March 01, 2022. Comments on DMT: Betaferon d\/c due to unavailability. Tobacco smoker: current  Tobacco type: 20. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:23.5 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Visit diagnosis:rpms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on February 01, 2018. Comments on DMT: Mitoxantrone. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 26.6 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.2 sec. 9-hole peg non-dominant:19.89 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on October 22, 2018. Comments on DMT: rebif, tecfidera. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 68.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: November 19, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:15.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mavenclad- Cladribine. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2014. Vit D at visit: 52.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:17.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.93 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.14 sec. 9-hole peg non-dominant:19.97 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Plegridy (peginterferon beta 1-a). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female. . Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.84. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on March 01, 2019. Comments on DMT: Rebif, Avonex, Tysabri. Tobacco smoker: current  Tobacco type: water-pipe. Alcohol drinsk per week: 1. Exercise hrs per week:3. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 24. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27 sec. 9-hole peg non-dominant:31.3 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 5. There were new relapses since the previous visit. DMT taken. Current DMT:tysabri- natalizumab on June 01, 2013. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 45.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: October 27, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 2. Total T1 Gad-enhancing lesions in Cervical spine: 2. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Both enhancing and non-enhancing lesions. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 8.6 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, l'hermitte sign. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2022. Tobacco smoker: non-smoker  Coffee cups per week: 7. Exercise hrs per week:1. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: February 01, 2023. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 2. The 25-foot walk done. 25-foot walk test time was 4.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:20.6 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on July 28, 2018. Comments on DMT: Rebif. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 39 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28 sec. 9-hole peg non-dominant:27.66 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2018. Tobacco smoker: non-smoker  Vit D at visit: 33.0. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: March 18, 2019. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.53 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.4 sec. 9-hole peg non-dominant:18.7 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:6. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:BELL'S PALSY. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2012. Comments on DMT: Betaferon 2001-2003, Avonex 2003-2009, Rebif Apr 2010-2012, Cladribine Jan 2006-2009. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 6.4 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:23.7 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: mabthera- rituximab. Comments on DMT: Rebif. Vit D at visit: 55.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 14, 2017. The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34 sec. 9-hole peg non-dominant:33.5 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 28. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.97 sec. 9-hole peg non-dominant:21 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:breastfeeding . New DMT:Solumedrol- IV Methylprednisolone. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:negative. IgG index in second:0.46. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:anterior uveitis. Outcome:completely recovered from illness. Name of co-morbidity:iridocorneal adhesions. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Name of co-morbidity:Sciatica. Outcome:ongoing illness. Name of co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:prolactinemia 2ry to Tegretol. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Klebsiella pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:vestibular migraine. Total relapses until visit: 2. Tobacco smoker: non-smoker  Vit D at visit: 22.8. MRI of brain or spine done. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Visit diagnosis:ris. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.94 sec. SDMT done. SDMT numerator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.41 sec. 9-hole peg non-dominant:20.69 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. Name of co-morbidity:Absence Seizures. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2018. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2016. Comments on DMT: Rebif March 2015 until Feb 2016. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 61.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.7 sec. 9-hole peg non-dominant:26.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory, motor weakness, shoulder pain. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on August 01, 2017. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 35. Vit D at visit: 44.0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 25 months?",
        "output":"After 25 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. IgG index in CSF:0.98. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.8. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on September 01, 2017. Comments on DMT: Rebif. Vit D at visit: 51.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 14, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.8 sec. 9-hole peg non-dominant:17.46 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2019. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 99. Cervical spine MRI date: October 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 999. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 8. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.5 sec. 9-hole peg non-dominant:15.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:ocrevus - ocrelizumab on August 27, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1ppd. The 25-foot walk done. 25-foot walk test time was 6.62 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30 sec. 9-hole peg non-dominant:3 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    }
]